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Abstract 
 
The impending global pandemic of obesity, type 2 diabetes and vascular disease 
suggests an urgent need for both prevention strategies and effective treatment.  Of all 
the common ethnic groups South Asians, who make up a fifth of the world‟s 
population, have the highest prevalence of both diabetes and vascular disease.  The 
high rates of diabetes, in particular, occur with lower average adiposity levels, 
suggesting that South Asians are more susceptible to the effects of obesity.  
Differences in insulin sensitivity and diabetes prevalence between South Asians and 
Europeans cannot be fully explained by differences in adiposity alone.  The aim of 
this thesis was to investigate whether differences in oxidative capacity and capacity 
for fatty acid utilisation in South Asians might contribute, using a range of whole-
body and skeletal muscle measures. 
Twenty South Asian men and 20 age and BMI-matched white European men 
underwent exercise and metabolic testing and muscle biopsy to determine expression 
of oxidative and lipid metabolism genes and of insulin signalling proteins.  In fully 
adjusted analyses, South Asians, compared to Europeans, exhibited significantly 
reduced insulin sensitivity; lower VO2max and reduced fat oxidation during 
submaximal exercise at the same exercise intensities.  South Asians exhibited 
significantly higher skeletal muscle gene expression of CPT1A and FASN and 
significantly lower skeletal muscle protein expression of PI3K and PKB Ser473 
phosphorylation.  Fat oxidation during submaximal exercise and VO2max both 
correlated significantly with insulin sensitivity index and PKB Ser473 
phosphorylation, with VO2max or fat oxidation during exercise explaining 10–13% of   3 
the variance in insulin sensitivity index, independent of age, adiposity and physical 
activity. 
These data suggest that reduced oxidative capacity and capacity for fatty acid 
utilisation at the whole body level are key features of the insulin resistant phenotype 
observed in South Asians, but that this is not the consequence of reduced skeletal 
muscle expression of oxidative and lipid metabolism genes. 
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Chapter 1 
Introduction and Literature Review 
 
1.1 Epidemiology of cardiovascular disease and associated risk factors 
Cardiovascular disease (CVD), encompassing coronary heart disease (CHD) and 
cerebrovascular disease, is the leading cause of death in the UK, accounting for 
around a third of all deaths (Capewell et al, 2010).  Associated with this is the rising 
prevalence of obesity and type 2 diabetes, with the majority of the UK population 
now being overweight or obese, and an estimated diabetes prevalence of 4.3%, 
equating to 2.8 million people (diabetes.org.uk).  
 
1.2 Ethnic differences in cardiovascular risk. 
It is well recognised that risk of morbidity and mortality from CVD and type 2 
diabetes is influenced by ethnicity. In particular, groups of West African (such as 
African-Americans and Afro-Caribbeans), Hispanic and South Asian descent are at 
increased risk compared to populations of white European descent, but while these 
populations experience an increased risk of vascular and metabolic disease, the 
prevalence of specific risk factors for these conditions varies considerably between 
the groups.   
 
Afro-Caribbeans in the UK have an increased prevalence of diabetes, hypertension 
and stroke compared to their white European counterparts, but a more favourable lipid 
profile with higher HDL cholesterol and lower triglycerides (TG), and lower mortality 
from coronary heart disease (McKeigue et al. 1991).  Classical cardiovascular risk 
factor prevalence in the African-American population is similar to UK Afro-  19 
Caribbeans (and they have a similar paradoxically healthy lipid profile) but they 
experience higher rates of CHD than white North Americans, possibly due to an 
increased prevalence of obesity (Ogden et al. 2006; US Bureau of the Census 2000).
  
North American native Indians have a higher prevalence of diabetes, hypertension and 
obesity than white North Americans.  They have less healthy lipid profiles, with lower 
HDL cholesterol and higher triglyceride, and almost double the incidence of 
cardiovascular disease  (Anand et al. 2001; Howard et al.1999). 
 
1.3 Cardiovascular risk in South Asian populations                                                      
South Asians (comprising people from India, Pakistan, Sri Lanka and Bangladesh) 
constitute 20% of the world‟s population and 4% of the UK population (Office for 
National Statistics 2003).  Of the common ethnic groups, they have the highest risk of 
cardiovascular disease and diabetes (Lee et al. 2001; McKeigue et al.1993), so 
provide an ideal model to study the interactions between ethnicity and metabolic and 
vascular disease risk.   
South Asians were one of the first ethnic groups recognized to have higher risk for 
cardiovascular disease.  Over 50 years ago, migrant Asian Indian males in Singapore 
were reported to have seven times the prevalence of cardiovascular disease of Chinese 
men, in a large series of autopsies (Danaraj et al. 1959).  The increased risk of 
myocardial infarction and cardiovascular death in South Asians has since been 
confirmed by a number of reports indicating that migrant South Asian populations in 
the UK, Singapore, Fiji, South Africa, Trinidad and North America have greater risk 
of cardiovascular disease than other populations in these countries (Enas et al. 1996; 
Grundy et al. 2005; McKeigue et al 1993; McKeigue et al. 1991; Wild & McKeigue 
1997).  More recently, the Interheart study, a global case control study (encompassing   20 
52 countries) found that myocardial infarction occurs on average 10 years earlier in 
South Asians than in white populations (Yusuf et al. 2004) and South Asians have 
also been found to require treatment of heart failure at a significantly younger age 
than European Whites (Singh & Bhattarai 2003).  
South Asian men and women in the UK experience approximately 50% higher age-
standardised CHD mortality than European whites (Wild & McKeigue 1997) and the 
CHD mortality in young South Asian men (aged less than 40) is over double that of 
Europeans (Balarajan et al. 1984; McKeigue et al. 1993)  Furthermore, a narrower sex 
difference in CHD risk between men and women is observed in South Asians, such 
that South Asian women may have a particularly elevated CHD risk: South Asian 
women in the UK experience proportionally greater risk than South Asian men, such 
that their CHD mortality rate is 46% greater than that of women in the general UK 
population, compared to 36% increased CHD mortality in South Asian men compared 
with men in the overall UK population (Balarajan et al. 1984; McKeigue et al. 1992).  
This finding is mirrored by the observed narrower sex-difference in HDL-cholesterol 
in South Asians in the United States (Chandalia et al. 2008).   
 
1.4 Excess insulin resistance and diabetes in South Asians  
The increased CHD mortality in the migrant South Asian population is not entirely 
explained by classical cardiovascular risk factors, such as cholesterol, blood pressure 
and smoking (Forouhi et al. 2006; McKeigue et al 1989; Miller et al. 1988; Miller et 
al.1989).  In fact South Asians living in the UK have, on average, a similar blood 
pressure to matched white Europeans (Agyemang et al. 2007) and a lower rate of 
cigarette smoking, although there are subgroup differences such as Bangladeshis   21 
tending to have high rates of smoking.  However, there is some evidence that 
increased insulin resistance, and its consequent effects, play a central role in the 
increased CHD risk seen in South Asians.  The Southall study (McKeigue et al. 1991) 
was the first large cross-sectional study to compare metabolic variables and 
anthropometric data from Indian and Pakistani subjects with that from age and BMI-
matched white European subjects.  This confirmed that Asians have a higher 
prevalence of diabetes (19% versus 4%), and allied to this they also had 
hyperinsulinaemia (both fasting and following an oral glucose load), central obesity 
(as measured by waist-hip ratio), hypertension and a dyslipidaemia characterised by 
higher triglyceride and lower HDL-cholesterol concentrations, but interestingly, not 
higher total cholesterol concentrations (although migrant South Asians have been 
found to have significantly higher total cholesterol concentrations than those of South 
Asians living in India (Bhatnagar et al. 1995)).   
 
The Southall study also found comparable LDL-cholesterol levels in South Asians 
and white Europeans, but South Asians have subsequently been found to have more 
small LDL particles, which are more atherogenic than large LDL particles (Kulkarni 
et al. 1999).  Even more recently South Asians have also been found to have more 
small HDL particles (Bhalodkar et al. 2004), which may also be related to increased 
CHD risk, as opposed to large HDL particles, which are thought to be protective.   
 
Additional studies have shown that even after adjustment for BMI, waist-hip-ratio, 
and skin fold thickness, insulin concentrations (both fasting and post glucose-load) 
remain significantly higher in South Asians
 (Davey G.J.G et al. 2000; Forouhi et al. 
1999), and further studies comparing South Asians with European whites matched for   22 
total body fat (measured by hydrodensitometry) revealed increased insulin resistance 
in the South Asians (Chandalia et al. 1999).  Thus greater insulin resistance is not 
simply due to excess adiposity.  Since the publication of the Southall study findings, 
there have been many further reports verifying its findings of greatly increased 
prevalence of type 2 diabetes in migrant South Asian populations (Chandalia et al. 
1999; Hughes et al. 1989; Knight et al. 1992; Laws et al. 1994; McKeigue et al 1991) 
and this is likely to be a key factor mediating their increased cardiovascular disease 
risk.   
 
The mean age of diabetes onset is over 10 years younger in both migrant South 
Asians and in those living in India compared to white Europeans (Mukhopadhyay et 
al. 2006; Ramachandran et al. 2002) and South Asians develop diabetes and metabolic 
disturbances associated with insulin resistance at lower BMIs than Europeans.  Data 
from the SHARE study (Razak et al. 2007) (Study of Health Assessment and Risk in 
Ethnic groups) indicates that South Asians living in Canada with a BMI of only 21 
kg.m
-2 experience an equivalent risk of diabetes to white Canadians with a BMI of 30 
kg.m
-2.  (i.e. a 25.5 kg difference in body mass for somebody 170 cm tall).  Thus South 
Asians are likely to experience exponential increases in diabetes risk with increasing 
adiposity at much lower BMI values than those from white European backgrounds.  
This concept is illustrated in Figure 1.1. 
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Figure 1.1 BMI and diabetes risk in South Asian and white populations.           
Diabetes risk for South Asian populations with increasing BMI is shifted to the left by 
9kg.m
-2.  Data for white populations are based on mean values from (Colditz et al. 
1995; Venkataraman et al. 2004). Data for South Asians are based on findings of the 
SHARE study (Razak, Anand, Shannon, Vuksan, Davis, Jacobs, Teo, McQueen, & 
Yusuf 2007). 
 
In addition, South Asians with type 2 diabetes also experience increased incidence of 
microvascular complications, such as diabetic retinopathy and nephropathy, even after 
adjustment for glycaemic control (Burden et al. 1992; Mather et al 1998).  The 
reasons for this are, as yet, unclear but may include higher triglyceride levels, which 
have been linked to greater microvascular complications. 
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1.5 When do metabolic and vascular differences manifest? 
In some (Yajnik et al. 2002; Yajnik et al. 2003) but not all (Simmons 1994) reports, 
lower birth weights, increased adiposity, hyperinsulinaemia and high triglycerides 
have been observed in South Asian neonates compared with European babies.  These 
findings, if corroborated in larger studies, suggest that the insulin resistant phenotype 
with high body fat observed in South Asians is evident form a very young age and, 
thus, at least in part, reflects some combination of genetic and/ or “early origins” 
(thrifty phenotype) effect.  There is conflicting evidence regarding the generational 
effect on birth weight.  One small study found that babies born to second generation 
migrant Indians living in the UK were larger than those born to first generation Asian 
women (Dhawan 1995), but two subsequent larger studies have shown that low birth 
weight persists in the second generation (Draper et al. 1995; Margetts et al. 2002).  
The extent to which generational birth weight differences might influence diabetes 
and CHD risk in early versus later generation South Asian migrants is not yet known.  
Such data might help to disentangle the relative importance of thrifty phenotype 
effects in mediating South Asians‟ increased cardiometabolic risk.    
 
In a cross-sectional comparison of children aged 8-11 years living in the UK, it was 
reported that those of South Asian origin had higher fasting and post-glucose insulin 
concentrations than children of European origin (despite similar waist and hip 
circumferences and lower ponderal indices) and a steeper rate of increase in insulin 
concentrations with increasing adiposity (Whincup et al. 2002).  Similarly, 13-16 
year-old British South Asian children had higher fasting glucose and insulin 
concentrations and HOMA-estimated insulin resistance than European boys, even 
after adjustment for differences in adiposity (Whincup et al. 2005).  In another report   25 
based on data from the 1999 Health Survey for England, Indian and Pakistani boys 
had an increased risk of being overweight and Pakistani girls had an increased risk of 
being obese compared to the general population (Saxena et al. 2004).  Postpubertal 
Asian Indian children living in urban India have also been found to have a high 
prevalence of insulin resistance, associated with increased central adiposity (Misra et 
al. 2004).        
 
Thus, the combined effect of greater insulin resistance for a given adiposity level in 
South Asians allied to greater levels of obesity in this ethnic group, which is 
increasing at a rapid rate in children (Reilly & Dorosty 1999), suggests this group is in 
greater need of interventions to reduce risk of metabolic diseases.  Such interventions 
may also need to start before adulthood to maximise potential efficacy.  Indeed, there 
is emerging evidence of cases of type 2 diabetes in obese South Asian (more so than 
European) children living in the UK (Drake et al. 2002; Ehtisham et al. 2000), 
mirroring the observations in the US in certain populations at increased risk of type 2 
diabetes, such as Hispanic Americans and Pima Indians, where the prevalence of type 
2 diabetes in the 10-14 age group is estimated to be 22.3 per 1,000 (Fagot-Campagna 
et al. 2000).   
 
In early adulthood clinical manifestations of insulin resistance, for example polycystic 
ovarian syndrome (PCOS) in women, begin to present.  South Asian women with 
PCOS present at a younger age than European white women, and with more severe 
clinical signs of insulin resistance, such as hirsutism, acne, acanthosis nigricans and 
infertility (Wijeyaratne et al. 2002). 
   26 
At this early stage in life, South Asians also exhibit various signs of vascular 
endothelial dysfunction, and increased arterial stiffness, which is a predictor of 
cardiovascular events.  Several small studies have demonstrated ethnic differences in 
endothelial function, including a study which reported reduced flow-mediated 
brachial artery vasodilation (Chambers et al. 1999) in young South Asians aged in 
their 20s to early 30s compared to matched Europeans, a study which found increased 
augmentation index , which is a non-invasive measure of arterial stiffness, in young 
South Asians (Din et al. 2006) and a further study which demonstrated reduced 
maximum vasodilatory response to the beta-2 agonist isoproterenol (Kapoor et al. 
1996).   
 
More recently, a larger study comparing non-diabetic US South Asians and Whites, 
with mean age 35, showed impaired vasodilatory response to sublingual nitroglycerin 
and following brachial artery occlusion during hyperinsulinaemic euglycaemic clamp 
in the South Asian group; a finding which correlated with degree of insulin resistance.  
Further evidence of endothelial dysfunction  was demonstrated by another study 
which found a reduction in the number and impaired function of circulating 
endothelial progenitor cells (which repair damaged endothelium) in non-diabetic UK 
South Asians compared to Whites, with a mean age of 26 (Murphy et al. 2007).  
   
These signs of endothelial dysfunction are accompanied by higher inflammatory (e.g. 
CRP, homocysteine) and thrombotic (lipoprotein a, PAI-1, fibrinogen) markers, and 
lower adiponectin levels (Anand et al. 2000; Forouhi et al. 2001; Valsamakis et al 
2003), all factors associated with higher risk of type 2 diabetes in South Asians.    27 
However, whether any of these parameters/ pathways is causally linked to excess 
diabetes risk remains uncertain. 
 
1.6 Potential mechanisms for increased insulin resistance in South Asians 
1.6.1 Genetic factors 
The mechanisms underlying differences in the metabolism of South Asians leading to 
increased insulin resistance and risk of diabetes and CHD have not been fully 
elucidated.  It is possible that in evolutionary terms, a survival advantage was 
conferred to populations most at risk of famine and/or infectious diseases, by the 
ability to store visceral fat when food sources were scarce and sporadic, as postulated 
by Neel‟s “thrifty genotype” hypothesis (Neel 1962).  Of the three fat compartments 
visceral fat is most easily mobilized so could have acted as a rapid supply of energy 
for the immune system when required.  The pro-inflammatory cytokines produced by 
adipose tissue may have been beneficial in the context of, for example, chronic 
infection with parasites or other pathogens, and could have increased the likelihood of 
survival throughout childhood in the context of the threat of severe infection.   These 
so-called “thrifty genes” and the storing of visceral adipose tissue have now become 
disadvantageous to populations who live in a sedentary state with abundant food 
supplies. 
 
In support of the thrifty genotype hypothesis, South Asians have been found to have a 
higher prevalence of some genetic defects of insulin signaling, compared to white 
Europeans.  Several polymorphisms of the ectonucleotide pyrophosphatase 
phosphodiesterase 1 (ENPP1) gene, which increase insulin resistance (Abate et al. 
2003; Bacci et al. 2005) are found more frequently in South Asians.  The K121Q   28 
polymorphism has been found to inhibit the insulin receptor in vitro, and is 
significantly associated with measures of insulin resistance (higher insulin AUC 
during oral glucose tolerance test, lower insulin sensitivity during hyperinsulinaemic 
euglycaemic clamp in vivo (Abate et al. 2003)).   
 
In addition, certain polymorphisms of the peroxisome proliferator-activated receptor 
(PPAR)-γ gene are thought to confer protection against type 2 diabetes (Altshuler et 
al. 2000; Deeb et al. 1998; Hara et al. 2000), but a study examining the effect of this 
genetic variance in South Asians, showed a lack of this protective effect, which is 
evident in European white populations, despite similar prevalence of the 
polymorphism in the two groups (Radha et al. 2006).  Certain variants of the 
transcription factor 7-like 2 gene (TCF7L2) have also been found to be major 
determinants of type 2 diabetes risk in South Asians and in European white 
populations, but it remains unclear whether there are differences in prevalence of 
these gene variants between ethnic groups (Humphries et al. 2006). 
 
1.6.2 Maternal and intra-uterine factors 
An alternative and complementary hypothesis is the “early origins” or “thrifty 
phenotype” hypothesis, which proposes that metabolic disturbances in utero, which 
often manifest in small birth size, can lead to predisposition to CHD, type 2 diabetes 
and other metabolic disorders in later life.  This was based on the observation that low 
birth weight increases risk of impaired glucose tolerance, type 2 diabetes and CHD in 
adulthood (Hales et al. 1991).  The most common form of the hypothesis postulates 
that poor maternal nutrition or impairments in maternal metabolism result in fetal 
undernutrition, leading to a programmed tendency towards nutritional thrift,   29 
combined with impaired fetal pancreatic β cell growth, and when these factors are 
combined with accelerated growth and weight gain in childhood, result in 
disturbances to glucose-insulin metabolism, a tendency towards adverse patterns of 
fat storage (i.e. in visceral compartments) and increased risk of diabetes (Hales & 
Barker 1992), particularly when food supplies are abundant and physical activity 
levels are low (Laaksonen et al. 2003).   
 
While both the thrifty genotype and thrifty phenotype hypotheses can help explain 
why moving from less to more obesogenic environments lead to increased risk of 
CHD and diabetes, it is not immediately clear why certain ethnic populations are more 
affected by insulin resistance and diabetes than others, as all populations have been 
subject to fairly similar changes in environment over the past few centuries.  One 
possibility is that historically white European populations moved away from 
agriculture and became “urbanised” much earlier, so their genes adapted to this 
change in lifestyle, while South Asians and other ethnic populations maintained 
agricultural, rural lifestyles for longer, and have only recently begun to move towards 
urbanisation.  There could also, conceivably be interactions between genes and 
climate or prevalence of environmental pathogens, which may have provided 
selection advantages for a thrifty genotype for longer in South Asia than in Europe.   
 
It is possible that the “thrifty phenotype” particularly affects South Asians, as many 
have recently undergone a transition from „traditional‟ to „westernised‟ environments, 
such that first generation migrant South Asian mothers (or mothers who have moved 
from rural to urban environments) are likely to be thin and undernourished 
antenatally, but their children will have grown up in a “westernised” urban   30 
environment, where they will have been more likely to experience accelerated growth 
during childhood and consequent increased adiposity and insulin resistance.  A 
“thrifty phenotype” effect could conceivably then persist in the subsequent generation 
as maternal insulin resistance and obesity can also have “programming” effects on the 
fetus leading to increased risk of obesity and metabolic disease later in life (Hales et 
al. 1991), but the size of this effect may diminish as increasing numbers of 
generations are exposed to Westernised lifestyles.  Data indicating lower birthweights 
in South Asian compared to European babies (Yajnik et al. 2002; Yajnik et al. 2003) 
and an increase in birthweights between the offspring of first and second generation 
Indian migrants to the UK (Dhawan 1995) would be consistent with a thrifty 
phenotype effect, but examination of birthweights and future metabolic disease risk in 
future generations of migrant South Asians is probably necessary before any final 
conclusions about the effect of the “thrifty phenotype” can be drawn.   
       
1.6.3 Mitochondrial efficiency? 
A further, recent hypothesis attempting to explain the tendency of South Asians to 
develop central obesity and its metabolic consequences,  is the “mitochondrial 
efficiency hypothesis” (Bhopal & Rafnsson 2009).  This theory postulates that genetic 
mutations of mitochondrial uncoupling protein genes (in response to climactic, 
nutritional and infectious triggers) have resulted in South Asians having a higher 
capacity to generate ATP, a chemical energy source, which allows energy within cells 
to be stored and released as required for metabolism.  This is thought to be a 
consequence of the more efficient conversion, of dietary calories to ATP, rather than 
heat, by “tightly coupled” mitochondria (i.e. mitochondria which will generate the 
maximum amount of ATP and the minimum amount of heat per calorie), through   31 
oxidative phosphorylation.  This hypothesis was based, however on one small study 
by Nair et al (Nair et al. 2008), who reported that middle-aged, non-diabetic Asian 
Indian men had increased skeletal muscle expression of genes involved with oxidative 
phosphorylation and the citrate cycle and increased capacity for mitochondrial ATP 
production than age, gender, and BMI matched Northern European Americans, 
despite being more insulin resistant.  The investigators concluded that mitochondrial 
dysfunction could not account for the South Asians‟ greater insulin resistance, and 
further, that their results suggested increased mitochondrial efficiency in South 
Asians.   
 
This finding is somewhat controversial, and does not tell the whole story.  In contrast 
to this data suggesting increased mitochondrial efficiency, existing evidence indicates 
that skeletal muscle oxidative capacity is characteristically reduced in insulin 
resistance and obesity (He et al. 2001; Kelley & Simoneau 1994; Simoneau et al. 
1999).  Evidence also suggests that there is no difference in basal metabolic rate 
(when adjusted for fat-free mass) between South Asians and Europeans (Soares et al. 
1998).  It is not known whether capacity for lipid oxidation is reduced in South Asians 
compared to Europeans, or whether these factors contribute to South Asians‟ 
increased insulin resistance, and as the study by Nair et al was small, further studies 
looking at ethnic differences in mitochondrial enzymes, uncoupling proteins and 
skeletal muscle lipid oxidation are required. 
1.6.4 Epigenetics                                                                                                                  
In addition to these potential genetic and “early origins” effects, it is possible that 
epigenetic differences between South Asians and other populations could contribute 
to their increased metabolic disease risk.  A “thrifty epigenotype” hypothesis has, in   32 
fact, recently been proposed, which suggests that epigenetic changes rather than DNA 
sequence polymorphisms explain most of the heritability of obesity and type 2 
diabetes (Stoger 2008).  Epigenetic effects describe heritable changes in gene 
expression, and thus function, which are stable over rounds of cell division, but which 
do not involve changes in the underlying DNA sequence, so can occur over shorter 
periods of time than gene-mutations (Bird 2002).  These changes can result from 
environmental stimuli and are, for example, seen in the effects of diet on chronic 
disease (Issa 2000).  Epigenetic changes, perhaps resulting from a change in diet or 
climate, may have a role to play in the metabolic differences which have developed in 
South Asian populations over, what is in evolutionary terms, an apparently short time-
frame.  This is an area which has not yet been investigated in South Asians and 
clearly warrants further study.           
1.6.5 Disorders of insulin secretion 
It is also worth considering additional rare causes of diabetes in South Asians which 
may manifest as type 2 diabetes, but which, in fact, result from impaired insulin 
secretion.  These potential causes of diabetes have not been described in South 
Asians.  They include monogenic diabetes, particularly MODY3, caused by hepatic 
nuclear factor (HNF) 1α mutations, which usually results in onset of diabetes in 
adolescence or early twenties, and latent autoimmune diabetes (LADA), which 
presents sub-acutely without ketoacidosis.  A recent study examined 96 young 
patients in Lucknow, India, who had been diagnosed with “type 2” diabetes before the 
age of 30 (Sahu et al. 2007).  They found that these young patients were markedly 
heterogeneous, with only 60% being overweight or obese, but despite this a low 
frequency of defects resulting in impaired insulin secretion was observed.  HNF 1α 
mutations were only discovered in 3% of a target sub-group tested and islet   33 
autoimmunity (assessed by glutamic acid decarboxylase and insulinoma antigen 2 
antibodies) was present in 3% of the total study population.  This study suggests that 
such defects are likely to represent a very small proportion of all Asians who are 
diagnosed as having type 2 diabetes.    
 
1.6.6 Migration and urbanisation 
The observed differences in insulin sensitivity between South Asians and white 
neonates and children suggest a constitutional or innate degree of insulin resistance 
which is likely to have a genetic and/ or “early origins” effect.  However it is also 
clear that environmental factors throughout life are important and postulated 
environmental causes, which may account for at least some of the increase in insulin 
resistance in South Asians, include urbanisation, diet and, perhaps in particular, lower 
levels of physical activity in this population.  It seems likely that there is a gene-
environment interaction, as South Asians seem to experience greater adverse 
consequences as a result of living in the same environment as white Europeans, for 
example, greater increases in insulin resistance with increasing obesity (Razak et al. 
2007; Whincup et al. 2002; Whincup et al. 2005). 
 
The prevalence of type 2 diabetes in urban India is around five times as high as that in 
rural areas (Ramachandran et al. 1992; Ramachandran et al. 1997) and this 
observation has been mirrored in Pakistan (Ramachandran et al. 2001; Shera et al. 
1999; Shera et al. 2007), Bangladesh (Abu et al. 1997) and Nepal (Singh & Bhattarai 
2003).  This could be related to the change from a traditional subsistence lifestyle 
involving physically active occupations with heavy manual labour in rural areas to 
sedentary jobs in the city, combined with increased income, more readily available   34 
food with high energy and fat content and better public transport (Ramachandran et al. 
1992; Ramachandran et al. 1999; Ramaiya et al. 1990).  Indeed, mean BMI in urban 
India is 22.3 kg.m
-2  (Ramachandran et al 1997), compared to 19.6 kg.m
-2 in rural 
India
  (Lubree et al. 2002; Ramachandran et al. 1992; Reddy 1999), a difference of 8 
kg in a person 170 cm tall, suggesting that decreased physical activity and/ or 
increased energy intake leading to increased adiposity is likely to be a key driver of 
the increase in type 2 diabetes associated with urbanisation in South Asia.  It is also 
known that when South Asians migrate further, to developed countries (i.e. Northern 
Europe, the United States and Australia/ New Zealand), they experience increased 
rates of diabetes compared to not only the white population, but also compared with 
their siblings and original communities in South Asia (Bhatnagar et al. 1995; 
Simmons et al. 1989) (see Figure 1.2).  Thus, urbanisation appears to have a 
disproportionately large adverse effect on diabetes risk in those of South Asian origin.   
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Figure 1.2 Diabetes prevalence in South Asian and white populations by country 
and area of residence.  Data for rural and urban India from (Razak, Anand, Shannon, 
Vuksan, Davis, Jacobs, Teo, McQueen, & Yusuf 2007); data for South Asians and 
whites in the UK from the Southall study (McKeigue, Shah, & Marmot 1991); data 
for South Asians in the USA from (Venkataraman, Nanda, Baweja, Parikh, & Bhatia 
2004) and data for whites in the USA from (Harris et al. 1998). 
 
1.6.7 Diet 
Globally, the consumption of dietary fat and sugar has increased dramatically over the 
last 20 years (Drewnowski & Popkin 1997; Popkin 2001) and studies looking at 
dietary intake in urban Asian Indians have found low intake of monounsaturated and 
polyunsaturated fatty acids (PUFA) and fibre, but high intake of saturated fats, 
carbohydrate and trans-fatty acids (largely related to the use of a hydrogenated oil 
called vanaspati, which is used to make ghee) (Misra et al. 2009).  Other reports show 
that over time, the dietary intake of migrant South Asians living in the United States 
changes to closely resemble that of the white American population (Raj et al. 1999), 
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but as their diets are no less healthy than those of white Americans, this in itself 
cannot explain why they are more insulin resistant than the background population.  
Diets of South Asians in the UK have been found to be generally healthier than that of 
the UK population as a whole, with lower total energy intakes, higher intakes of 
complex carbohydrate, vegetable fibre and PUFA (McKeigue et al. 1985; Miller et al. 
1988; Sevak et al. 1994).  Although UK South Asians‟ diets have been found to be 
low in n-3 PUFA, and to have a low n-3 to n-6 PUFA ratio (Lovegrove et al. 2004), 
an intervention trial examining the effect of supplementation of n-3 PUFA showed no 
improvement in insulin sensitivity in South Asians (Lovegrove et al. 2004).  Thus, 
there is no real evidence to suggest that less healthy eating habits can explain South 
Asians‟ disproportionately high insulin resistance and risk of diabetes. 
 
1.6.8 Physical activity 
Levels of physical activity have been found to be related to glycaemia, in UK South 
Asians (Gill et al. 2011) and in Australians (Dunstan et al. 2005), with strong 
independent associations found between sitting time and glucose concentrations 2 
hours post OGTT in South Asians (Gill et al. 2011), and associations between hours 
of television viewing and insulin resistance in Australians (Dunstan et al. 2005).  The 
latter study also demonstrated an inverse relationship between hours of physical 
activity per week and insulin resistance. 
 
Unfortunately, a number of studies have reported significantly lower physical activity 
levels in South Asians living in the UK, compared with the general population (Hayes 
et al 1994; Barnett et al. 2005; Dhawan & Bray 1997; Fischbacher et al. 2004; Hayes 
et al. 2002; Health Education Authority 2000). Notably the 2004 Health survey for   37 
England reported that Indians, Pakistanis and Bangladeshis are respectively 14%, 
30% and 45% less likely to meet the recommended target for physical activity than 
the general population. 
 
The reasons for this are unclear but some studies have shown that South Asian women 
in particular experience many barriers to increasing physical activity, including other 
illnesses, cultural norms and social expectations (Lawton et al. 2006).  Qualitative 
research has suggested that cultural attitudes to changes in lifestyle, particularly 
increasing exercise, can be difficult to overcome (Vyas et al. 2003), and that conflicts 
of interest may often exist, between the desire to exercise and fear of social 
disapproval (Grace et al. 2008). 
   
It should be noted that most of the published studies investigating ethnic differences 
in physical activity in adults have been reliant on self-report questionnaires, which are 
known to be of limited validity, reliability and sensitivity, compared to objective 
measures of physical activity (Shephard 2003).  In addition, in the context of different 
ethnic groups, the same questions may be subject to different cultural interpretations, 
which will also have an impact on the data obtained (Fischbacher et al. 2004).  Only 
one recent study has provided objective evidence, using accelerometers, that South 
Asian children aged 9-10 years old have lower levels of physical activity than white 
European children of the same age (Owen et al. 2009).  This finding requires 
confirmation in adults, with a view to examining the relationship between physical 
activity and insulin resistance, but it does seem to be the case that South Asians may 
adopt particularly sedentary lifestyles when they migrate to Westernised countries, 
which could exacerbate their underlying predisposition to insulin resistance.    38 
The Indian Diabetes Prevention Programme demonstrated that increasing physical 
activity can prevent type 2 diabetes in South Asians.  The lifestyle intervention used 
was modest, compared with those used in the US Diabetes Prevention Programme 
(Knowler et al. 2002) and in the Finnish Diabetes Prevention Study (Laaksonen et al. 
2005), and unlike the US and Finnish studies, did not produce any weight loss.  
Despite this, the investigators found that 30 minutes of brisk walking per day (with ~ 
60% adherence) reduced the incidence of diabetes by around 30% in Indian men and 
women with impaired glucose tolerance (Ramachandran et al. 2006).  Additional data 
from prospective cohort studies (Helmrich et al. 1991; Lynch et al. 1996) indicate that 
the benefits of increasing physical activity in reducing insulin resistance and risk of 
diabetes are likely to be most marked in groups who are most insulin resistant and 
most at risk of developing diabetes at baseline.  This evidence suggests that sedentary 
South Asians should increase their physical activity levels to reduce their diabetes 
risk.    
 
1.7 The role of adipose tissue in insulin resistance 
Increased adiposity and an adverse pattern of fat partitioning in South Asians is likely 
to play a key role in insulin resistance and development of the metabolic syndrome.  
Adipose tissue is now recognised to be an endocrine organ and not merely an inert 
storage depot for triglyceride.  It is exquisitely sensitive to the antilipolytic effect of 
insulin, a response which is blunted in insulin resistance, type 2 diabetes (Karpe & 
Tan 2005)
 and obesity
 (Coppack et al. 1992).  This impaired response to insulin, in 
combination with expanded fat mass, results in increased release of NEFA into the 
circulation, ultimately contributing to ectopic fat accumulation and in turn reduced   39 
muscle and liver glucose uptake and utilisation with resultant hyperglycaemia and 
hyperinsulinaemia (see Figure 1.3). 
 
 
Figure 1.3 Hypotheses attempting to explain the increased insulin resistance in 
South Asian populations 
 
It is now well accepted that abdominal adiposity is associated with insulin resistance 
and its associated cardiovascular consequences (Kissebah & Krakower 1994; 
Wajchenberg 2000).  The concept that different abdominal adipose tissue 
compartments differentially influence risk of insulin resistance and diabetes is an area 
of great current research interest.  For example there is evidence from several studies 
to suggest that visceral adipose tissue (VAT) in particular is implicated in insulin 
resistance and metabolic syndrome (particularly in hyperinsulinaemia and 
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dyslipidaemia) (Despres 1993; Thorne et al. 2002; Vohl et al. 2004), including a study 
which looked at surgical resection of visceral adipose tissue (omentectomy) in obese 
patients undergoing gastric banding (Thorne et al. 2002).  This latter study reported 
that, in comparison to patients who had gastric banding alone, those who had had 
visceral adipose tissue removed experienced similar weight loss but a 2 to 3-fold 
greater improvement in insulin sensitivity and fasting glucose levels.  In contrast, loss 
of subcutaneous adipose tissue via liposuction has been shown to have no metabolic 
effect (Klein et al. 2004). 
In contrast, recent research comparing body fat distribution and insulin resistance in 
South Asians with that in white North Americans found insulin resistance (assessed 
by hyperinsulinaemic euglycaemic clamp) to be associated with increased total body 
fat and subcutaneous abdominal fat, and also with increased adipocyte size in the 
South Asian group, but investigators found no difference in intra-peritoneal fat (VAT) 
between the two groups (Chandalia et al. 2007).  This intriguing finding suggests that, 
at least in the South Asian population, visceral adipose tissue may not be the clear 
culprit linked to greater insulin resistance, but rather excess subcutaneous adipose 
tissue, and is consistent with prior studies which report deep subcutaneous adipose 
tissue to be particularly detrimental to insulin sensitivity (Kelley et al. 2000; Misra et 
al. 1997).   
The finding of similar quantities of visceral adipose tissue in the two populations may 
also suggest a problem with adipose tissue functionality rather than quantity in South 
Asians.  Chandalia et al reported that abdominal subcutaneous adipocytes were larger 
in South Asians, compared to men of white European descent and that these larger, 
perhaps dysfunctional adipocytes released less adiponectin and more NEFAs   41 
(Chandalia et al. 2007) in to the circulation.  This finding has recently been 
corroborated by Anand and colleagues (Anand et al 2011), who found that adjustment 
for adipocyte size ameliorated differences in insulin sensitivity between a larger 
groups of South Asians (n = 56) and Europeans (n = 52) accross a range of BMIs.  
Further evidence of dysfunctional adipose tissue exists in the literature, with 2 studies 
having found large adipocytes to be predictive of insulin resistance and type 2 
diabetes independent of total adiposity
 (Drolet et al. 2008; Weyer et al. 2000).  The 
recent observation that South Asians with normal BMI have higher levels of NEFA 
and leptin, lower levels of adiponectin and impaired suppression of NEFA during an 
oral glucose tolerance test, compared with European whites matched for total fat mass 
(Abate et al. 2004), also supports the hypothesis of dysfunctional, insulin resistant 
adipose tissue.      
It has also been suggested that deep compartments of subcutaneous adipose tissue 
may contribute more to insulin resistance than more superficial subcutaneous adipose 
tissue compartments.  Indeed, a recent report proposed the “adipose tissue overflow 
hypothesis” (Sniderman et al. 2007) as an explanation for increased insulin resistance 
in South Asians.  Its authors suggested that adipose tissue is divided into primary and 
secondary compartments, based on sequence of development, the primary 
compartment being superficial subcutaneous adipose tissue and the secondary 
compartment comprising deep subcutaneous adipose tissue and visceral adipose 
tissue, which are related to dyslipidaemia and insulin resistance.  With surplus energy 
intake the primary compartment becomes “full” and secondary compartments develop 
and expand, giving rise to their associated adverse metabolic consequences.  They 
hypothesised that South Asians have smaller primary compartments than white 
Europeans and that therefore a more rapid deposition of fat occurs into “adverse” fat   42 
compartments.  This hypothesis would be consistent with a more rapid onset of 
dyslipidaemia and insulin resistance in South Asians at lower BMI and lower total 
percentage body fat.  Clearly, this hypothesis requires more formal testing. 
A further possibility is that South Asians may have a relatively smaller proportion of 
brown adipose tissue making up total fat mass than Europeans.  This type of fat is 
now known to persist beyond the neonatal period and to generate heat from dietary 
energy, thus is responsible for some contribution toward glucose disposal (Cannon & 
Nedergaard).  There have been no studies investigating brown adipose tissue in South 
Asians, or indeed in any ethnic population.   
Adipose tissue is also responsible for the production and release of hormones 
adiponectin, visfatin, leptin, resistin and active cortisol (via the enzyme 11-β-
hydroxysteroid dehydrogenase type 1) as well as the pro-inflammatory cytokines 
tumour necrosis factor-α (TNF α), interleukin 6 (IL-6), the anti-inflammatory 
cytokine adiponectin (which correlates to insulin sensitivity) (Yamauchi et al. 2002), 
and the pro-coagulant factors plasminogen activator inhibitor-1 (PAI-1) and tissue 
plasminogen activator (t-PA).  The inflammatory response is reflected by high 
sensitivity CRP, which has been shown to predict cardiovascular events (Ridker et al. 
1998).  
Studies looking at these risk markers in South Asian populations have found higher 
levels of high sensitivity CRP (Chambers et al. 2001; Forouhi et al. 2001) , IL-6 
(Petersen et al. 2006), t-PA (Forouhi et al. 2003) leptin (Kalhan et al. 2001; Yajnik et 
al. 2002) and PAI-1 (Anand et al. 2000; Kain et al. 2001), together with significantly 
lower adiponectin levels (Mohan et al. 2005; Ryo et al. 2004; Snehalatha et al. 2003) 
compared with white populations.  Many of these differences have been found to   43 
persist after adjustment for total or abdominal fat mass (Abate et al. 2004; Chandalia 
et al. 2007).  Low adiponectin concentrations and increased leptin, IL-6 and TNF 
concentrations are associated with an increased risk of type 2 diabetes (Hu et al. 2004; 
Li et al. 2009; Wannamethee et al. 2007) and these markers are mechanistically 
implicated in insulin resistance.  It is, therefore possible that differences in adipose 
tissue function which result in dysregulation of adipokines within adipose tissue, 
independently of adipose tissue mass, contribute to the altered adipokine profile and 
greater insulin resistance observed on South Asians.  Further investigation of gene 
and protein expression of adipokines within adipose tissue in South Asians is required 
to test this hypothesis. 
 
Homocysteine, lipoprotein (a) and fibrinogen, which are novel risk factors for insulin 
resistance and vascular disease, are also reported to be elevated in South Asians 
(Bhatnagar et al. 1995; Chambers & Kooner 2001).   
 
Whilst all these differences are of interest, it should be appreciated that there are 
currently no prospective studies which determine to what extent (if any) these risk 
factor perturbances explain excess diabetes or vascular risk in South Asians.   
Moreover, it is entirely possible that such differences, and excess risk of metabolic 
diseases in South Asians, may be largely accounted for by differences in fat location 
and reduced physical activity.  On the other hand it is possible, that differences in 
adipose tissue function which result in dysregulation of adipokines within adipose 
tissue, independently of adipose tissue mass, contribute to the altered adipokine 
profile and greater insulin resistance observed on South Asians.  Further investigation 
of gene and protein expression of adipokines within adipose tissue in South Asians is   44 
required to test this hypothesis, as are future prospective studies with better baseline 
phenotyping to better disentangle independent risk factors for incident diabetes and 
vascular events. 
     
 1.8 The role of skeletal muscle in insulin resistance 
Skeletal muscle is responsible for 75% of all insulin stimulated glucose uptake, and 
most of this glucose (i.e. that which is not oxidized) is directed towards glycogen 
synthesis.  Defects in muscle intracellular glucose transport are, therefore, a key 
determinant of whole-body insulin resistance (Petersen & Shulman 2002).  A relative 
oversupply of lipid to skeletal muscle due to increased fatty acid delivery or decreased 
fatty acid oxidation may precipitate insulin resistance in muscle by inducing an 
accumulation of intramyocellular lipid: triglyceride (IMTG) and the fatty acid 
metabolites, long-chain acyl-CoA (LCACoA), diacylglycerol (DAG) and ceramide 
(Goodpaster & Brown 2005).  Studies have shown that infusion of lipid induces acute 
insulin resistance in muscle, probably due to increased DAG mass and PKC activity 
(Itani et al. 2002) and it is known that type 2 diabetes and insulin-resistant states are 
associated with chronically elevated circulating levels of NEFA.   
 
While previous studies  have reported a correlation between intramyocellular 
triglyceride (IMTG) and insulin resistance (Krssak et al. 1999, Pan et al. 1997), it is 
now not thought to be a causal factor, and at least one study (which examined IMTG 
in South Asians) has shown no correlation between IMTG and insulin resistance 
(Forouhi et al. 1999).  IMTG is known to be increased in athletes (Goodpaster et al. 
2001) and has also been found to increase by over 50% in response to acute exercise, 
an effect which is accompanied by improved insulin sensitivity and reductions in   45 
intramyocellular ceramide and DAG (Schenk & Horowitz 2007) suggesting separate 
mechanisms for IMTG accretion in athletes and insulin resistant states.  More 
recently, beneficial metabolic changes in skeletal muscle have been found to occur in 
response to chronic exercise in obese older adults, also accompanied by increases in 
IMTG, glycogen storage, capillary density and percentage of type 1 oxidative muscle 
fibers (Dube et al. 2008).   
 
There is some recent evidence that the relationship between IMTG and insulin 
resistance may be specific to muscle fibre type, with one study reporting greater 
IMTG content in type 1, but not type 2 myocytes in insulin resistance, associated with 
a lower proportion of type 1 myocytes (Coen et al. 2010).  No studies to date have 
investigated differences in skeletal muscle fibre type between South Asians and 
Europeans.     
 
Pattern of distribution of lipid within muscle could also be a determinant of skeletal 
muscle insulin sensitivity, however at least one study found similar patterns of IMCL 
storage in patients with type 2 diabetes, normoglycaemic controls and trained 
endurance athletes (van Loon et al. 2004)    
 
It is, therefore thought that in obesity and insulin resistance, excessive fatty acid 
delivery leads to an adverse pattern of fat partitioning in myocytes, with more fatty 
acids being directed towards a build-up of DAG, ceramide and LCACoA, and less 
towards stable triglyceride (Horowitz 2007). 
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The insulin signalling pathway in normal skeletal muscle is illustrated in Figure 1.4.  
When excess LCACoA, DAG and ceramide are present, they have been proposed to 
inhibit insulin action through the activation of protein kinase C (PKC) and c-Jun-
terminal kinase (JNK) which inhibit insulin receptor (IR) tyrosine kinase activity, 
tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1), and protein kinase B 
(PKB) activity (Hegarty et al. 2003; Schmitz-Peiffer 2000).  In addition, PKC inhibits 
insulin-stimulated phosphatidylinositol 3 kinase (PI3K) activity and may also result in 
oxidative stress through activation of the IKK/ NFK-β pathway (which is a pro-
inflammatory pathway) (Itani et al.. 2002). 
 
 
 
Figure 1.4 The insulin signalling pathway in skeletal muscle 
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Altered insulin signalling at various stages in the insulin signalling pathway has been 
described in patients with type 2 diabetes, obesity, PCOS and other insulin resistant 
states, although defects which are absolutely characteristic of insulin resistance have 
yet to be described, as there are a large number of studies with apparently 
contradictory findings.  IRS-1 expression has been found to be both reduced 
(Brozinick et al. 2003; Stentz & Kitabchi 2007) and unchanged (Hammarstedt et al. 
2003; Krook et al. 2000; Rajkhowa et al. 2009) in insulin resistant states, and there are 
also conflicting results from studies examining the expression of p85, the regulatory 
subunit of P13K, in insulin resistance (Adochio et al. 2009; Bandyopadhyay et al. 
2005; Barbour et al. 2005; Colomiere et al. 2009; Friedman et al. 1999; Hammarstedt 
et al. 2005b), and of PKB (Bandyopadhyay et al. 2005; Hojlund et al. 2008; Karlsson 
et al. 2005; Kim et al. 1999; Krook et al. 1998; Meyer et al. 2002).  This is clearly an 
area where further studies are required to resolve this issue.  To the best of the 
author‟s knowledge, there have been no previously published data comparing insulin 
signalling molecule expression in South Asians and Europeans, or indeed between 
any ethnic groups, so this is also an area which requires investigation.  
 
The sphingolipid ceramide was first implicated in insulin resistance in 1990, when its 
levels were found to be high in muscle of the obese Zucker rat (Turinsky et al. 1990).  
More recently the inhibition of ceramide synthesis has been found to markedly 
improve glucose tolerance and delay the onset of frank diabetes in these obese rats 
(Holland et al. 2007). 
 
There is some indirect evidence to suggest that these mechanisms may contribute to 
the insulin resistant phenotype of South Asians. For a given level of adiposity, South   48 
Asians exhibit higher circulating concentrations of NEFA than matched individuals of 
European descent (Abate et al. 2004) and fatty acid uptake into muscle, although 
regulated by fatty acid transporters such as fatty acid translocase (FAT/CD36), is 
largely dependent on circulating fatty acid concentrations (Bonen et al. 2004). In 
addition, one study found over 30% higher IMTG in South Asians compared with 
BMI-matched Europeans, although intra-muscular concentrations of fatty acid 
intermediates were not specifically quantified in this study (Forouhi et al. 1999). 
 
It is hypothesised that the accumulation of fatty acid intermediates in insulin resistant 
skeletal muscle is not only due to lipid oversupply (as a result of high circulating 
levels of NEFA) but is also a consequence of impaired fatty acid oxidation by skeletal 
muscle.  There is an increasing body of evidence to suggest that impaired skeletal 
muscle oxidation of fatty acids, represented by reduced mitochondrial enzyme activity 
(e.g. citrate synthase and β-hydroxoacyl CoA dehydrogenase) is strongly associated 
with insulin resistance (Bruce et al. 2003).  In addition activity of the mitochondrial 
enzyme carnitine palmityltransferase (CPT I), the rate-limiting enzyme for entry of 
long-chain acyl-CoA (LCACoA) into mitochondria, is reduced in insulin resistant 
muscle (Kim et al. 2000; Simoneau et al. 1999). Furthermore, expression of skeletal 
muscle acetyl-CoA carboxylase β (ACC β) – which regulates fatty acid oxidation by 
catalysing the carboxylation of acetyl CoA to form malonyl CoA, which in turn 
inhibits CPT 1 (Ruderman et al. 1999) – is reduced following weight loss in obese 
subjects and these reductions correlate strongly with reductions in fasting insulin 
concentrations (Rosa et al. 2003).  
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Exercise tests can provide a number of indices of in vivo skeletal muscle and whole 
body oxidative capacity.  It has been reported that maximal oxygen uptake, or VO2 
max (i.e. a measure of whole-body oxidative capacity, which correlates strongly with 
skeletal muscle oxidative enzyme activities in heterogeneous populations
 (Bekedam et 
al. 2003; Maughan & Gleeson M 2004)) is a strong predictor of whole-body insulin 
sensitivity in white Europeans and this is independent of visceral adiposity and family 
history of type 2 diabetes (Bekedam et al. 2003; Nyholm et al. 2004; Thamer et al. 
2003). Furthermore, a recent study reported that in rats selectively bred for high or 
low aerobic capacity from the same founder population, the animals bred for low 
aerobic capacity had 58% lower VO2max (by definition) but also exhibited 131% 
higher fasting insulin and 20% higher fasting glucose than their counterparts bred for 
high aerobic capacity (Wisloff et al. 2005), consistent with substantially greater 
insulin resistance. 
 
Limited data are available, which indicates that differences in whole body oxidative 
capacity are evident when comparing men of South Asian descent with those of 
Europeans.  VO2max values in sedentary South Asians are typically around 10-15% 
lower than comparable sedentary European groups (Davey et al. 2000; Hardy & Eston 
1985; Verma et al. 1979).  Interestingly, the relatives of patients with type 2 diabetes, 
who, like South Asians, have increased insulin resistance (Barwell et al. 2008; 
Ezenwaka et al. 2001; Humphriss et al. 1997; Perseghin et al. 1997)
 and risk of type 2 
diabetes (Kobberling J & Tillil H 1982; Ohlson et al. 1988) also have significantly 
lower values for VO2 max (~10-15% lower) than age, BMI and body-fat matched 
controls (Nyholm et al. 2004; Thamer et al. 2003).  It is therefore tempting to 
speculate that increased insulin resistance in South Asians compared to Europeans   50 
may be, at least in part, a consequence of reduced skeletal muscle oxidative capacity, 
particularly with respect to fatty acid oxidation, leading to a mismatch between fatty 
acid delivery and utilization within muscle.  This suggestion warrants further 
investigation.  
 
1.9 Does excess liver fat play a role in insulin resistance in South Asians? 
Ectopic fat can accumulate in the liver as well as in skeletal muscle, partly as a result 
of excess of circulating NEFA, delivered via the portal vein (which drains VAT), and 
via the systemic circulation.  A further mechanism for the development of ectopic 
liver fat is increased de novo hepatic lipogenesis, due to the hyperinsulinaemia seen in 
insulin resistance, and because of altered patterns of storage of dietary carbohydrate, 
which is diverted away from skeletal muscle glycogen synthesis and towards hepatic 
lipogenesis.  The latter mechanism suggests that excess liver fat secondary to de novo 
hepatic lipogenesis occurs, partly as a result of skeletal muscle insulin resistance.  
Recent research verifies this by demonstating that acute exercise can ameliorate this 
effect in young, lean, insulin-resistant men by redressing the balance towards skeletal 
muscle glycogen synthesis and away from hepatic lipogenesis, resulting in a 30% 
reduction in hepatic lipogenesis following a single bout of exercise (Rabol et al. 
2011).   
 
Ectopic fat results in hepatic insulin resistance, nonalcoholic fatty liver disease 
(NAFLD) and eventually cirrhosis and portal hypertension.  Although the molecular 
mechanisms underlying this are not fully understood, it is hypothesized that increased 
fatty acid delivery to hepatocytes results in hepatic steatosis (i.e. an increase in 
intrahepatic triclyceride and diacylglcerol) which, similar to the accumulation of fatty   51 
acid intermediates in skeletal muscle, activates protein kinase C and JNK 1.  These 
enzymes interfere with insulin signalling by reducing tyrosine phosphorylation of 
IRS-1 and IRS-2.  Ultimately, the ability of insulin to activate hepatic glycogen 
synthase is reduced, and this stimulates gluconeogenesis (Samuel et al. 2004) .  
Hepatic steatosis strongly correlates with insulin resistance, and indeed the liver 
enzyme alanine aminotransferase, which is elevated in around 70% of patients with 
fatty liver, has been shown to be predictive of type 2 diabetes (Sattar et al. 2004). 
 
Limited data suggest that the prevalence of NAFLD in South Asians is high, and 
strongly associated with diabetes and IGT (Amarapurkar et al. 2007; Mohan et al. 
2009), and that excess hepatic lipid may contribute to insulin resistance in South 
Asians.  One such report found that South Asian men exhibited a 3 to 4-fold increase 
in the prevalence of insulin resistance (measured by HOMA) compared to White, East 
Asian, Black and Hispanic groups.  This was accompanied by a 2-fold increase in 
hepatic triglyceride content and IL-6, in the South Asians compared to the other 
ethnic groups (Petersen et al. 2006), although the groups were only matched for BMI 
and not for body-fat percentage, which may have confounded the results.  While it is 
not possible to infer a causal relationship between hepatic lipid accumulation and 
hepatic insulin resistance in South Asians from these data, they are consistent with the 
hypothesis that increased circulating NEFA in South Asians leads to ectopic fat 
accumulation culminating in “end-organ” insulin resistance.  Again, this is an area 
where further study is needed.        
 
 
   52 
1.10 Future Research Needs 
As the reasons behind the increased prevalence of insulin resistance and diabetes in 
South Asians remain elusive, further research is required.  Imaging studies, using 
MRI, to corroborate the location of excess adipose tissue and its relationship to 
adverse metabolic profiles are needed, as well as muscle phenotyping studies, 
examining muscle lipid oxidation and insulin signalling, and more prospective studies 
relating traditional and, in particular, novel risk factors to event risks.  Studies with 
objective ascertainment of real levels of physical activity in South Asians, and 
controlled exercise intervention trials, would also be beneficial to determine the extent 
to which physical activity level can modulate insulin sensitivity and diabetes risk in 
this group. 
 
It is clear that there is a higher prevalence of type 2 diabetes and CHD in South 
Asians, compared with white European populations, and it has become increasingly 
clear that risk factors related to these manifest early in life, so genetic or programming 
factors are relevant.  In line with the latter observation, South Asians are more 
sensitive to the effects of weight gain and may move fat more quickly to adverse fat 
locations (centrally, either to deep subcutaneous abdominal stores or to visceral 
compartments) and some preliminary evidence suggests that they may also move fat 
more quickly to skeletal muscle and the liver, with associated metabolic 
consequences.    
 
The low prevalence of diabetes in rural India (Mohan et al. 2008) suggests that 
increased diabetes risk can be avoided by management of diet and lifestyle to 
incorporate more physical activity, and to maintain a lean body weight.  Clinically,   53 
therefore South Asians have a greater need to be physically active and to remain lean 
than their white European counterparts but unfortunately, there is evidence that South 
Asians are in fact less active, and in some developed countries their obesity levels are 
greater than those seen in the indigenous population. Thus, in parallel with the need 
for further research, there is an urgent need for a worldwide public health policy 
targeting South Asians from a young age, to encourage and enable them to remain 
lean and become more physically active.  Cultural and religious factors should be 
taken into account and there should be an emphasis on producing culturally 
appropriate, targeted information and on working with existing South Asian 
organisations within communities.  The pilot UK Asian Diabetes Study (UKADS) is 
an example of how a culturally-specific approach can improve outcomes (O'Hare et 
al. 2004).  This looked at differences in blood pressure, lipids and diabetes control in 
361 South Asian patients with diabetes, who had been randomised to receive either 
conventional care or enhanced care (with Asian link workers supporting patients, 
organising education and explaining the purpose of medication).  The patients who 
had enhanced care had significantly greater blood pressure reductions and total 
cholesterol reductions after a year than those in the conventional group.  Although the 
target population in this study was patients with diabetes, a similar sort of scheme 
could be used to educate and encourage families of South Asian diabetes patients or 
schoolchildren about increasing physical activity levels and improving diets.          
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1.11 Summary 
In conclusion, the preceding literature review will have made the reader aware of the 
magnitude of the problem of increased insulin resistance in South Asians, along with 
the resultant increased morbidity and mortality associated with type 2 diabetes and 
cardiovascular disease in this population.  The review also examined current 
hypotheses speculating about the underlying mechanisms for South Asians‟ increased 
insulin resistance.  Genetic differences which result in alterations in skeletal muscle 
and adipose tissue function, combined with an increasingly obesogenic environment 
which promotes sedentary lifestyles and “Westernised diets” are likely to be 
important. Given the major influence that skeletal muscle has on whole-body insulin 
sensitivity, and the fact that South Asians have been found to have differences in 
skeletal muscle structure (i.e. increased intramyocellular lipid), investigating skeletal 
muscle function in South Asian populations is a logical step towards providing insight 
into the mechanisms underlying insulin reistance in this population. 
 
This thesis aims to test the hypothesis that insulin resistance in South Asians is 
caused, at least in part, by a defect in skeletal muscle oxidative capacity, resulting in 
reduced oxidation of fatty acids.  Increased circulating NEFA, which has been 
observed in South Asians, up-regulates fatty acid uptake into the skeletal muscle and 
this increased uptake combined with reduced oxidation produces a mismatch between 
fatty acid uptake and oxidation, resulting in the accumulation of intramyocellular lipid 
and subsequent impairment of insulin signalling.   
 
The studies described in Chapter 3 aim to investigate this hypothesis by examining 
lifestyle, physical and metabolic characteristics of sedentary, normoglycaemic South   55 
Asian men compared to matched European controls, to determine the influence of 
lifestyle and adiposity as potential mediators of insulin resistance in South Asians. 
Additionally, it aims to identify differences in skeletal muscle function between the 
two groups, through measurement of cardiovascular fitness, of whole-body fat 
oxidation during incremental exercise, and at rest, and of skeletal muscle oxidative 
and lipid metabolism genes expression. 
 
The tests performed in Chapter 4 will examine insulin signalling, with an aim of 
discovering ethnic differences in protein expression of various components of the 
insulin signalling pathway in skeletal muscle samples, both fasting and following 
insulin stimulation. 
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Chapter 2 
General Methods 
 
2.1 Introduction 
This chapter describes the methods employed to recruit volunteers for the study, for 
the measurement of anthropometric, metabolic and cardiorespiratory variables and for 
all laboratory analyses.  This study was conducted with the ethical approval of the 
North Glasgow NHS Trust Research Ethics Committee and was conducted according 
to the principles expressed in the Declaration of Helsinki.  All participants gave 
written informed consent (appendix A2).   
 
2.2 Subject recruitment 
All subjects were Glasgow residents, and were apparently healthy.  They were 
recruited via local advertising using newspapers and radio broadcasts.  Recruitment 
posters were displayed around the Glasgow University main campus, Garscube 
campus and and Strathclyde University campus.  A number of local general 
practitioners agreed to display recruitment posters in their surgery waiting rooms.  In 
addition posters were displayed in outpatient clinic areas of the Western Infirmary, 
Gartnavel General Hospital and Glasgow Royal Infirmary.  Potential volunteers could 
access information about the study through a weblink sited on the University Sports 
and Recreation website. In addition to this, volunteers were able to provide basic 
contact details and note their interest by submission of a webform which was emailed 
to the principal investigators.  Information about the study was disseminated by word-
of-mouth, by both the investigators and by volunteers themselves, and was 
responsible for a small proportion of the total number of subjects recruited.    57 
Volunteers were given an information sheet, which described in detail the purposes of 
the study, the study protocol, and any potential risks and discomforts associated with 
participation (appendix A1).  A confidential questionnaire about past medical history 
and family history of disease was completed by all subjects (appendix A3), as were 
questionnaires about physical activity (appendix A4) and diet (appendix A5).  Resting 
blood pressure was measured using a mercury sphygmomanometer (Accoson, Essex, 
UK) and a fasting blood sample was collected to test glucose, cholesterol and lipid 
profile in addition to liver, renal and thyroid function.  The following criteria were 
used for subject recruitment: 
 
  Male aged 18 – 40 years 
  South Asian (i.e. Pakistani, Indian, Bangladeshi or Sri Lankan) or Northern 
  European (i.e. British, Irish, French, German, Dutch, Scandinavian) 
  Non-smoking 
  Relatively sedentary (i.e. taking part in less than 2 hours of planned aerobic 
  exercise per  week and working in sedentary job) 
  Blood pressure < 160/90 mmHg 
  Plasma glucose concentration < 7.0 mmol.l
-1 and no known diabetes 
  Normal liver, renal and thyroid function 
 
Volunteers taking prescribed medications were not excluded from the study, provided 
that their prescription was stable and did not include medications which are 
recognised to modulate carbohydrate or lipid homeostasis.  Figure 2.1 illustrates the 
recruitment process, and the number of volunteers involved in the study, including   58 
drop-outs and those who were excluded from the study.  The reasons given for 
volunteers dropping out of the study were: 
  Too much of a time commitment (1 European) 
  Financial compensation perceived to be too little (1 South Asian) 
  Fear of blood tests/ muscle biopsy (2 Europeans, 1 South Asian) 
  No reason given and contact lost (4 Europeans, 2 South Asians) 
 
   
 
Figure 2.1 Flow chart demonstrating volunteer recruitment with details of 
dropouts and exclusions at each stage of the study.  
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criteria                 
27 Europeans
screened
24 South Asians
screened
20 Europeans
completed study
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2.3 Exercise stress test 
All subjects underwent a Bruce Protocol Exercise Tolerance Test (BPETT) (Bruce, 
Kusumi, & Hosmer 1973) to ensure that there were no cardiovascular 
contraindications to their participation in the study.  This consists of an incremental 
exercise test with 3-minute stages, during which workload increases in a stepwise 
fashion with every stage, due to increases in both the speed and the gradient of the 
treadmill.  In the study 12-lead electrocardiogram (ECG) tracings were obtained using 
a Quinton Q710 ECG machine (Quinton instruments Co, Bothwell, WA, USA), at 
rest, during each of the 3 minute stages of the Bruce protocol, and during recovery.  
Blood pressure was measured at rest, prior to the exercise test and then 5 minutes 
post-exercise.  The BPETTs were all performed and interpreted by the author (a 
registered medical practitioner with Advanced Life Support (ALS) accreditation). All 
volunteers achieved an adequate workload on BPETT and remained free of symptoms 
and electrocardiographical signs of coronary artery insufficiency.  One volunteer, 
however, developed ECG signs suggestive of abnormal cardiac conduction during the 
ETT.  He was referred to the cardiology clinic at Glasgow Royal Infirmary for further 
evaluation, and underwent echocardiography, which did not reveal any structural or 
functional cardiac abnormalities. 
 
2.4 Anthropometric measurements 
All measurements were performed using standardised methods according to the 
International Society for the Advancement of Kinanthropometrics (ISAK) protocol 
(Marfell-Jones M et al. 2006).  The same ISAK-accredited experimenter performed 
all measurements to abolish any possibility of inter-observer variability.  All 
measurements were taken twice, and a mean value was taken for each.   60 
 2.4.1  Height and body mass 
Height was measured to the nearest 0.1 cm using a free standing stadiometer (Invicta 
Plastics Ltd, Leicester, UK).  Subjects stood barefoot with their heels together, their 
backs against a fixed backboard and their heads orientated in the Frankfurt plane (i.e. 
the position where the inferior margin of the orbit is in line with the upper margin of 
the ear canal).  The stretch technique was used, such that subjects were asked to 
inspire, at which point gentle upward pressure was applied to the lower jaw, and a 
sliding headboard was lowered to the top of the head, with enough pressure to 
compress the hair.  Body mass was measured to the nearest 0.05 kg using a manual 
balance weighing scale (Avery Industrial Ltd, Leicester, UK).  Subjects were weighed 
and measured barefoot and wearing light clothing (typically shorts and a t-shirt). 
 
2.4.2  Waist and hip circumferences 
Waist and hip circumferences were measured to the nearest 0.1 cm using a steel 
measuring tape (Hoechstmass Balzer GmbH, Frankfurt, Germany), with the subject 
wearing light clothing (typically shorts only) and standing with their feet together.  
Waist circumference was measured at the narrowest point between the costal margin 
and the iliac crests (or if this could not be identified, at the level midway between the 
costal margin and the iliac crests), with the abdominal muscles relaxed.  Hip 
circumference was measured around the maximal circumference of the buttocks, at 
approximately the level of the pubic symphysis.  Waist-hip ratio was determined by 
dividing the mean waist circumference by the mean hip circumference. 
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2.4.3  Skinfold measurement. 
   
Figure 2.2 Suprailiac and biceps measurement sites 
 
 
Skinfold measurements were taken at the biceps, triceps, subscapular and suprailiac 
sites, on the right hand side of the body.  Suprailiac sites and biceps sites are 
illustrated in Figure 2.2 above.  They were measured using Harpenden skinfold 
callipers (Holtain Ltd, Crymych,UK) to the nearest 0.1 mm.  The same set of callipers 
was used for all subjects.  All readings were taken three seconds after closure of the 
calliper jaws, to avoid excess compression of adipose tissue.  Sites for skinfold 
measurement were located using bony landmarks as follows: 
  Biceps – midway between the acromial process and the superior head 
of the radius on the midline, anteriorly, with the forearm supinated 
  Tricep – midway between the acromial process and the superior head 
of the radius on the midline, posteriorly, with the forearm supinated 
  Subscapular – 20 mm below the inferior angle of the scapula and 45 
  degrees to the lateral side of the body 
  Suprailiac – immediately superior to the iliac crest in the mid-axillary 
line 
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2.5 Assessment of Body Composition 
Dual X-ray absorptiometry (DEXA), which is well recognised as an accurate method 
for assessing body composition and body fat distribution (Gallagher & Song 2003) 
was used for this purpose in the study.  Lean body mass and fat mass were calculated 
for each subject, and all scans were performed by the same operator who was an 
experienced radiographer, and with a GE Medical LUNAR Prodigy DEXA scanner 
(GE Healthcare Diagnostic Imaging, Slough, Berkshire, UK). Scan data were 
interpreted using the scanner‟s generic software. Scans were performed in the 
Radiology Department of the Royal Hospital for Sick Children, Yorkhill, Glasgow 
and all subjects were informed that DEXA scanning necessitates the delivery of a 
small dose of radiation (figure quoted 0.0007 mSV, or one fiftieth of the radiation 
dose delivered during a standard chest X-ray). 
 
2.6 Expired air measurements 
Expired air collections were made using two separate techniques.  Douglas bags were 
used to collect expired air at rest immediately prior to all exercise tests and during 
both treadmill exercise protocols.  The ventilated hood method was used during the 
final study visit, for collection of expired air and measurement of metabolic rate at 
rest, both in the fasted state and post glucose ingestion. 
 
2.6.1  Expired air measurements using Douglas bags 
At rest, prior to exercise, and throughout all exercise sessions, Douglas bags were 
used to collect expired air samples.  Immediately prior to resting measurements, 
subjects completed a 10-minute run-in period, sitting in a chair, to ensure that they 
were adequately rested.  A nose clip and a mouthpiece connected to a lightweight 2-  63 
way valve (2700 Series, Hans Rudolf Inc, USA) were then introduced to the subject 
for 3 minutes before any air collection, for subject comfort and familiarisation.  
Thereafter, expired air samples were collected into 100 or 150 litre Douglas bags 
(Cranlea and Co, Birmingham, UK), via the mouthpiece valve and a length of plastic 
tubing connected to the Douglas bag by a further 2-way valve.  Resting measurements 
were taken over two 5-minute periods. 
 
During the maximal exercise test, the mouthpiece and nose clip were worn 
continuously, the mouthpiece being supported by an adjustable headset.  During the 
submaximal test, however, the mouthpiece and nose clip were passed to the subject 
two and a half minutes into each four minute exercise stage, allowing 30 seconds 
before the expired air collections were taken at minutes 3 to 4.  They were then 
removed until two and a half minutes into the next stage.   
 
Following the collection of expired air into a Douglas bag, a small volume of gas was 
passed through a flow meter and into a gas analyser (Servomex 4000 Series, 
Servomex Group Ltd, East Sussex, UK) where the percentage of oxygen and carbon 
dioxide was measured.  The remaining expired air was extracted by a vacuum and 
passed through s dry gas meter (Harvard Apparatus Ltd, Kent, UK), which also 
measured the temperature of the air.  VO2 and VCO2 were calculated and the 
respiratory exchange ratio was calculated using indirect calorimetry.   
 
Prior to all measurements, Douglas bags were evacuated and the gas analyser was 
calibrated against reference gases of known oxygen and carbon dioxide content (BOC 
Gases, BOC Ltd, Surrey, UK)       64 
2.6.2  Resting expired air measurements using ventilated hood 
Basal metabolic rate and energy substrate utilisation were measured in all subjects 
after an overnight fast of at least 12 hours.  Subjects attended the metabolic suite, 
where they were asked to lie on a couch in a supine position.  After 10 minutes of 
lying down, the ventilated hood with surrounding plastic skirt connected to an 
Oxycon-Pro (Viasys Healthcare, Warwick, UK) analyser was placed over the 
subject‟s head.  During the measurement, room air was drawn into the hood, and 
expired air was extracted at the same rate in to the Oxycon-Pro system for analysis.  
Expired oxygen and carbon dioxide were determined, allowing calculation of oxygen 
consumption (VO2) and carbon dioxide production (VCO2).  Measurements were 
taken for 25 minutes, with VO2 and VCO2 results averaged over 1 minute, and an 
average of the final 15 minutes of data was used for the calculation of respiratory 
exchange ration, energy expenditure and rate of energy substrate utilisation using 
indirect calorimetry. 
 
This resting measurement was also repeated for all subjects 2 hours after a glucose 
load (standard 75 gram oral glucose tolerance test). 
 
Prior to use, the Oxycon-Pro system was calibrated using reference gases (Viasys 
Healthcare, Warwick, UK) of a known oxygen and carbon dioxide content, and 
corrections were made for barometric pressure and ambient temperature.  
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2.7 Exercise tests 
All exercise tests were performed in a purpose built laboratory, using a motorised 
treadmill (Woodway GmbH, Weil am Rhein, Germany).  Prior to both the VO2 max 
and the submaximal test protocols, and in addition to the resting measurement, 
subjects underwent a warm-up phase, which consisted of a 10 minute walk on the 
treadmill at 5 km.h
-1 on a 0% gradient.  Expired air was collected at minutes 8 until 9 
and 9 until 10. 
 
 
2.7.1  Maximal exercise test 
Prior to the maximal exercise test, all subjects had undergone a familiarisation 
session, which took place in conjunction with the screening exercise stress test.  The 
purpose of this was to allow all subjects the opportunity to practise walking on a 
treadmill, to experience walking with the nose clip and mouthpiece in place, and 
therefore, to minimise any tendency towards hyperventilation during the exercise 
tests.  After the warm-up phase the treadmill speed was increased to 5.5 km.h
-1, and 
the gradient was increased to 3%.  Thereafter, every 2 minutes the gradient was 
increased by a further 3%, until a gradient of 21% was reached, after which the 
gradient remained constant at 21% but the speed was increased by 3 km.h
-1 every 2 
minutes.  All subjects were verbally encouraged to continue until exhaustion, and 
expired air samples were collected over one minute during the last 3 or 4 stages of the 
test.  Immediately after the VO2 max test, subjects stepped back onto the treadmill and 
completed a cool-down phase for 5 minutes at 4 km.h
-1 and 0% gradient.  This is 
illustrated in Figure 2.3.   
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The achievement of VO2 max was confirmed by an RER of 1.00 and a heart rate 
which was at least 85% of age-predicted maximum heart rate.  In addition, a supra-
maximal test was performed at 115% of peak work rate to confirm a plateau in VO2.  
This test lasted for 2.5 minutes with expired air samples collected every 30 seconds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 VO2max test protocol 
 
 
2.7.2 Submaximal exercise test to determine lactate threshold 
For this test, individual protocols, specifically tailored for each subject, based on their 
VO2 max were created.  Following the warm-up phase, the treadmill speed was 
increased to 5.5 km.h
-1, and the gradient was increased up to a pre-determined value, 
based on VO2max.  Each stage of the sub-maximal exercise test lasted for 4 minutes 
and expired air collections were taken at minutes 3-4 of each stage.  Thereafter, heart 
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rate and RPE score were recorded and a capillary blood sample was taken for later 
analysis to determine lactate concentration.  The treadmill gradient was then increased 
by 1% and this was repeated for a total of 8 stages.  Thereafter subjects again 
completed a cool-down phase for 5 minutes at 4 km.h
-1 and 0% gradient.  This is 
illustrated in Figure 2.4   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4 Typical submaximal exercise test protocol 
 
2.8 Measurement of heart rate and rate of perceived exertion 
Heart rate was measured using short-range telemetry (Polar S610i Heart Rate 
Monitor, Polar Electro, Oy, Kempele, Finland).  Heart rate was monitored throughout 
all exercise sessions and during the recovery phase of each session.  Rate of perceived 
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exertion was recorded at 4 minute intervals, at the end of each exercise stage during 
the lactate profile exercise test, using the Borg Scale (Borg 1982).  
 
2.9 Indirect Calorimetry 
Expired air samples were collected at rest and during the exercise tests, as described 
in section 2.4.  For each exercise stage and rest period (fasting or post glucose), mean 
VO2 and VCO2 were used to calculate energy expenditure, by indirect calorimetry, 
using equations derived by Frayn (Frayn 1983). 
 
Urinary nitrogen was not measured directly in the study, however, as a constant rate 
of nitrogen excretion has previously been described as 0.00011g.kg
-1  (Flatt et al. 
1985; Melanson et al. 2005), and as there is no evidence to suggest ethnic differences 
in nitrogen excretion, this value was applied to the equations below, for all resting 
measurements, in all subjects with the constant N calculated as: 
 
N (g.min
-1) = 0.00011 x body mass (kg)        (Equation 2.1) 
 
Using Frayn‟s equations, VO2 and VCO2 were calculated as below: 
 
VO2 (l.min
-1) = 0.746 CHO + 2.03 fat + 6.04 N       (Equation 2.2) 
VCO2 (l.min
-1) = 0.746 CHO + 1.43 fat + 4.89 N      (Equation 2.3) 
 
where CHO is carbohydrate and N is nitrogen excretion.  Using the above equations, 
it was possible to calculate VO2 and VCO2 , corrected for protein oxidation.  Using 
equations 2.2 and 2.3 VO2 and VCO2 were calculated, also corrected for protein   69 
oxidation, so it was possible to calculate non-protein oxygen consumption (NPVO2) 
and non-protein carbon dioxide consumption (NPVCO2).  Non-protein respiratory 
quotient (NPRQ) was calculated using the following equation: 
NPVO2 (l.min
-1) = 0.746 CHO + 2.03 fat - 6.04 N       (Equation 2.4) 
NPVCO2 (l.min
-1) = 0.746 CHO + 1.43 fat - 4.89 N     (Equation 2.5) 
NPRQ = NPVCO2 / NPVO2             (Equation 2.6) 
 
Energy substrate oxidation was calculated as follows: 
 
Fat oxidation (g.min
-1) = (NPVO2 – NPVCO2) / 0.6     (Equation 2.7) 
Carbohydrate oxidation (g.min
-1) = (4.55 x NPVCO2)  
      – (3.21 x NPVO2)       (Equation 2.8) 
Protein oxidation (g.min
-1) = n x 6.25         (Equation 2.9) 
 
Energy expenditure (EE) was calculated by multiplying the amount of substrate 
oxidised by the energy density value appropriate to each substrate according to the 
methods of Brody (Brody 1999)  and Mottram (Mottram 1979): 
 
EE (kJ) = (fat x 39) + carbohydrate x 1.55) + (protein x 17.0)  (Equation 2.10) 
 
Net energy expenditure and substrate utilisation were calculated by subtracting the 
baseline rate from the total energy expenditure/ substrate utilisation to give the rise 
above resting values.  
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2.10 Blood sampling 
Three different techniques were used for blood sampling.  Screening blood tests were 
collected by venepuncture, from an antecubital vein.  During the metabolic 
assessment visit, regular venous blood samples were taken from a cannula, prior to 
adipose tissue and muscle biopsies, and at minutes 0, 30, 60, 90 and 120 post oral 
glucose tolerance test (75 grams of anhydrous glucose diluted in water and lemon 
juice).  During exercise tests capillary blood samples were taken. 
 
2.10.1  Venous blood 
Venous blood was collected from an indwelling cannula (Biovalve, 18G/ 1.2 mm, 
Vygon, France), placed in a large antecubital vein, via a three-way tap with a 10 cm 
length of tubing (Connecta Plus, BD, Sweeden).  Venous cannulae were flushed with 
non-heparinised saline (0.9% NaCl) to maintain patency, and blood samples were 
collected into 10 ml tubes containing K3EDTA (BD Vacutainer systems, Plymouth 
UK).  In instances where blood could not be successfully collected in this manner, 
venepuncture was used to take blood from an antecubital or forearm vein.  Blood 
samples were immediately placed on ice and then into a refrigerated centrifuge 
(Andreas Hettich GmbH & Co. KG, Tuttlingen, Germany) within 15 minutes of 
collection and plasma and red blood cells were separated.  Plasma was then pipetted 
into screwcap microtubes (2.0 ml, Alpha Laboratories, Hampshire, UK) in 0.5 ml 
aliquots and stored at -80
oC. 
 
On the baseline blood sample (i.e. the very first sample taken before the biopsies), 
remaining red cells were washed with 5 mls of normal saline (0.9% NaCl) and   71 
centrifuged at 2500 rpm for 10 minutes, and this was repeated twice.  Red cells were 
pipetted into 2 ml screwcap microtubes in 1 ml aliquots, and stored at -80
oC.      
 
2.10.2  Capillary blood 
Capillary blood was collected during both the maximal and submaximal exercise tests 
in order to determine lactic acid concentration.  During the maximal exercise test 
samples were taken at minutes one, 3 and 5 post-maximal effort, and during the 
submaximal exercise test samples were taken at the end of each four-minute stage (8 
samples in total).  Each sample was taken using a contact-activated lancet (Becton 
Dickinson & Co, Plymouth, UK) to pierce the skin on the right thumb, and blood was 
collected into a 20 μl micropipette (Blaubrand GmbH, Germany).  The capillary blood 
was then dispensed into an Eppendorf tube containing 200 μl of 0.4 mol perchloric 
acid, mixed and immediately placed on ice.  Within 1 hour of collection samples were 
centrifuged for 1 minute at 140,000 rpm.  The supernatant was separated and stored at 
-80
oC.   
 
2.11 Blood sample analysis  
2.11.1  Screening blood tests 
All study subjects had blood tests taken at screening for the following analyses: 
  Urea and electrolytes 
  Liver function tests 
  Glucose 
  Total cholesterol, HDL-cholesterol (LDL-cholesterol – calculated using 
  Freidwald equation), Triglyceride. 
  TSH, free T4   72 
These analyses were performed in the biochemistry laboratory at Gartnavel General 
Hospital. 
  
2.11.2  Insulin 
Plasma insulin (appendix B1) was measured in the Vascular Biochemistry department 
at Glasgow Royal Infirmary using a commercially available ELISA kit which utilises 
a solid phase two-site enzyme immunoassay with <0.01% cross-reactivity with pro-
insulin (Mercodia AB, Uppsala, Sweden).  Coefficient of variation was <4% and all 
samples were analysed in duplicate by colleagues at Glasgow Royal Infirmary. 
 
2.11.3  Spectrophotometric procedures 
Plasma glucose (appendix B2), NEFA (appendix B3), triglyceride (appendix B4) and 
lactic acid (appendix B5) analysis were carried out at the University of Glasgow on 
defrosted fasting plasma samples  (Roche diagnostics GmbH, Mannheim, Germany. 
Wako Chemicals GmbH, Germany).  LDL-cholesterol concentrations were calculated 
using the Friedwald equation (Friedewald, Levy, & Fredrickson 1972).  All 
measurements of glucose, TG and NEFA were performed on a Cobas Mira Plus 
(ABX Diagnostics, France).  Lactic acid was measured on an Ascent flourometer 
(Thermo scientific, Surrey UK).  Coefficient of variation for spectrophotometric 
analyses was <3.1%.  These analyses were all carried out by the author and colleagues 
at the University of Glasgow.    
 
2.11.4  Radioimmunoassay procedures 
Leptin (appendix B6) was measured by colleagues at Glasgow Royal Infirmary using 
a radioimmunoassay method developed internally.   73 
2.11.5  Inflammatory markers 
Adiponectin, IL-6 and TNF-α concentrations were also measured by colleagues at 
Glasgow Royal Infirmary and were determined by ELISA (R+D systems Europe, 
Abingdon, UK) 
 
2.11.6  Accuracy of blood anaylsis procedures 
Quality control sera were used to ensure accuracy of all of the above analyses 
(Mercodia AB, Uppsala, Sweden. Phoenix Europe GmbH, Karlsruhe Germany. Roche 
Diagnostics GmbH, Mannheim, Germany, Randox Laboratories Ltd, Co Antrim, 
Ireland.  Wako Chemicals GmbH, Germany).  For all analyses, samples were tested in 
2 separate batches, each containing samples from an equal number of South Asian and 
European subjects. 
 
2.12 Metabolic Assessment 
During the final study visit, subjects attended fasting and had a resting expired air 
collection taken, using the ventilated hood system.  Following this, a cannula was 
inserted and after 10 minutes the first blood sample was taken.  Skeletal muscle 
biopsies were then performed.  A further blood sample was taken and then a drink 
containing 75 grams of glucose was taken over a 3 minute period.  Further blood 
samples were taken at 30 minute intervals thereafter for 2 hours, and then the resting 
expired air collection was repeated.  Because of a concern about the possibility of 
stress-induced hyperglycaemia following muscle biopsy, pre and post biopsy blood 
samples were taken for measurement of baseline glucose and insulin.    
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2.12.1  Percutaneous skeletal muscle biopsy using semi-open technique 
With the subject still lying supine on the examination couch, the biopsy site was 
identified by measuring 20 cm above the right patella and projecting a line laterally.  
The skin was marked at this site, which overlies the lateral aspect of the vastus 
lateralis muscle.  
 
A sterile drape was then tucked under the subject‟s leg and the skin surrounding the 
marked site was cleaned with sterile swabs and iodine solution.  The skin was 
infiltrated with approximately 10ml of 2% lidocaine, and 10 minutes were allowed for 
the anaesthetic effect to occur. 
 
An incision was made to the skin at the biopsy site with a sterile scalpel 
approximately 1 centimetre wide and deep, and biopsy forceps (Weil-Blakesley 
forceps, Gowlands Ltd, Croydon, UK) were inserted.  Subcutaneous tissue was blunt - 
dissected using the forceps until the muscle layer was reached, and a small amount of 
muscle tissue, approximately 400mg, was removed and dispensed onto a piece of 
muslin stretched over a plastic box.    
 
A sterile swab and pressure were applied and then a further sample was taken.  
Pressure was then applied for 10 minutes, after which the wound was closed with 
paper stitches (Luekostrip skin closures, Smith+Nephew, London, UK) and covered 
with a sterile dressing (Mepore dressing, Molnlyke healthcare, Gothenburg, Sweden). 
 
All subjects were advised to avoid vigorous exercise for 24 hours. 
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2.13 Analysis of muscle samples 
2.13.1 Determination of skeletal muscle insulin signaling protein expression 
Immediately following biopsy, samples were divided into 6 separate pieces.  Four of 
the 6 pieces were snap frozen in liquid N2 and 2 pieces were allowed to recover for 30 
minutes in 10 ml of Krebs-Ringer-Hepes buffer (118 mM NaCl, 25 mM Hepes-
NaOH, pH 7.4, 5 mM NaHCO3, 4.7 mM KCl, 1.2 mM MgSO4, 1.2 mM NaH2PO4, 
2.5 mM CaCl2, 5mM glucose, 0.1% (w/v) bovine serum albumin) at 37
oC, gassed 
with 100% O2 prior to incubation for 10 min.  They were then incubated in the 
presence or absence of human soluble insulin (Actrapid, NovoNordisk, Bagsvaerd, 
Denmark) at a concentration of 10 nmol/l for 10 minutes, after which both samples 
were placed into screw cap microcentrifuge tubes, snap frozen in liquid N2 and then 
stored at -80
oC. 
 
Muscle samples were placed in a Dounce homogenizer with homogenisation buffer 
(50mM Tris (hydroxymethyl) aminomethane (pH 7.5 at 4
oC), 250mM sucrose, 1mM 
EDTA, 1mM EGTA, 5mM NaF, 5mM NaPPi, 250mM mannitol, 1mM DTT, 0.1mM 
benzamidine, 0.1mM PMSF, 1mM vanadate, 5μg/ml SBTI) at a concentration of 1:8 
volumes.  Lysates were created by passing the glass pestle up and down the tube 20 
times, until the samples were fully homogenized. 
 
Samples were then transferred into microcentrifuge tubes and centrifuged at 350,000g 
for 30 minutes to separate the cytosolic fraction.  The supernatant was pipetted into 
separate tubes and stored at -80
oC.  The pellet was then resuspended in the same 
homogenisation buffer (at a concentration of 1:3 volumes) with 1% (v/v) NP-40 and   76 
centrifuged at 100,000g for 60 minutes, after which the supernatant, containing the 
membrane (particulate) fraction, was pipetted into separate tubes. 
Protein content of each sample was calculated according to the method of Bradford 
(Bradford 1976).  Samples were loaded (10-20µg / lane) onto an 8% SDS-
polyacrylamide gel, resolved by SDS-PAGE and transferred to nitrocellulose prior to 
Western Blotting.  Blots were probed with commercially available antibodies raised 
against insulin receptor (insulin receptor ( subunit), insulin receptor substrate (IRS) 
proteins –1 and –2, phosphatidylinositol 3‟-kinase (p85 and p110 subunits), PTEN, 
PKB ( and ), GLUT4 and PKC isoforms.  Resultant bands were quantified by 
densitometry and compared with an internal standard to assess expression levels.  
 
Phosphorylation of PKB at Ser473 was assessed in the muscle homogenates described 
above by Western blotting using phosphorylation site-specific antibodies. 
   
2.13.2 Determination of skeletal muscle expression of oxidative and lipid 
metabolism genes 
Skeletal muscle RNA was extracted using an E.Z.N.A. Tissue RNA kit (Omega Bio-
Tek, Inc., Norcross, GA) according to the manufacturer‟s protocol using Precellys 
Ceramic Homogenisation beads (CK14, PEQLAB Ltd, Farnborough, UK) and a 
Hybaid Ribolyser (Thermo Scientific, Loughborough, United Kingdom). cDNA was 
synthesised using an Applied BioSystems High Capacity cDNA Reverse 
Transcription kit (Life Technologies Corporation, Carlsbad, CA) with random 
hexamers according to the manufacturers protocol, but doubling the volumes to 
increase yield. Quantitative polymerase chain reaction (qPCR) assays were designed   77 
for each transcript using the Roche Universal Probe Library Assay Design Center 
(http://www.roches-applied-science.com/) 
 
Messenger RNA (mRNA) expression levels of transcripts were measured in triplicate 
using the Universal Probe Library Set (Roche diagnostics GmbH, Mannheim, 
Germany.) and Absolute QPCR Mix (ABGene, Epsom, UK).  Each reaction 
contained 1.35µL of each primer (10 µmol/L stock), 0.15 µL probe, amd 1µL 
complementary DNA in a final volume of 15 µL.  Cycle threshold outliers (C1) were 
removed using the median absolute deviation method (0.6745 * absolute difference of 
data point from median/ median) with a maximum acceptable threshold of 3.5.  
Average amplification efficiency for each assay was determined using version 7.5 of 
LinReg PCR (Ramakers et al. 2003) after exclusion of Ct outlier data points and 
efficiency values lying greater than ± 1.96 standard deviations (SDs) from the mean.  
Non- Ct outliers were averaged for each triplicate and corrected for amplification 
efficiency (Ct * log [mean efficiency]/ log).  For each assay, reactions on multiple 
plates were required, so control samples were run on plates with Ct values on 
subsequent plates to be directly comparable to those on plate 1, using the formula Ct 
(on plate X) + “average Ct control samples plate 1” – “average Ct control samples plate 
X”. 
 
Four potential calibrator genes (ACTB, GAPDH, RPLP0 AND RLP10) were 
compared for stability under experimental conditions using NormFinder (Andersen, 
Jensen, & Orntoft 2004) RPLP0 was found to be the most stable across all subject 
groups and intervention conditions.  The corrected Ct values for each target gene and 
RPLP0 were used to calculate the delta Ct and the average delta Ct of the baseline   78 
control group was used to calculate the delta delta Ct.  The relative expression values 
used for statistical analyses were given by 2 
-delta delta Ct. 
 
 2.13.3  Determination of skeletal muscle mitochondrial DNA (mtDNA) to 
nuclear DNA (nDNA) ratio 
DNA was extracted from muscle using a QIAamp DNA Mini Kit (Qiagen Ltd., 
Crawley, UK) according to the manufacturer‟s protocol (including the RNase 
treatment) using Precelly‟s Ceramic Homogenisation beads (CK14, PEQLAB Ltd, 
Farnborough, United Kingdom, and a Hybaid Ribolyser (Thermo Scientific, 
Loughborough, United Kingdom). qPCR assays were designed using the Roche 
Universal ProbeLibrary Assay Design Center, for the mitochondrial genome 
overlapping two neighbouring genes (tRNA leucine 1 and NADH dehydrogenase 1) 
and the nuclear genome using the β2-adrenergic receptor gene promoter.  Relative 
DNA levels were determined in a similar fashion to the mRNA expression levels.   
         
All analyses of muscle samples in sections 2.13.1 -2.13.3 were carried out by 
colleagues at the University of Glasgow (Dr Gillian Milne and Dr Colin Moran). 
 
2.14 Power calculation 
Sample size calculation was based on differences in insulin sensitivity and VO2max 
between the South Asian and European groups. Based on data from the Southall 
study, 2-hour post-glucose load insulin concentrations were ~2.1 times higher in 
South Asians than BMI-matched Europeans (41 vs 19 µU.ml
-1) and the population 
standard deviations (SD) in 2-hour insulin concentrations were 10 µU.ml
-1 (52% of 
the mean) and 38 µU.ml
-1 (94%), respectively, for the European and South Asian   79 
populations(McKeigue et al. 1991). Assuming a population SD of 100%, 20 subjects 
in each group would be needed to detect a 90% difference in 2-hour insulin between 
South Asians and Europeans with 80% power at α = 0.05. VO2max values in 
sedentary South Asians are typically ~15% lower than comparable sedentary 
European groups(Hardy & Eston 1985; Verma et al. 1979) and the population SD in 
VO2max for healthy young sedentary European/South Asian adults is ~15% (Hardy & 
Eston 1985; Verma et al. 1979).  Groups of 20 subjects would enable us to detect a 
13% difference in VO2max between South Asians and Europeans with 80% power at 
α = 0.05. This number of subjects (i.e. 20 per group) would enable us to detect 
significant correlations between variables of 0.42 at α = 0.05 within each group 
separately and of 0.30 at α = 0.05 for the two subject groups combined.  Correlations 
in the literature between insulin sensitivity and indices of oxidative capacity/fat 
oxidation rates (e.g. VO2max, oxidative enzyme activities, fasting fat oxidation) are in 
the order of 0.6 to 0.8 (Bruce et al. 2003; Nyholm et al. 2004). To allow for 20% 
dropout the initial plan was to recruit 25 subjects in each group.  
  
2.15 Statistical Methods 
Data were analysed using Statistica (version 6.0, StatSoft Inc., Oklahoma) and 
Minitab (version 14, Minitab Inc., Pennsylvania).  Data were tested for normality 
using the Ryan-Joiner normality test and transformed as appropriate.  Box-Cox plots 
were used to determine the most appropriate transformation for data which did not 
follow a normal distribution.   
 
General linear models were used to compare data between European and South Asian 
groups.  As age and BMI were not identical between the two groups, statistical   80 
analysis of all variables was undertaken both unadjusted and after adjustment for age 
and BMI, to confirm that this did not influence the study outcomes.  Further 
adjustment for other variables was undertaken as appropriate to determine whether 
observed differences between groups in variables of interest were independent of 
possible confounders.  
 
Univariate regression analysis was used to determine relationships between variables.  
A homogeneity-of-slopes regression model was used to identify whether the slope of 
relationships between variables differed between the South Asian and European 
groups.  Where the slopes differed significantly between the groups, univariate 
regressions were performed for the South Asian and European groups separately, 
otherwise univariate regressions were performed on the combined group to maximize 
statistical power. 
 
To determine the extent to which relationships between variables were in independent 
of confounders, partial correlations were undertaken adjusting for potential 
confounders (such as such as age, BMI, fat mass and physical activity level).  This 
classic statistical approach has been used previously to determine the independent 
effects of individual variables within multi-factorial systems on biological outcomes 
(Speakman et al. 2002; Westerterp & Speakman 2008).   
 
Statistical significance was accepted at the p < 0.05 level.   
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Chapter 3 
Effects of lifestyle, adiposity and oxidative capacity on insulin 
resistance in South Asian and European men 
 
3.1 Introduction 
The association of cardiorespiratory fitness with skeletal muscle fat oxidation is 
evidenced by the strong relationship between maximum oxygen uptake (VO2max) and 
skeletal muscle oxidative enzymes in Europeans (Helge et al. 2006; Sahlin et al. 2007; 
Venables et al. 2005).  VO2max is a strong predictor of whole-body oxidative capacity 
and insulin sensitivity in Europeans, independent of visceral adiposity and family 
history of type 2 diabetes (Bruce et al. 2003; Nyholm et al. 2004).  
    
As described in chapter 1, functional measures of substrate utilisation at the limb or 
whole-body level have demonstrated this relationship between skeletal muscle fatty 
acid oxidative capacity and insulin sensitivity, with the discoveries of reduced whole-
body fatty acid oxidation in obese individuals (Kelley et al. 1999; Kim et al. 2000) 
and reduced fat oxidation across the leg in individuals with type 2 diabetes (Kelley & 
Simoneau 1994), both of which correlate strongly with insulin sensitivity (Kim et al. 
1999).  In keeping with this finding, low VO2max values are often (Bruce et al. 2003; 
Melanson et al. 2005; Nyholm et al. 2004) but not always (Ostergard et al. 2006) 
associated with insulin resistance in white American and European populations.   
A low level of cardiorespiratory fitness is an independent predictor of type 2 diabetes 
(Wei et al. 1999), and is likely that fitness influences insulin sensitivity, at least in 
part, via effects on muscle lipid metabolism (Goodpaster & Brown 2005; Goodpaster 
et al. 2003), as trained individuals oxidize more fat during exercise than untrained   82 
individuals at any given exercise intensity (Holloszy 1967).  In addition, significantly 
lower VO2max values (~10-15% lower) have been found in relatives of patients with 
type 2 diabetes, who are more insulin resistant than matched controls (Ezenwaka et al. 
2001; Humphriss et al. 1997; Perseghin et al. 1997), and have about three times the 
risk of developing diabetes compared to those with no diabetes family history 
(Kobberling & Tillil 1982; Ohlson et al. 1988), and compared with age, BMI and 
body-fat matched controls (Nyholm et al. 2004; Thamer et al. 2003).   
 
Further evidence that skeletal muscle fatty-acid oxidation contributes to insulin 
sensitivity is described in detail in chapter 1.  Briefly, activities of the skeletal muscle 
mitochondrial enzymes responsible for both fat oxidation and transport of fatty acids 
into the mitochondria (D, citrate synthase, CPT1) (Bruce et al. 2000; Simoneau 
et al. 1999), have been found to correlate strongly with whole-body insulin sensitivity 
in Europeans, and the enzyme ACC which down-regulates fat oxidation, is reduced 
following weight loss in obese subjects, and these reductions in ACC correlate 
strongly with reductions in fasting insulin concentrations (Simoneau et al. 1999).   
 
Limited data indicate that a difference in whole body oxidative capacity is also 
evident when comparing men of South Asian origin with those of European descent – 
VO2max values in sedentary South Asians are typically ~15% lower than those in 
comparable sedentary European groups (Hardy & Eston 1985; Verma et al. 1979).  
One group of investigators (Hardy & Eston 1985) performed measurements of body 
composition in addition to measurements of cardiorespiratory fitness, and no 
significant anthropometric differences were observed between the two groups.  
Neither study measured insulin sensitivity, nor examined the relationship between   83 
insulin sensitivity and cardiorespiratory fitness.  This difference in fitness could, at 
least partly explained by the low levels of physical activity typically seen in South 
Asians (at least, those living in the UK) compared with their European counterparts 
(Barnett et al. 2005; Dhawan & Bray 1997; Fischbacher et al. 2004; Hayes et al. 2002; 
Health Education Authority 2000).  
 
Taking into account the known relationships between VO2max, whole-body fat 
oxidation (the majority of which takes place in skeletal muscle) and insulin 
sensitivity, it is possible to speculate that although increased fatty acid delivery to 
skeletal muscle could contribute to increased skeletal muscle insulin resistance in 
South Asians, reduced capacity for fatty acid oxidation may also play a role in 
inducing a mismatch between fatty acid uptake and fatty oxidation in skeletal muscle. 
 
In addition to skeletal muscle function and fitness, dietary factors, such as the quantity 
and quality of fat and carbohydrate intake, may also influence insulin sensitivity, 
although until recently there had not been any large intervention studies examining 
this issue.  Previous studies, one cross sectional (Maron et al. 1991), and one 
intervention involving very small numbers (Lovejoy et al. 1998) suggested that there 
was a positive correlation between total and saturated dietary fat intake and fasting 
insulin concentrations, independent of weight.  The recent RISCK trial (Jebb et al. 
2010), however, was a large controlled intervention trial examining the effect of diets 
which were high or low in saturated fatty acids (SFAs) and monounsaturated fatty 
acids (MUFAs) and which had high or low glycaemic index.  The investigators found 
that the type of fat consumed (i.e. replacing SFAs with MUFAs) had no effect on   84 
insulin sensitivity, although there was a non- significant trend towards improved 
insulin sensitivity with a low fat diet.  
 
Evidence regarding the effect of carbohydrate quantity and type on insulin sensitivity 
is less well established.  The popular “Atkins diet” fuelled interest in the effects of 
carbohydrate intake on insulin sensitivity, and subsequently some small intervention 
studies found improvements in insulin sensitivity in non-diabetic individuals on a 
very low carbohydrate diet (Meckling et al. 2002; Meckling et al. 2004; Volek et al. 
2004). Other studies, however, had conflicting results, with at least one small study 
demonstrating improved insulin sensitivity in patients with type 2 diabetes on a high 
carbohydrate diet (Sargrad et al. 2005).  Clearly, further larger studies are required to 
clarify the question of whether carbohydrate quantity affects insulin sensitivity.  
Carbohydrate quality may also exert an effect and it has been suggested that low 
glycaemic index (GI) diets may improve insulin sensitivity, although study methods 
and findings are inconsistent.  Several small studies seem to support this theory 
(Aston 2006; Frost et al. 1996; Frost et al. 1999), but the RISCK trial found no effect 
on insulin sensitivity of a low GI compared to a high GI diet. 
 
The effect of dietary protein intake on insulin sensitivity is also unclear, with some 
studies finding no effect of high protein intake (Sargrad et al. 2005) and others 
suggesting beneficial effects on insulin sensitivity of a high protein diet in both 
animal models (Belobrajdic et al. 2004) and in patients with type 2 diabetes (Linn et 
al. 1996; Parker et al. 2002). 
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The fact that diet influences insulin sensitivity suggests that dietary differences 
between South Asian and European populations are likely to be relevant in 
determining causes of insulin resistance in South Asians.  As mentioned in chapter 1, 
however, there is no real evidence that UK South Asians have poorer diets than the 
UK population as a whole (McKeigue et al. 1985; Miller et al. 1988; Sevak et al. 
1994), indeed diets of UK South Asians have been reported to be, if anything, 
generally healthier than those of the general population, with lower total energy 
intakes, higher intakes of complex carbohydrate, vegetable fibres and polyunsaturated 
fatty acids (PUFAs) (Sevak et al. 1994), so there is no clear evidence that differences 
in insulin sensitivity and diabetes risk are explained by unhealthy dietary habits.  It 
could be the case, however, that South Asians are more susceptible to metabolic 
consequences from the same degree of dietary Westernisation as Europeans.     
 
The association of adipose tissue function, including production of hormones, 
adipokines and pro-inflammatory cytokines with insulin resistance is also important, 
and has been discussed fully in chapter 1.  Data suggest that differences in circulating 
concentrations of these hormones and cytokines, indicating possible differences in 
adipose tissue functionality, may also be associated with insulin resistance in South 
Asians  (Anand et al. 2000; Chambers et al. 2001; Forouhi et al. 2003; Forouhi et al. 
2001; Kain et al. 2001; Petersen et al. 2006; Ryo et al. 2004).  This hypothesis 
requires to be tested further by examination of gene and protein expression of 
adipokines within the adipose tissue of South Asians and Europeans, and studies in 
this area are in progress.   
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The first aim of this part of the study was, therefore, to investigate whether there were 
any phenotypic differences between South Asians and Europeans in body 
composition, insulin sensitivity and other metabolic variables including fatty acids 
and adipokines, and to examine any relationships between these variables.  The 
second aim was to investigate whether there were any behavioural factors (e.g. in diet 
or physical activity levels) which might explain previously described differences in 
insulin sensitivity. 
 
3.2 Methods 
3.2.1 Volunteers  
Volunteers were recruited, screened and enrolled in the study as detailed in section 
2.2. Specific inclusion criteria are also defined in this section.  Further information 
detailing recruitment response and excluded volunteers can be found in Figure 2.1. 
The South Asian group was composed of 20 men of Indian, Pakistani and 
Bangladeshi origin.  The European group was composed of 20 men of British, French 
Scandinavian origin, although one European man was subsequently excluded form the 
final data analysis, because of the discovery, during the study, of a diagnosis of 
diabetes.   
 
South Asians and Europeans were well matched for age (South Asians 26.9  3.9 
years, Europeans 24.5  5.5 years, p = 0.12) and BMI (South Asians 23.6  2.9 kg.m
-
2, Europeans 22.6  2.7, p = 0.31).  
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3.2.2 Study design 
All participants underwent evaluation of physical characteristics, body composition, 
and cardiorespiratory fitness, and participated in metabolic assessment as detailed in 
sections 2.3, 2.4, 2.6 and 2.12.  All subjects also completed a food questionnaire and 
physical activity questionnaire. 
 
3.2.3 Evaluation of energy and macronutrient intake 
In order to calculate energy and macronutrient intake, all subjects completed a 120-
item food frequency questionnaire (appendix A5) (Fehily, Yarnell, & Butland 1987). 
 
3.2.4 Evaluation of habitual physical activity 
In order to evaluate habitual physical activity levels, the long version of the validated 
International Physical Activity Questionnaire (IPAQ) was also completed (appendix 
A4) (Craig et al. 2003). 
 
3.2.5 Evaluation of cardiorespiratory fitness 
Cardiorespiratory fitness was measured by predicted VO2max and lactate threshold, as 
described in section 2.7. 
 
3.2.6 Metabolic testing 
As described in section 2.12, after a 12-hour fast, all subjects attended the metabolic 
investigation suite at the Institute of Diet, Exercise and Lifestyle (IDEAL). Resting 
metabolic rate was measured and substrate utilisation calculated (see sections 2.6.2 
and section 2.9) and fasting blood samples were taken (section 2.10.1).  A 
percutaneous skeletal muscle biopsy, using the semi-open technique described by   88 
Henriksson (Henriksson 1979) (see section 2.12.1) was preformed and samples were 
immediately snap frozen in liquid nitrogen.  An oral glucose load was then consumed 
(75g of glucose in 300ml) and blood samples were taken for glucose, insulin, NEFA 
and TG at 30-minute intervals for 2 hours. 
 
3.2.7 Blood sample analysis 
After centrifugation all plasma samples were stored at -80ºC in labelled 2 ml 
Eppendorf tubes (Alpha Laboratories, Hampshire, UK). Glucose, NEFA, total 
cholesterol, HDL-cholesterol, TG and CRP were all measured by spectrophometric 
techniques as described in Section 2.11.3. LDL-cholesterol was calculated by the 
Friedewald equation (Friedewald, Levy, & Fredrickson 1972). Insulin, adiponectin, 
resistin, leptin, TNFα, IL-6 were measured by ELISA technique as described in 
section 2.11.5 
 
3.2.8 Calculation of glucose, insulin and NEFA concentrations and insulin 
sensitivity during oral glucose tolerance test  
The mean concentration of glucose, insulin and NEFA during the oral glucose 
tolerance test (OGTT) was calculated by dividing the area under variable vs. time 
curve (total AUC) by the duration of the OGTT (mean during OGTT). The rise (or 
suppression) of glucose, insulin and NEFA was calculated by subtracting the area 
under the fasting concentration vs. time curve from the total AUC and dividing the 
obtained value by the duration of the OGTT (rise during OGTT). For variables where 
values decreased from baseline after glucose ingestion (e.g. NEFA), the rise during 
OGTT was negative and represented the area above the curve extending up to the 
baseline value, providing an index of post-glucose suppression. Insulin sensitivity was   89 
calculated using the Insulin Sensitivity Index (ISI) as described by Matsuda and 
DeFronzo (Matsuda & DeFronzo 1999).  
 
3.2.9 Analysis of muscle samples for quantification of mitochondrial enzyme 
activity/ gene expression  
This analysis was performed as described in section 2.13.2. 
 
3.2.10 Analysis of muscle samples to determine skeletal muscle mitochondrial 
DNA (mtDNA) to nuclear DNA (nDNA) ratio. 
This analysis was performed as described in section 2.13.3. 
 
3.2.11 Statistical analysis 
Data were analysed using Statistica (version 6.0, StatSoft Inc., Tulsa, Oklahoma) and  
Minitab (version 13.1, Minitab Inc., State College, Pennsylvania). Prior to analysis, 
all data were tested for normality using the Anderson-Darling normality test and, if 
necessary, logarithmically transformed. All data between South Asians and Europeans 
was compared using unpaired t-tests. Univariate linear regressions were performed, 
using logarithmically transformed data where required. Correlations between ISI and 
other variables were performed for the South Asians and European groups.  
To determine the extent to which variables were related to ISI independently of age, 
BMI and fat mass, univariate linear regressions were then performed between the 
residuals for ISI of the regression between ISI and age, ISI and BMI and ISI and total 
fat mass.  This, in effect, provides the correlations between ISI and other variables 
adjusted for the effect of age, BMI and total fat mass.  Significance was accepted at p 
≤ 0.05.    90 
3.3 Results 
3.3.1 Demographic and heath screening data 
All volunteers lived in Glasgow at the time of the study, with 18 of the European men 
and 4 of the South Asian men having lived in the UK for their whole lives.  Sixteen of 
the South Asians who were born outside the UK, and mean (± SD) duration of UK 
residence was 2.5 ± 5 years, although 11 of them had been resident in the UK for less 
than 1 year. Ten of the South Asians were Indian, 9 were Pakistani and one was Sri 
Lankan, and all of the Europeans were from northern Europe, 18 being British.  One 
European volunteer was French and 1 was British/Finnish. 
 
There was no ethnic difference in mean DepCat score, which is a measure of 
socioeconomic deprivation, with a scale ranging from DepCat 1, which is most 
affluent, to DepCat 7, which is most deprived (Carstairs & Morris 1991).  Mean (± 
SD)  DepCat scores were 4.7 ± 1.9 in South Asians, and 5.2 ± 1.6 in Europeans (p = 
0.65). 
  
All participants were non-smokers, aged 18-40 years, in generally good health, with 
blood pressure <160/90 mmHg, and no known history of diabetes or cardiovascular 
disease.  The only volunteers taking any medication were one European using steroid 
and β2 agonist inhalers for asthma and topical steroids for eczema and another 
European using topical steroids for eczema.  
 
3.3.2 Anthropometric characteristics and body composition data 
A summary of anthropometric data is shown in Table 3.1.  There was no significant 
difference in age, body mass or BMI between South Asians and Europeans in   91 
unadjusted analysis, but South Asians were shorter in height with significantly higher 
total, trunk, arm and leg fat mass and, with correspondingly lower total, trunk, arm 
and leg lean mass than the Europeans.  These differences persisted after adjustment 
for age and BMI.  Further adjustment for fat mass abolished differences in trunk, arm 
and leg fat between groups, indicating no significant differences in regional fat 
distribution between South Asians and Europeans.  Adjustment for physical activity 
did not affect these data.  There was no significant difference in waist or hip 
circumference or in waist-hip ratio between the two groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   92 
Table 3.1 Anthropometric and body composition data.  
 
  South 
Asians 
Europeans  p-value  Age and 
BMI- 
adjusted p-
value 
Age, BMI and fat 
mass- adjusted p-
value 
Age (years) 
 
26.9 ± 3.9  24.5 ± 5.5  0.12  -  - 
BMI (kg.m
-2) 
 
23.6 ± 2.9  22.6 ± 2.7  0.31  -  - 
Body mass (kg) 
 
71.8 ± 10.1  72.5 ± 8.8  0.82  0.13  0.034 
Height (cm) 
 
174.4 ± 7.1  179.0 ± 6.8  0.046  0.11  0.028 
Total fat mass (kg) 
 
18.4 ± 5.3  13.6 ± 5.2  0.007  < 0.0005  - 
Trunk fat mass (kg) 
 
10.0 ± 3.3  7.1 ± 3.3  0.009  < 0.0005  0.520 
Arm fat mass (kg) 
 
1.4 ± 0.5  1.0 ± 0.5  0.02  0.008  0.606 
Leg fat mass (kg) 
 
6.3 ± 1.6  5.0 ± 1.5  0.009  0.004  0.618 
Fat-free mass (kg) 
 
53.4 ± 6.6  58.9 ± 5.9  0.010  0.001  0.034 
Total lean mass (kg) 
 
50.0 ± 5.8  56.3 ± 5.6  0.001  < 0.0005  0.009 
Trunk lean mass (kg) 
 
22.7 ± 2.8  26.4 ± 2.6  < 0.0005  < 0.0005  0.003 
Arm lean mass (kg) 
 
6.2 ± 0.8  6.5 ± 0.9  0.25  0.08  0.327 
Leg lean mass (kg) 
 
17.5 ± 2.3  19.5 ± 2.1  0.007  0.002  0.026 
Waist circumference 
(cm) 
 
82.3 ± 7.5  78.8 ± 6.8  0.14  0.30  0.778 
Hip circumference 
(cm) 
97.3 ± 5.8  96.6 ± 1.1  0.69  0.59  0.463 
Values are mean   SD 
 
 
 
3.3.3 Diet data 
There was no significant difference in total daily energy intake or in macronutrient 
intake between the two groups.  Self reported alcohol intake was significantly higher 
in the European group than the South Asian group, and other notable differences   93 
included significantly higher dietary calcium, Vitamin D and Vitamin C intake in the 
European group.  These data are illustrated in Tables 3.2 and 3.3. 
 
Table 3.2 Macronutrient intake data  
 
  South Asians  European  p-value 
 
Total energy intake 
(MJ.day
-1) 
8.8  2.0  9.4  2.0  0.41 
Fat (g.day
-1)  71  18  80  26  0.19 
Carbohydrate (g.day
-1)  290  90  260  50  0.20 
Protein (g.day
-1)  87  17  98  25  0.12 
Values are mean  SD 
 
 
Table 3.3 Micronutrient and alcohol data  
 
  South Asians  European  p-value 
 
Vitamin C (mg.day
-1)  82.1  20.8  112.3  52.2  0.02 
Vitamin D (μg.day
-1)  1.88  1.2  3.61  2.6  0.01 
Calcium (mg.day
-1)  1046  177.7  1232  247.1  0.01 
Vitamin B12 (μg.day
-1)  6.3  1.8  8.04  2.90  0.03 
Vitamin B6 (mg.day
-1)  2.1  0.5  2.57 0.72  0.02 
Riboflavin (mg.day
-1)  2.1  0.4   2.44  0.53  0.01 
Sodium (mg.day
-1)  1779.6  499.7  2310.7  598.0  0.004 
Zinc (mg.day
-1)  9.9  1.8  12.1  3.2  0.008 
Alcohol (g.day
-1  3  7  20  17  0.0002 
Values are mean  SD 
 
 
Interestingly, the South Asians consumed significantly more complex carbohydrates 
(i.e. dietary starch) than the Europeans, although there was no difference between the 
groups in consumption of simple carbohydrate and no difference in glycaemic index 
or glycaemic load between the two groups.  Data regarding carbohydrate type and 
quality are shown in Table 3.4.  Dietary intake of the B-vitamins B12, B6 and 
riboflavin was also significantly lower in the South Asian group, as was intake of   94 
elemental sodium, zinc and chloride. There was no significant difference in 
consumption of any other mineral  
 
Table 3.4 Carbohydrate data  
 
  South Asians  European  p-value 
 
Complex carbohydrate (g.day
-1) 
 
181.4 ± 61.2   140.8  30.3  0.01 
Simple carbohydrate (g.day
-1) 
 
107.6  36.9  118.0  31.1  0.35 
Glycaemic index 
 
49.8  4.3  47.2  5.0  0.08 
Glycaemic load 
 
145.0  48.3  122.4  25.6  0.08 
Values are mean  SD 
 
 3.3.4 Metabolic data  
There was no significant difference in fasting pre and post biopsy glucose and insulin 
concentrations in either group.  There was no significant difference in fasting glucose 
or insulin concentrations between South Asians and Europeans.  Two hours post oral 
glucose tolerance test (OGTT) glucose concentrations were not significantly different 
in the two groups, nor was the area under the curve (AUC) of plotted glucose 
concentrations, over the 2 hour period of the GTT.   
 
However, insulin concentration 2 hours post GTT and insulin AUC were significantly 
higher in South Asians, compared to Europeans, both in unadjusted analysis and 
following adjustment for age, BMI and fat mass.  Adjustment for trunk fat mass, 
rather than total fat mass did not alter the findings, but adjustment for percentage 
body fat, rather than total fat mass resulted in loss of the significant difference in 2-
hour (p = 0.13) insulin.  These data are illustrated in Figure 3.1.   95 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Plasma insulin (A), glucose (B) and NEFA (C) concentrations in South 
Asians and European subjects, fasting, and in responses to a 75g oral glucose 
tolerance test.   
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Insulin sensitivity index was significantly lower in South Asians, and fasting HDL 
concentration was also significantly lower, both differences which were retained after 
adjustment for age, BMI and fat mass and also after adjustment for percentage body 
fat, rather than total fat mass.  When ISI values were further adjusted for VO2max or 
for the rate of fat oxidation during sub-maximal exercise at 55% VO2max, the 
significant difference between South Asians and Europeans was abolished (p = 0.16 
and 0.12 respectively).  There was no observed significant difference between the 2 
groups in insulinogenic index, which is a measure of β-cell function, and no 
significant difference in fasting NEFA concentration, NEFA AUC, fasting total 
cholesterol, triglyceride, AST or ALT concentrations.  Resting metabolic rate was 
significantly lower in South Asians but this difference was abolished after adjustment 
for fat mass.  There was no difference in rate of fat oxidation (expressed per kg fat-
free mass) between the groups.  These data are summarised in Table 3.5. 
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Table 3.5 Metabolic data  
  South 
Asians 
Europeans  p-value  Age and BMI 
adjusted p-
value 
Age,BMI and fat 
mass adjusted p-
value 
Fasting glucose* 
(mmol.l
-1) 
5.14 ± 0.47  5.24 ± 0.52  0.53  0.50  0.94 
Fasting insulin* 
(mU.l
-1) 
6.56 ± 3.53  5.39 ± 4.20  0.11  0.17  0.023 
Glucose AUC 
(mmol.l
-1.h) 
13.89 ± 2.35  14.74 ± 2.82  0.35 
 
0.46  0.74 
Insulin AUC 
(mU.l
-1.h) 
105.4 ± 53.6  72.9 ± 48.0  0.036 
 
0.045  0.099 
2 hour insulin* 
(mU.l
-1) 
46.6 ± 29.6  27.5 ± 5.3  0.017  0.031  0.043 
Insulin sensitivity 
index
† 
5.89 ± 2.93  7.96 ± 3.49  0.048  0.047  0.012 
Insulinogenic index 
* 
 
19.20 ± 
14.75 
11.10 ± 6.10  0.075  0.57  0.52 
Fasting NEFA* 
(mmol.l
-1) 
0.41 ± 0.13  0.44 ± 0.57  0.85  0.99  0.85 
NEFA AUC* 
(mmol.l
-1.h) 
 
0.51 ± 0.16  0.52 ± 0.28  0.38 
 
0.39  0.60 
Fasting total 
cholesterol 
(mmol.l
-1) 
4.46 ± 0.89  4.07 ± 0.85  0.17  0.37  0.34 
Fasting HDL 
cholesterol 
(mmol.l
-1) 
1.08 ± 0.22  1.37 ± 0.20  < 0.0005  0.001  0.002 
Fasting TG* 
(mmol.l
-1) 
 
1.18 ± 0.65  0.87 ± 0.56  0.054  0.13  0.13 
Resting metabolic 
rate (kJ.kg fat-free 
mass
-1.day
-1) 
 
114.1 ± 9.0  118.6 ± 10.8  0.170  0.378  0.059 
Resting fasted fat 
oxidation  (mg.kg
-
1fat-free mass.min
-1 
1.47 ± 0.44  1.38 ±0.43  0.548  0.510  0.862 
 
Values are mean  SD. *statistical analysis performed on log transformed data, 
†statistical analysis performed on square-root transformed data.
   insulinogenic index 
= insulin (30-0)/glucose (30-0) 
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3.3.5 Physical activity and exercise test data 
Although it is possible that the physical activity questionnaire used may not have been 
sufficiently sensitive to detect real differences in physical activity, no significant 
difference in habitual physical activity level between the two groups was 
demonstrated, nor was therea difference in most individual activities contributing to 
this, including walking and work-related activity.  The only type of physical activity 
where there was a reported difference between the 2 groups was cycling, with 
Europeans reporting significantly more cycling than South Asians.  Physical activity 
data are shown in Table 3.6. 
 
Table 3.6 Physical activity data 
 
  South Asians  European  p-value 
 
Sitting (min.day
-1) 
 
124.9 ± 48.6  130.0 ± 52.1  0.78 
Walking (min.day
-1) 
 
75.8 ± 92.3  51.4 ± 47.1  0.3 
Moderate exercise 
(min.day
-1) 
17.0 ± 44.8  10.8 ± 19.9  0.57 
Vigorous exercise 
(min.day
-1) 
6.3 ± 12.6  8.5 ± 8.0  0.51 
Cycling (min.day
-1) 
 
0  5.6 ± 10.8  0.03 
Total physical activity 
(MET-mins.day
-1) 
254 ± 114  290 ± 229  0.75 
Values are mean  SD 
 
South Asians had lower levels of cardiorespiratory fitness (reflected by VO2max, 
expressed both per kilogram of total body mass and per kilogram of fat-free mass) 
than Europeans.  Fat oxidation (per kilogram whole body mass and fat-free mass) 
during incremental submaximal exercise was also significantly lower in South Asians, 
when expressed as an absolute value and as a percentage of VO2max, but fat oxidation   99 
at rest was not significantly different between the two groups.  Carbohydrate 
oxidation during incremental submaximal exercise was similar in both groups at the 
same relative exercise intensity (i.e. with intensity expressed as a percentage of 
VO2max but higher in South Asians at the same absolute exercise intensity).  Fitness, 
physical activity and fat oxidation data are presented in Table 3.7, Figure 3.2 and 
Figure 3.3. 
 
Table 3.7 Fitness and fat oxidation data  
 
  South 
Asians 
Europeans  p-value  Age and 
BMI 
adjusted 
p-value 
Age,BMI and 
fat mass -
adjusted 
p-value 
VO2max 
(l.min
-1) 
 
2.89 ± 0.48  3.80 ± 0.60  <0.0005 
 
< 0.0005  0.001 
VO2max 
(ml.kg
-1.min
-1) 
 
40.6 ±  6.6  52.4 ± 5.7  < 0.0005  < 0.0005  0.001 
VO2max 
(ml.kg
-1 fat-free 
mass.min
-1) 
 
54.1 ± 6.6  64.3 ± 5.8  < 0.0005  < 0.0005  0.001 
Fat oxidation (mg.kg
-
1.min
-1) 
@ 55% VO2max 
 
3.77 ± 2.02  6.55 ± 2.60  0.001  0.010  0.012 
Fat oxidation (mg.kg 
fat-free mass
-1.min
-1) 
@ 55% VO2max 
 
5.08 ± 2.75  8.01 ± 0.63  0.005  0.003  0.011 
Fat oxidation (mg.kg
-
1.min
-1) 
@ 25 ml.kg
-1.min
-1 
 
3.46 ± 2.20  6.00 ± 1.93  0.001  0.002  0.020 
Values are mean  SD 
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Figure 3.2 Fat oxidation (A) and carbohydrate oxidation (B) during incremental 
submaximal exercise. Intensity expressed in terms of absolute oxygen uptake 
(i.e. ml.kg
-1.min
-1). P-values shown are for the main-effect difference between 
European and South Asian groups, either unadjusted, or adjusted for age, BMI and fat 
mass. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 Fat oxidation (A) and carbohydrate oxidation (B) during incremental 
submaximal exercise. Intensity expressed relative to each individual’s maximum 
oxygen uptake (i.e. percentage VO2max ). P-values shown are for the main-effect 
difference between European and South Asian groups, either unadjusted, or adjusted 
for age, BMI and fat mass. 
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3.3.6 Skeletal muscle mtDNA to nDNA ratio 
There was no difference in skeletal muscle mtDNA to nDNA ratio between South 
Asians and Europeans (mean (95%CI) South Asians 0.94 (0.71 to 1.21), Europeans 
1.13 (0.82 to 1.49), p = 0.39). 
   
3.3.7 Skeletal muscle expression of oxidative and lipid metabolism genes   
Expression of oxidative and lipid metabolism genes in skeletal muscle is shown in 
Table 3.8. Expression of carnitine palmitoyltransferase 1A (CPT1A) was 1.79-fold 
greater (p = 0.023) and expression of fatty acid synthase (FASN) was 1.96-fold 
greater (p = 0.036) in South Asians than Europeans. 
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Table 3.8 Oxidative and lipid metabolism gene expression in skeletal muscle 
 
  South Asians  Europeans  p   Age and BMI 
adjusted p  
Age, BMI 
and fat mass 
adjusted 
 
CD36 
 
1.15 (0.94 to 1.41)  1.00 (0.81 to 1.23)  0.343  0.210  0.168 
CPT1A 
 
1.79 (1.32 to 2.43)  1.00 (0.69 to 1.46)  0.023  0.013  0.007 
CPT1B 
 
1.22 (0.89 to 1.68)  1.00 (0.71 to 1.40)  0.406  0.244  0.088 
CPT2 
 
1.16 (1.00 to 1.34)  1.00 (0.74 to 1.36)  0.388  0.282  0.459 
HADHA 
 
1.25 (0.98 to 1.59)  1.00 (0.77 to 1.30)  0.233  0.078  0.049 
HADHB 
 
1.23 (0.96 to 1.57)  1.00 (0.75 to 1.33)  0.296  0.356  0.538 
ACACA 
 
1.32 (0.86 to 2.04)   1.00 (0.7 to 1.43)  0.342  0.201  0.109 
ACACB 
 
1.25 (0.84 to 1.86)  1.00 (0.69 to 1.46)  0.422  0.183  0.141 
CS 
 
1.10 (0.84 to 1.44)  1.00 (0.79 to 1.27)   0.606  0.303  0.066 
CS (long transcript) 
 
1.29 (1.04 to 1.6)  1.00 (0.8 to 1.26)   0.122  0.061  0.031 
CS (short transcript) 
 
1.09 (0.79 to 1.5)  1.00 (0.73 to 1.37)  0.712  0.323  0.064 
COX1 
 
1.07 (0.72 to 1.59)  1.00 (0.69 to 1.44)  0.805  0.515  0.447 
FASN 
 
1.96 (1.19 to 3.25)   1.00 (0.72 to 1.39)  0.036  0.025  0.111 
FADS3 
 
1.65 (1.19 to 2.28)  1.00 (0.64 to 1.56)  0.082  0.037  0.023 
Values are mean (95% CI, expressed relative to mean value in European group).   
Abbreviations: CD36 Cluster of differentiation 36; CPT carnitine palmitoyltransferase; 
HADHA hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-
Coenzyme A hydratase (trifunctional protein), alpha subunit; HADHB hydroxyacyl-
Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase, 
beta subunit; ACACA acetyl-Coenzyme A carboxylase alpha; ACACB acetyl-Coenzyme A 
carboxylase beta; CS citrate synthase; COX 1 cytochrome c oxidase 1; FASN fatty acid 
synthase; FADS 3 fatty acid desaturase 3   103 
3.3.8 Adipose derived hormones, pro-inflammatory cytokines and cell - adhesion                      
molecules 
There were no significant differences between South Asians and Europeans in plasma 
concentrations of the adipose derived hormone adiponectin.  Plasma leptin 
concentration was significantly higher in the South Asians.  There were no differences 
in plasma concentrations of the pro-inflammatory cytokines TNF-α and interleukin-6 
(IL-6) or in concentrations of the call-adhesion molecule selectin.  These data are 
illustrated in Table 3.9 
 
 
Table 3.9 Adipose derived hormones, cytokines and selectin 
 
  South 
Asians 
Europeans  p value  Age, BMI and fat 
mass -adjusted 
p value 
Adiponectin 
(μg.ml
-1) 
4.10 ± 2.35  4.84 ± 2.41  0.34  0.28 
Leptin 
(ng.ml
-1)* 
4.52 ± 1.76  3.36 ± 1.56  0.020  0.31 
Selectin 
(ng.ml
-1) 
37.2 ± 12.89  35.66 ± 14.51  0.73  0.82 
IL-6 
(pg.ml
-1)* 
1.23 ± 0.77  1.19 ± 0.75  0.535  0.849 
TNF
(pg.ml
-1)
# 
0.78 ± 0.89  0.57 ± 0.57  0.366  0.248 
 
Values are mean  SD *statistical analysis performed on log transformed data, 
#statistical analysis performed on square-root transformed data 
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3.3.9 Anthropometric correlates with insulin sensitivity index 
The regression slopes for these relationships did not differ significantly between 
South Asians and Europeans so data are presented for the combined group.  As 
predicted, when the group was examined as a whole, there was a significant 
correlation between square root ISI and BMI (r = -0.373, p = 0.019), waist 
circumference (r = 0.387, p = 0.015) and trunk fat mass (r = 20.359, p= 0.025). 
Square-root ISI correlated significantly with height (r = 0.329, p= 0.041) and lean 
mass (r = 0346, p = 0.028).  None of the other measured body composition variables 
significantly correlated with square root ISI.  These data are presented in Figures 3.4 
and 3.5.  None of the other anthropometric or body composition variables, including 
total body mass significantly correlated with square root ISI.   
 
The groups were examined separately to determine whether there were any 
relationships between anthropometric variables and ISI particular to either of the 
ethnic groups.  In the South Asian group, there were significant negative correlations 
between square root ISI and waist circumference (r = -0.633, p = 0.03), hip 
circumference (r = -0.447, p = 0.048) and waist-hip ratio (r = -0.503, p = 0.024).  In 
the European group there was a significant negative correlation between square root 
ISI and BMI (r = -0.461, p = 0.047), which was not observed in the South Asians 
group.  In addition, ratio of trunk to limb fat mass (r = -0.474, p = 0.04) and waist-hip 
ratio (r = -0.492, p = 0.033) correlated negatively with square root ISI, and a positive 
correlation existed between square root ISI and height (r = 0.498, p = 0.030).   
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Figure 3.4 Relationship between waist circumference and square-root insulin 
sensitivity index 
 
 
Figure 3.5 Relationship between trunk fat and square-root insulin sensitivity 
index 
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3.3.10 Physiological correlates with insulin sensitivity index 
In unadjusted univariate correlations, VO2max, expressed in ml.kg
-1.min
-1 (r = 0.399,   
p = 0.012) or ml.kg
-1 fat-free mass.min
-1 (r = 0.352, p = 0.028) correlated significantly 
with square-root ISI.  In addition, fat oxidation during sub-maximal exercise at 55% 
VO2max, expressed in ml.kg
-1.min
-1 (r = 0.423, p = 0.011) (Figure 3.6) or in ml.kg
-1 
fat-free mass.min
-1 (r = 0.409, p = 0.015), and fat oxidation at an absolute VO2 of  
25 ml.kg
-1.min
-1 (r = 0.370, p = 0.029) correlated significantly with square-root ISI. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 Relationship between rate of fat oxidation during submaximal 
exercise and square-root insulin sensitivity index 
 
 
Adjustment for age, BMI, fat mass and physical activity slightly attenuated the 
relationships.  However, even after adjustment for these variables significant 
relationships were observed between square root ISI, and fat oxidation during 
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submaximal exercise at 55% VO2max, expressed in mg.kg
-1.min
-1 (r = 0.335,                
p = 0.049) or in mg.kg
-1 fat-free mass.min
-1 (r = 0.370, p = 0.029).  After adjustment, 
there remained a borderline significant relationship between square root ISI and 
VO2max expressed in ml.kg
-1 fat-free mass.min
-1 (r = 0.315, p = 0.051).  Thus, 
independent of age, body composition and physical activity level, VO2max or fat 
oxidation during submaximal exercise explained 10-13% of the variance (i.e. r
2) in 
square-root ISI.   
 
Neither fat oxidation rate at rest nor resting metabolic rate (however expressed) 
correlated significantly with square-root ISI. In addition, fat oxidation rate at rest did 
not correlate significantly with fat oxidation rates during exercise (however 
expressed).  
 
 
3.4 Discussion 
The aims of the study were firstly to determine whether there were any differences in 
insulin sensitivity or in other metabolic variables associated with insulin resistance 
between South Asians and Europeans which were independent of differences in body 
composition.  An additional aim was to investigate possible lifestyle differences, such 
as dietary intake and habitual exercise and to examine differences in cardiorespiratory 
fitness and skeletal muscle fat oxidation.  Further, the study aimed to investigate 
relationships between fat oxidation and insulin sensitivity, to establish whether or not 
this could explain differences in insulin sensitivity between the two ethnic groups. 
 
Data from the study demonstrate no significant difference in total energy or 
macronutrient intake between South Asians or Europeans, although South Asians   108 
reported higher complex carbohydrate intake.  There were also significant differences 
in intake of Vitamin C and Vitamin D, and in intake of a number of micronutrients, 
with the South Asians reporting significantly lower intake of all of these dietary 
components.  These findings are of interest, as hypovitaminosis D is increasingly 
recognized in UK South Asians, especially women (Ford et al. 2006; Roy et al. 2007) 
and serum vitamin D concentrations have been found to be associated positively with 
insulin sensitivity and measures of β cell function in non-diabetic individuals (Chiu et 
al. 2004) and negatively with diabetes risk (in heterogeneous US populations, not 
including subjects of South Asian origin) (Scragg et al. 2004). Plasma vitamin C is a 
good surrogate measurement of fruit and vegetable intake and has also, in at least one 
study been shown to inversely correlate with diabetes risk (Harding et al. 2008). 
 
The observation that there was no significant difference in habitual physical activity 
between South Asians and Europeans in this study is not in keeping with previous 
published studies, which suggest that UK South Asians have lower physical activity 
levels than the background population.  However most of the published studies to date  
investigating ethnic differences in physical activity in adults relied on self-report 
questionnaires, which are of limited validity and reliability compared to objective 
measures of physical activity (Shephard 2003).  Data obtained from questionnaires 
may also be subject to differences in cultural interpretation of the questions 
(Fischbacher et al. 2004).  Only one recent study has provided objective evidence, 
using accelerometers, that South Asian children aged 9-10 years old have lower levels 
of physical activity than white European children of the same age (Owen et al. 2009).  
This finding requires confirmation in adults, with a view to examining the relationship 
between physical activity and insulin resistance, but it does seem to be the case that   109 
South Asians may adopt particularly sedentary lifestyles when they migrate to 
Westernised countries, which could potentiate their innate predisposition to insulin 
resistance.      
 
Despite no significant differences in diet or physical activity, the South Asian subjects 
displayed the characteristic phenotype of increased adiposity and particularly 
abdominal fat distribution (significantly higher total body fat mass, with increased 
truncal obesity than the European subjects) and a characteristic lipid profile with 
similar total cholesterol concentrations to Europeans but significantly lower HDL 
cholesterol concentrations.   
 
As expected, and in keeping with this characteristic phenotype, the South Asian 
subjects were significantly more insulin resistant than the European subjects.  
Interestingly the reduction in insulin sensitivity was not fully explained by differences 
in adiposity – the insulin sensitivity index remained significantly different even after 
adjustment for age, BMI, physical activity and fat-mass.  There was no significant 
difference in insulinogenic index, which is a marker of β cell function, between the 
South Asians and Europeans, suggesting that β cell function is preserved, with 
compensatory hyperinsulinaemia overcoming the effects of insulin resistance and 
post-prandial hyperglycaemia. 
 
A large adipose tissue mass is known to be associated with increased lipolysis and 
resultant higher circulating NEFA concentrations (Boden 1997; Delarue & Magnan 
2007), and NEFA concentrations are sometimes, but not always elevated in insulin 
resistant states (Corpeleijn et al. 2009), so the present study results finding South   110 
Asian subjects to have similar NEFA concentrations (and post-glucose NEFA AUCs) 
to European subjects, despite significantly larger fat mass are somewhat surprising, 
although could be explained by the fact that circulating NEFA levels generally tend to 
be very low, difficult to measure, and are a poor marker of fatty acid flux/ 
mobilisation.   
 
The South Asians also had strikingly reduced cardiorespiratory fitness as measured by 
VO2max than the Europeans with values, which were, on average 25% lower, whether 
this was expressed per kilogram of total body mass or per kilogram of fat-free mass 
(with a highly significant p value of 0.001).   
 
The finding of no ethnic differences in plasma concentrations of the adipose derived 
hormone adiponectin contrasts with prior studies in South Asians (Chandalia et al. 
2007), and suggests that this may not be an important factor in insulin resistance in 
South Asians.  Plasma leptin concentrations were higher in the South Asians, simply 
reflecting increased fat mass, so as expected, the difference in plasma leptin 
concentration did not persist after adjustment for fat mass.  The concentrations of IL-
6, TNF-α  and the cell-adhesion molecule selectin were also comparable between the 
two groups, suggesting that increased production and /or activity of pro-inflammatory 
cytokines is not causal of or  associated with insulin resistance in South Asians, again 
conflicting evidence to that from previous studies (Abate et al. 2004; Nair, Bigelow et 
al. 2008). 
 
In contrast to the observations made at the whole body level, South Asians did not 
exhibit lower expression of oxidative and lipid metabolism genes in skeletal muscle   111 
biopsies than Europeans, and indeed expression of CPT1A and FASN were higher in 
South Asians. In addition, other than a negative correlation between expression of 
CPT1A and ISI in the South Asians – the opposite direction of the expected 
association – expression of none of these genes was related to whole-body insulin 
sensitivity. Furthermore, the mtDNA to nDNA ratio, which provides an index of 
mitochondrial biogenesis (Williams et al. 1986), did not differ between the two 
groups. Our data therefore indicate that reduced skeletal muscle expression of 
oxidative and lipid metabolism genes does not explain the increased insulin resistance 
observed in South Asians.  The author is unaware of previous studies examining 
differences in whole body fat oxidation in any ethnic population, either at rest or in 
the context of exercise.  Although the new observation of reduced whole-body fat 
oxidation during exercise in South Asians was made, it is not possible, from the 
present data, to state conclusively that an innate defect in skeletal muscle is the cause 
of this phenomenon. 
 
This study has a number of limitations.  Firstly, insulin sensitivity was assessed from 
glucose and insulin responses to an oral glucose tolerance test, rather than using the 
gold-standard euglycaemic hyperinsulinaemic clamp. However, the insulin sensitivity 
index used in this study correlates well with clamp-derived measures of insulin 
sensitivity (Matsuda & DeFronzo 1999), and has been widely accepted in the 
literature, with over 1000 citations in the last decade.  In addition it was only the 
expression of genes involved in oxidation and lipid metabolism in skeletal muscle 
which was measured, and while none of these was lower in the South Asians than the 
Europeans, indicating that transcription of these genes is not defective in South Asian 
muscle, further study is needed to determine whether differences in protein levels or   112 
activity of these enzymes exist between South Asian and European skeletal muscle.  
Finally, although the men were extensively phenotyped, IMTG and skeletal muscle 
concentrations of lipid intermediates were not directly measured in this study and 
further investigation is needed to ascertain the extent to which these differ between 
South Asians and Europeans, and how they relate to capacity for fat oxidation during 
exercise and insulin sensitivity. 
 
The novel findings of this study were that South Asians oxidized less fat than 
Europeans during exercise, and that VO2max and fat oxidation during submaximal 
exercise correlated significantly with whole-body insulin sensitivity, independently of 
age, body composition and physical activity level, explaining 10-13% of the variance 
in insulin sensitivity.  This suggests that reduced oxidation and utilization of fatty 
acids by skeletal muscle is an important association with the insulin resistant 
phenotype typically seen in South Asians.  
 
The significantly higher expression of CTP1A and FASN observed in the South 
Asians suggest that reduced fat oxidation is not a result of reduced skeletal muscle 
expression of oxidative and lipid metabolism genes. 
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Chapter 4 
Skeletal muscle insulin signalling in South Asian and European Men 
 
4.1 Introduction 
The studies performed in Chapter 3 found the South Asian subjects to be more insulin 
resistant than their matched Europeans counterparts.  They displayed the 
characteristic phenotype seen in South Asians of increased adiposity, particularly 
increased truncal fat, indicative of central obesity.  However, differences in insulin 
sensitivity between South Asian and European subjects persisted after adjustment for 
age, BMI and fat mass.  This finding, together with the observation of reduced whole 
body fat oxidation during exercise, and the fact that skeletal muscle during exercise is 
the major contributor to fat oxidation, suggests a novel mechanism for insulin 
resistance i.e. that altered skeletal muscle function could be implicated.   
 
Altered skeletal muscle function causing reduced oxidation of fatty acids could result 
in the accumulation of lipid intermediates with deleterious effects, and this could 
conceivably affect insulin signalling within skeletal muscle.  If altered insulin 
signalling was to be demonstrated in South Asians this could arise either as a direct 
result of the effect of IMCL accumulation or it could be an innate alteration in insulin 
signalling.  Regardless of the cause, if the alteration impaired insulin signalling, 
glucose transport into skeletal muscle cells would be reduced, therefore skeletal 
muscle would be insulin resistant.  Because of the significant influence of skeletal 
muscle on whole body metabolism, insulin resistance within skeletal muscle results in 
a series of metabolic perturbations which over years leads to whole-body insulin 
resistance (Petersen & Shulman 2002).   114 
As mentioned in Chapter 1, aberrations in insulin signalling at various stages in the 
insulin signalling pathway have been observed in patients with type 2 diabetes and 
other insulin resistant states.  There is no clear consensus about specific defects as 
many studies have produced conflicting results.  For example, studies examining IRS-
1 phosphorylation in the skeletal muscle of patients with type 2 diabetes, have found 
it to both reduced (Bjornholm et al. 1997; Stentz & Kitabchi 2007) and unchanged 
(Krook et al. 2000), suggesting that IRS-1 may not be a key protein in insulin 
resistance.  
 
Reductions in expression of the p85, the regulatory subunit of PI3K has been 
observed in obesity in one study (Colomiere et al.2009) but most studies have fond 
increased p85 expression in insulin resistance (Bandyopadhyay et al. 2005; Barbour et 
al. 2005; Friedman et al.1999; Hammarstedt et al. 2003).   
 
Downstream of PI3K, protein kinase B (PKB), or Akt, is an important protein in the 
insulin signaling pathway.  Of its several isoforms PKBβ is thought to have the most 
significant role in insulin signalling, based on studies examining the PKB β knockout 
mouse, which is insulin resistant and develops a type 2 diabetes-like syndrome (Cho 
et al. 2001; Cleasby et al. 2007).  Activation of protein kinase B/Akt, requires it to be 
phosphorylated at 2 sites; threonine 308 and serine 473. Impaired insulin-stimulated 
PKB phosphorylation/ activity has been observed in skeletal muscle from subjects 
with type 2 diabetes (Karlsson et al. 2005; Krook et al. 1998), low birth weight 
(Jensen et al. 2008) and PCOS (Hojlund et al. 2008), yet other studies have reported 
no significant difference in insulin-stimulated PKB activity or phosphorylation in   115 
skeletal muscle of subjects with type 2 diabetes (Bandyopadhyay et al. 2005; Kim et 
al. 1999; Meyer et al. 2002). 
 
Animal studies exploring the effect of induced insulin resistance by continuous 
glucose infusion have demonstrated that chronic hyperglycaemia and resultant 
increased circulating NEFA concentrations activate skeletal muscle protein kinase C 
isoforms via the accumulation of diacyglycerol and long chain acyl Co-A (LCACoA) 
which are potent PKC activators (Griffin et al. 1999; Laybutt et al. 1999).  Human 
studies using lipid infusion to induce insulin resistance by causing an acute increase in 
circulating NEFA have reproduced these findings, observing increased DAG mass 
and corresponding increased PKC activity (Itani et al. 2002).  In addition, PKC 
activity has been found to be increased in the skeletal muscle of obese insulin resistant 
subjects, compared with that in non-obese controls (Itani et al. 2000).  There have not 
yet been any studies examining PKC activity in type 2 diabetes in human skeletal 
muscle but in this context PKC is likely to be linked to impaired insulin signalling and 
reduced glucose transport.  More recently, a number of atypical protein C isoforms 
(zeta, lambda and iota), have been discovered  which seem to have paradoxically 
reduced activation in the skeletal muscle of insulin-resistant animal models (Standaert 
et al. 2002) but which also have not yet been investigated in human insulin resistance. 
 
In obese subjects, with and without type 2 diabetes,  GLUT 4 expression in skeletal 
muscle is reduced (Dohm et al. 1991), whereas in type 2 diabetes GLUT 4 expression 
is similar to that in non-diabetic controls (Handberg et al. 1990; Pedersen et al. 1990).  
This suggests that although quantity of GLUT 4 is similar, function or trafficking may 
be impaired in diabetic subjects.  There is some evidence for abnormal GLUT 4   116 
function/ distribution in type 2 diabetes, with one study finding abnormal GLUT 4 
transport and location in human subjects with insulin resistance and type 2 diabetes 
(Garvey et al. 1998) and a further study in a mouse model of type 2 diabetes showing 
significantly reduced insulin-stimulated GLUT 4 translocation to the plasma 
membrane in diabetic mice compared with controls (Miura et al. 2001).  Interestingly 
GLUT 4 translocation and subsequently glucose transport has been found to be 
increased by exercise (Wallberg-Henriksson et al. 1988), which may partially explain 
the improvements in insulin sensitivity seen in exercise training. 
 
There have not yet been any published studies examining protein expression of 
components of the insulin signalling pathway specifically in South Asian populations, 
nor in any other ethnic groups.  The aim of the study described in this chapter was, 
therefore to characterise the expression of proteins in the insulin signalling pathway in 
South Asians and Europeans to identify at which points in the pathway differences 
exist.  This would not only facilitate understanding of the mechanism underpinning 
insulin resistance in South Asians, but may also assist the identification of potential 
targets for future pharmacological therapies.  
 
4.2 Methods  
4.2.1 Volunteers  
Volunteers were those described in section 3.2.1.  They were recruited, screened and 
enrolled in the study as detailed in section 2.2.  Specific inclusion criteria are also 
defined in section 2.2, where further information detailing recruitment response and 
excluded volunteers can also be found. 
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The final study groups therefore consisted of the well-matched 20 South Asians and 
19 Europeans fully described in Chapter 3. 
 
4.2.2 Study design 
All participants underwent muscle biopsy using the technique described in section 
2.12.1.  Samples were analysed, as outlined in section 2.13.1 to determine differential 
skeletal muscle insulin signalling in the two groups, under both basal and insulin-
stimulated conditions.  
 
4.2.3  Muscle biopsy 
After a 12 hour fast, percutaneous skeletal muscle biopsy was performed, as described 
fully in section 2.12.1.  Biopsy samples were allowed to recover for 30 minutes in 10 
ml of Krebs-Ringer-Hepes buffer supplemented with 25mmoll
-1 D-glucose and 0.1% 
(w/v) BSA at 37
oC, which had been pre-gassed with 100% (v/v) O2 for 5 minutes.  
They were then incubated in the presence or absence of human soluble insulin 
(Actrapid, NovoNordisk, Bagsvaerd, Denmark) at a concentration of 10 nmol/l for 10 
minutes, after which both samples were placed into screw cap microcentrifuge tubes, 
snap frozen in liquid N2 and then stored at -80
oC. 
 
4.2.4  Analysis of muscle samples 
Muscle biopsy samples were analysed as fully described in section 2.13.  Briefly, 
samples were homogenised and centrifuged to separate cytosolic and particulate 
fractions.  Following protein estimation and transfer to nitrocellulose, samples were 
subjected to Western blotting and probed with antibodies against insulin receptor 
(insulin receptor ( subunit), insulin receptor substrate (IRS) proteins –1 and –2,   118 
phosphatidylinositol 3‟-kinase (p85 and p110 subunits), PTEN, PKB ( and ), 
GLUT4 and PKC isoforms.  Resultant bands were quantified by densitometry and 
compared with an internal standard to assess expression levels.  Phosphorylation of 
PKB at Ser473 was assessed in the muscle homogenates described above by Western 
blotting using phosphorylation site-specific antibodies. 
    
4.2.5 Statistical analysis 
Data were analysed using Statistica (version 6.0, StatSoft Inc., Tulsa, Oklahoma) and  
Minitab (version 13.1, Minitab Inc., State College, Pennsylvania). Prior to analysis, 
all data were tested for normality using the Ryan-Joiner normality test and, if 
necessary, logarithmically transformed. All data between South Asians and Europeans 
was compared using unpaired t-tests. Univariate linear regressions were performed, 
using logarithmically transformed data where required. Correlations between ISI and 
other variables were performed for the South Asians and European groups.  
Significance was accepted at p ≤ 0.05.  
 
4.3 Results 
4.3.1 Basal insulin signaling protein expression 
Due to technical problems, it was not possible to obtain data on skeletal muscle 
insulin signalling protein expression for all participants.  There was also an outlier in 
the data for protein expression of the p110 subunit of PI3K, in that, on statistical 
analysis this value was over 9 standard deviations from the mean so it was not 
possible to normalise the data.  This data point was therefore removed from the 
analysis.  PKC θ was not measured because of difficulties acquiring the appropriate   119 
antibody.  Insulin signalling protein expression data and the number of observations 
for each variable are shown in Table 4.1 and Figure 4.1. 
 
 In muscle samples which were not insulin-stimulated, protein expression of IRS-1 
was significantly lower in South Asians than European in unadjusted analysis.  
However these data were only available for a small subset of the total cohort (n = 8 
South Asians and 7 Europeans) and this difference was abolished on adjustment for 
age and BMI; and age, BMI and fat mass.  Protein expression of the p85 subunit of 
PI3K was ~50% lower in South Asians than Europeans, and although this finding was 
also based on a small number of observations (n = 8 South Asians and 8 Europeans), 
this difference remained significant after adjustment for age, BMI and fat mass.   
 
Unstimulated PKB protein expression was also ~50% lower in South Asians (n = 14) 
than Europeans (n = 12).  This difference remained after adjustment for age and BMI, 
and became borderline significant after further adjustment for fat mass (p = 0.054).  
Phosphorylation of PKB at Ser473 was over 60% lower in South Asians (n = 14) than 
Europeans (n = 11) and this remained significant after adjustment.  Neither protein 
expression of the p110 subunit of PI3K, nor protein expression of PKC 1 in either 
the cytosolic or microsomal fractions differed significantly between South Asians and 
Europeans. 
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Table 4.1 Skeletal muscle insulin signalling protein expression under basal 
conditions. 
  South 
Asians 
Europeans  p-value  Age and 
BMI- 
adjusted 
p-value 
Age, BMI 
and fat 
mass- 
adjusted 
p-value 
IRS-1 
(n = 8 South Asians, 7 
Europeans) 
 
0.35 
(0.13 to 0.56) 
1.00 
(0.50 to 1.50) 
0.028  0.699  0.699 
PI3K, p85 subunit 
(n = 8 South Asians, 8 
Europeans) 
 
0.51 
(0.28 to 0.75) 
1.00 
(0.84 to 1.16) 
0.005  0.079  0.049 
PI3K, p110 subunit 
(n = 5 South Asians, 14 
Europeans) 
 
1.05 
(0.82 to 1.28) 
1.00 
(0.78 to 1.22) 
0.800  0.281  0.159 
PKB* 
(n = 16 South Asians, 12 
Europeans) 
 
0.51 
(0.36 to 0.71) 
1.00 
(0.57 to 1.75) 
0.041  0.003  0.054 
PKB Ser473 
phosphorylation* 
(n = 14 South Asians, 11 
Europeans) 
 
0.38 
(0.27 to 0.52) 
1.00 
(0.74 to 1.38) 
< 0.0005  < 0.0005  0.019 
Cytosolic PKC 1 
(n = 8 South Asians, 9 
Europeans) 
 
0.94 
(0.61 to 1.27) 
1.00 
(0.64 to 1.37) 
0.813  0.739  0.759 
Microsomal PKC 1 
(n = 8 South Asians, 9 
Europeans) 
# 
0.85 
(0.55 to 1.20) 
1.00 
(0.25 to 2.30) 
0.824  0.907  0.734 
 
Values are mean (95% CI), expressed relative to mean value in European group. 
*statistical analysis performed on log transformed data, 
#statistical analysis performed 
on square-root transformed data. 
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Figure 4.1 Skeletal muscle insulin signalling protein expression in South Asian 
and European men under basal conditions. 
 
Values are mean (95% CI), expressed relative to mean value in European group. 
*statistical analysis performed on log transformed data, 
#statistical analysis performed 
on square-root transformed data.  Significant p values (after adjustment for age, BMI 
and fat mass) are shown on the graph.  All other differences are not significant after 
adjustment  
 
4.3.2 Insulin signaling protein expression with insulin stimulation 
In unadjusted analysis, insulin stimulated IRS-1 protein expression was significantly 
lower in South Asians, but this difference was lost after full adjustment for age, BMI 
and fat mass.  Notably, protein expression of the p85 subunit of PI3K was also again 
significantly lower, as it was under basal conditions, and this difference persisted after 
full adjustment.  There was no difference in the expression of any of the other insulin 
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signaling proteins in response to insulin stimulation, not in the ratio of total PKB to 
Ser473 phosphorylated PKB.  These data are presented in Table 4.2.  Figure 4.2 
shows a representative blot, which illustrates the method used to quantify insulin 
signalling protein expression in South Asians and Europeans with and without insulin 
stimulation.   
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Table 4.2 Insulin stimulated skeletal muscle insulin signalling protein expression 
  South 
Asians 
Europeans  p-value  Age and 
BMI- 
adjusted p-
value 
Age, BMI 
and fat mass- 
adjusted p-
value 
IRS-1 
(n = 8 South Asians, 7 
Europeans) 
 
0.43 
(0.17 to 0.69) 
1.00 
(0.74 to 1.26) 
0.009  0.29  0.15 
PI3K, p85 subunit 
(n = 8 South Asians, 8 
Europeans) 
 
0.61 
(0.42 to 0.81) 
1.00 
(0.78 to 1.22) 
0.02  0.81  0.03 
PI3K, p110 subunit 
(n = 5 South Asians, 14 
Europeans) 
 
1.15 
(0.78 to 1.54) 
1.00 
(0.82 to 1.18) 
0.41  0.21  0.25 
PKB* 
(n = 16 South Asians, 12 
Europeans) 
 
0.55 
(0.43 to 0.68) 
1.00 
(0.52 to 1.48) 
0.067  0.61  0.58 
PKB Ser473 
phosphorylation 
(n = 14 South Asians, 11 
Europeans) 
 
0.91 
(0.70 to 1.12) 
1.00 
(0.67 to 1.33) 
0.63  0.37  0.49 
Cytosolic PKC 1 
(n = 8 South Asians, 9 
Europeans) 
 
1.14 
(0.85 to 1.44) 
1.00 
(0.66 to 1.34) 
0.55  0.93  0.83 
Microsomal PKC 1 
(n = 8 South Asians, 9 
Europeans)  
 
1.25 
(0.41 to 1.85) 
1.00 
(0.33 to 1.67) 
0.80  0.29  0.15 
Ratio PKB/ Ser473 PKB  1.25 
 (0.76 to1.76) 
1.00 
(0.62 to 1.38) 
0.43  0.99  0.57 
Values are mean (95% CI), expressed relative to mean value in European group. 
*statistical analysis performed on log transformed data. 
As illustrated in Figure 4.3, basal log PKB phosphorylation at Ser473 for the whole 
study group correlated significantly with square-root ISI (r = 0.407, p = 0.044), even 
after adjustment for age (r = 0.404, p = 0.045), although there was no significant 
correlation after adjustment of square-root ISI for age and BMI or age and fat mass.   124 
4.3.3 Relationship between insulin signalling protein expression and insulin 
sensitivity  
When the data were analysed separately according to ethnicity, there was no 
significant correlation between phosphorylation of PKB at Ser473 (or any other 
insulin signalling protein) and square root insulin sensitivity in South Asians, but a 
borderline significant correlation between these variables in Europeans, when insulin 
sensitivity was adjusted for age and BMI (r = 0.554, p = 0.077) or age and fat mass (r 
= 0.546,  
p = 0.082) (Table 4.3). 
 
Figure 4.2 Example western blot 
Soluble cytosolic (C) and microsomal (M) 
fractions were prepared from muscles 
incubated ex vivo in the presence or 
absence of insulin. Fractions were 
resolved by SDS-PAGE and subjected to 
immunoblotting with the antibodies 
indicated.  Representative blots are shown 
from 2 South Asian subjects and a 
European subject. 
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Table 4.3 Relationships between insulin signalling proteins under basal 
conditions and ISI (unadjusted), ISI adjusted for age, age+BMI and age+fat 
mass.  
  Unadjusted 
r 
Age-
adjusted r 
Age + BMI 
adjusted r 
Age + fat mass 
adjusted r 
IRS-1 
 
-0.047  -0.054  -0.160  -0.170 
PI3K p85 
 
0.138  0.132  0.026  0.046 
PI3K p110β 
 
-0.142  -0.143  -0.403  -0.422 
PKB* 
 
0.083  0.084  0.169  0.046 
PKB Ser473 
phosphorylation* 
0.407  0.404  0.379  0.277 
Cytoplasmic PKC β1 
 
0.276  0.276  0.275  0.268 
Microsomal PKC β1#  
 
0.452  0.452  0.405  0.433 
Statistical analysis performed on log transformed data, 
#statistical analysis performed 
on square-root transformed data. Statistically significant correlations are shown in 
bold 
 
PKB phosphorylation at Ser473 for the whole study group also correlated 
significantly with various indices of adiposity (see Table 4.4).  It correlated negatively 
with total fat mass, arm, leg and trunk fat mass and also with triceps and subscapular 
skinfold thickness.  It correlated positively with total fat-free mass and total, leg and 
trunk lean mass.  There was no significant correlation between biceps or suprailiac 
skinfold thickness and PKB phosphorylation at Ser473. 
 
PKB Ser473 phosphorylation was, however, very strongly correlated with indices of 
cardiorespiratory fitness (see Table 4.5), including VO2max and fat oxidation during 
sub-maximal exercise at 55% of VO2max (whether expressed in ml.kg
-1.min
-1 or in   126 
ml.kg
-1 fat-free mass.min
-1), and fat oxidation at an absolute VO2 of 25 mg.kg
-1.min
-1.  
There was no significant correlation between PKB Ser473 phosphorylation and 
resting VO2 or resting fat oxidation. 
 
None of the other measured insulin signalling proteins correlated significantly with 
square-root insulin sensitivity index, or any indices of body composition. However,  
protein expression of IRS-1 correlated significantly with VO2max, expressed in  
ml.kg
-1.min
-1 (r = 0.677, p = 0.006) or ml.kg
-1 fat-free mass.min
-1 (r = 0.649,  
p = 0.009). 
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Table 4.4 Correlations between log PKB Ser473 and indices of adiposity 
Variable  r value  p value 
Total fat mass   -0.440  0.028 
Arm fat mass  -0.433  0.031 
Leg fat mass  -0.401  0.047 
Trunk fat mass  -0.434  0.030 
Total lean mass  0.538  0.006 
Arm lean mass  0.282   0.172 
Leg lean mass  0.546  0.005 
Trunk lean mass  0.539  0.005 
Biceps skinfold  -0.354  0.083 
Triceps skinfold  -0.399  0.048 
Subscapular skinfold  -0.439  0.028 
Suprailiac skinfold  -0.349  0.087 
Statistically significant correlations are shown in bold 
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Table 4.5 Correlation between log PKB Ser473and indices of cardiorespiratory 
fitness 
Variable  r value  p value 
VO2max (ml.kg
-1.min
-1)  0.634  0.001 
VO2max (ml.kg
-1fat-free mass.min
-1)  0.539  0.005 
Fat oxidation at VO2 25 ml.kg
-1.min
-1  0.588  0.025 
Fat oxidation at 55% VO2max  
(mg.kg
-1.min
-1) 
0.475  0.004 
Fat oxidation at 55% VO2max  
(mg.kg
-1fat-free mass.min
-1) 
0.449  0.036 
Statistically significant correlations are shown in bold 
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Figure 4.3 Scattergrams illustrating relationships between PKB Ser473 
phosphoryation and insulin sensitivity index (A), VO2max (B), total fat mass (C) 
and trunk fat mass (D). 
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4.4. Discussion 
The aim of the study described in this chapter was to determine whether there was any 
difference in protein expression of some of the insulin signalling enzymes in the 
skeletal muscle of South Asians compared to Europeans, which might explain their 
increased insulin resistance.  Protein expression of some of the major components of 
the insulin signalling pathway in skeletal muscle was found to be lower in South 
Asians compared to Europeans, even after adjustment for age, BMI and total fat mass.   
 
In the fasted state, the protein expression of both Ser473 phosphorylated PKB and the 
p83 subunit of PI3K was significantly and markedly lower (by at least 50% ) in South 
Asians than in Europeans.  This was despite the fact that measurements were made 
using muscle biopsy samples which had been exposed only to basal endogenous 
fasting insulin levels, differences in which are unlikely to be confounders, as the 
South Asian subjects had a tendency for higher fasting insulin concentrations, which 
would be expected to, if anything, increase PI3K p80 and Ser473 phosphorylation. 
 
Following insulin stimulation, the only significant difference which remained after 
full adjustment for age, BMI and fat was that South Asians had significantly lower 
expression of the p83 subunit of PI3K.  There was no correlation between basal or 
insulin-stimulated p83 expression and insulin sensitivity.   
 
The PKB findings are noteworthy, as basal Ser473 phosphorylation of PKB was over 
60% lower in South Asians and it correlated significantly with whole-body insulin 
sensitivity, which was not the case with any of the other insulin signalling proteins.  
In addition, PKB Ser473 phosphorylation correlated strongly and significantly with   131 
whole-body fat oxidation rates during exercise, suggesting that differences in capacity 
for fat oxidation between Europeans and South Asians may influence insulin 
sensitivity via effects at this point in the insulin signalling pathway.   
 
This finding is important because PKB has, for almost 20 years, been known to be an 
important enzyme in the insulin signaling cascade (Brazil & Hemmings 2001).  
Phosphorylation at Ser473
 is essential for its activation, and alterations in this 
enzyme‟s activity have previously been observed in insulin-resistant states.  It has 
been found to be reduced in type 2 diabetes (Krook et al. 1998) and in insulin resistant 
low-birth weight men (under insulin stimulated conditions (Jensen et al. 2008)).  In 
addition, the thiazolidinedione class of drugs, which are known to improve insulin 
sensitivity have been shown, in vitro, to increase PKB Ser473
 phosphorylation in 
human umbilical vein endothelial cells (Wu et al. 2009).   
 
PKB Ser473 phosphorylation, in both adipose tissue, and muscle, leads to a chain of 
events which stimulate glucose transport via increased GLUT 4 expression and 
recruitment to the cell membrane.  Ultimately glucose uptake into the myocyte is 
increased, so increased PKB Ser473
  phosphorylation is associated with increased 
insulin sensitivity (Cho et al. 2001; Hill et al. 1999; Kohn et al. 1996; Ueki et al. 
1998; Wang et al. 1999).  Our study findings are consistent with these previous study 
findings, with the significant positive correlation between PKB phosphorylation at 
Ser473 and insulin sensitivity indicating that findings at skeletal muscle level 
influence whole body insulin sensitivity i.e. increasing PKB Ser473 phosphorylation 
increases whole-body insulin sensitivity. 
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Also of note, the p85 subunit of PI3K was the only enzyme which had consistently 
reduced expression in South Asians, both in basal and insulin stimulated conditions.  
This finding was particularly intriguing as it is unexpected in the context of most of 
the previously published literature examining p85 expression, which mostly reports 
increased, rather than reduced p85 expression in insulin resistance.  This issue will be 
explored further in the general discussion.       
   
In addition to the above differences, there was also a trend towards lower protein 
expression of IRS-1, another key insulin signaling protein, and lower expression of 
PKB in South Asians, which although significantly lower in unadjusted analysis, 
became non-significantly different on adjustment for adiposity.  Because the numbers 
were small, it may simply be that the study was under-powered to detect differences 
in IRS-1, or it may be that increased adiposity is causally linked to reduced IRS-1 
expression.  It would be interesting to investigate whether differences in IRS-1 protein 
expression would become significant despite adjustment for adiposity in a larger 
number of subjects, as it could be that South Asians have variations in insulin 
signaling at various points in the pathway, rather than just at one point.  This would, 
potentially provide more opportunities to intervene from a therapeutic point of view.  
 
There were no differences between South Asian and European muscle in protein 
expression of cytosolic or microsomal PKC 1, suggesting that PKC 1 does not 
appear to be implicated as a mechanism for the increased skeletal muscle insulin 
resistance observed in South Asians.   
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The main limitation of this study was that expression of insulin signalling proteins 
was only assessed in the basal state – i.e. signalling protein expression in response to 
fasting insulin concentrations – and in response to maximal insulin stimulation.  
While the direction of the differences in expression in the basal data between South 
Asians and Europeans precludes potential confounding by differences in fasting 
insulin concentrations (South Asians had reduced signalling despite a tendency for 
higher insulin concentrations), this study does not provide data on insulin signalling 
across the range of physiological insulin concentrations and further study is needed to 
ascertain whether insulin signalling differs between South Asians and Europeans at 
insulin concentrations between basal and maximal. 
 
Nonetheless, these findings suggest key differences in insulin signalling in the skeletal 
muscle of South Asians and Europeans.  One possible explanation for this is the effect 
of the increased IMCL observed in South Asians, on expression of key insulin 
signaling proteins.  At least one study (Forouhi et al. 1999) however, has 
demonstrated no significant relationship between IMCL (triglyceride) and whole-
body insulin sensitivity.  This may be because the quantity of IMCL itself is not 
responsible for insulin resistance, but rather the rate of its turnover (Corcoran et al. 
2007) or the proportion IMTG which is made up of the lipid intermediates DAG and 
ceramides, which have been associated with insulin resistance (Petersen & Shulman 
2006) and which have the specific effects on insulin signalling, mainly via PKC, 
which are mentioned in detail above (Griffin et al. 1999; Laybut et al. 1999) 
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Another possibility is that the difference in insulin signalling observed between the 
South Asians and Europeans are a result of an innate skeletal muscle defect.  It is not 
possible from this study to determine if either of the above mechanisms, or a 
combination of both, is responsible, as one of the limitations of the study was that 
IMCL and lipid intermediates were not quantified.  If increased lipid intermediates in 
South Asians were the only explanation for impaired insulin signalling in South Asian 
muscle, a difference in PKC might be expected, given the known effects of DAG as a 
potent activator of PKC (Griffin et al. 1999; Laybutt et al. 1999; Wolf 2008).  
However there was no observed difference in PKC, rather PKC expression in South 
Asian and European muscle was found to be similar.  This suggests either that an 
alternative mechanism is at least partly responsible for impaired insulin signalling in 
South Asian skeletal muscle or that DAG has a lesser effect on the 1 isoform of 
PKC, the activity of which was measured in this study, compared with the striking 
effect it is thought to have on the θ isoform of PKC (Wolf 2008). 
 
The novel findings of this study were significantly lower skeletal muscle protein 
expression of PI3K and PKB Ser473 phosphorylation in South Asians and a 
correlation between Ser473
 phosphorylation and both fat oxidation during 
submaximal exercise and VO2max.  These findings suggest that the reduced capacity 
for fat oxidation oberved in South Asians may affect insulin sensitivity via effects on 
these particular enzymes.     135 
Chapter 5 
 
General Discussion 
 
5.1 Experimental Chapter Summaries 
The aims of Chapter 3 were to describe the lifestyle and phenotypic differences 
between South Asians and Europeans, with a focus particularly, on differences in 
adiposity, cardiorespiratory fitness and insulin sensitivity and to examine relationships 
between these variables.  The results confirm that South Asians display increased 
adiposity and lower lean mass, markedly reduced cardiorespiratory fitness and 
increased insulin resistance, compared with Europeans, and that this may be, in part, 
as a result of South Asians‟ reduced ability to oxidize fat during exercise, which was a 
novel finding of the study.  VO2max and fat oxidation during submaximal exercise 
were correlated significantly with whole-body insulin sensitivity suggesting that these 
are important associations.  In addition South Asians exhibited higher expression of 
the CPT1A and FASN genes, suggesting that impaired mitochondrial oxidative 
capacity is unlikely to be the mechanism underpinning their reduced skeletal muscle 
oxidative capacity.  
 
Chapter 4 examined differences in insulin signalling between South Asians and 
Europeans, and found reduced protein expression of PI3K p85 subunit in both basal 
and insulin-stimulated states, and markedly reduced (60% lower) phosphorylation of 
PKB at Ser473 in South Asians.  These differences persisted after adjustment for age, 
BMI and fat mass, suggesting a real difference in insulin signalling between South 
Asian and European skeletal muscle.  In addition PKB Ser473 phosphorylation 
correlated positively with insulin sensitivity and with whole body fat oxidation during   136 
exercise, suggesting that differences in capacity for fat oxidation between South 
Asians and Europeans may alter insulin signaling via effects at this specific point in 
the insulin signaling pathway. 
 
5.2 Ethnic differences in whole body and skeletal muscle fat oxidation  
Two key findings of Chapter 3 were reduced whole-body fat oxidation by around 
40% in South Asians during submaximal exercise, and a correlation between fat 
oxidation during exercise and insulin sensitivity.  There was no difference in whole-
body fat oxidation at rest, and no relationship between resting fat oxidation and 
insulin sensitivity.  This disparity could potentially result from the fact that whole-
body fat oxidation during exercise largely reflects fat oxidation in skeletal muscle, 
whereas at rest skeletal muscle only contributes about 20-30% of resting energy 
expenditure (Zurlo et al. 1990), thus whole-body fat oxidation at rest is to a large 
degree determined by other tissues.  In the studies described in Chapter 3, fat 
oxidation increased, 3-6 fold during exercise compared to at rest and this increase 
would almost exclusively be attributable to changes in skeletal muscle. Thus, if 
skeletal muscle, rather than whole-body fat oxidation is the key regulator of insulin 
sensitivity, the relationship will be more clearly revealed in whole-body 
measurements made during exercise rather than at rest.   
 
It is also possible that a deficiency in the capacity of muscle to oxidise fat becomes 
more evident when energy demand is high, and is thus revealed during exercise. 
These findings highlight the value of exercise testing in providing new insights into 
muscle metabolism in a relatively non-invasive manner.  
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Cardiorespiratory fitness is closely associated with skeletal muscle lipid oxidative 
capacity (Helge et al. 2006; Sahlin et al. 2007; Venables et al. 2005) and it is likely 
that fitness influences insulin sensitivity, at least partly, via effects on muscle lipid 
metabolism (Goodpaster & Brown 2005; Goodpaster et al. 2003). In the Chapter 3 
studies, adjusting ISI values for either VO2max or rate of fat oxidation during exercise 
abolished the difference in insulin sensitivity between the South Asian and European 
groups, and strong correlations were evident between VO2max and fat oxidation during 
exercise (r = 0.58 to 0.67, depending on units of measurement, all p < 0.0005). This 
supports the suggestion that low oxidative capacity/ capacity for fatty acid utilisation 
is a central feature of the South Asian insulin resistance phenotype, and highlights the 
fact that the lower cardiorespiratory fitness and reduced capacity to oxidize fat in this 
group are likely to largely reflect the same underlying mechanism. 
 
Unexpectedly, and in contrast to the observations made at the whole body level the 
reduction in fat oxidation seen in South Asians was not reflected by a reduction in 
skeletal muscle expression of mitochondrial oxidative and lipid metabolism genes in 
skeletal muscle biopsy samples, but rather expression of some of these genes was 
higher in South Asians.  There was no relationship between whole-body insulin 
sensitivity and expression of any of the mitochondrial oxidative or lipid metabolism 
genes.  
 
In Europeans, capacity for mitochondrial fat oxidation in ex vivo muscle biopsy 
samples has been shown to correlate strongly with whole-body fat oxidation during 
sub-maximal exercise (but not at rest) (Sahlin et al. 2007); this is consistent with 
observations in the study where positive correlations were observed between skeletal   138 
muscle expression of oxidative and lipid metabolism genes and fat oxidation during 
submaximal exercise in the European group.  However, strikingly, this pattern was 
reversed in the South Asian group where negative correlations were observed between 
skeletal muscle gene expression and fat oxidation during exercise, and significant 
interactions in the relationships between skeletal muscle gene expression and fat 
oxidation during exercise were evident between the European and South Asian 
groups.  These relationships are illustrated in Figure 5.1.     139 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 Relationships between exercise fat oxidation and skeletal muscle expression of 
oxidative and lipid metabolism genes. Significant correlations (p<0.05) are denoted by an 
asterisk. P (int) signifies p-value for interaction in relationship between gene expression and fat 
oxidation between European and South Asians groups.Thus, the South Asians with the highest expression of oxidative and lipid metabolism 
genes oxidised the least fat during exercise, indicating a dissociation between 
mitochondrial function and the reduced whole body oxidative capacity with increased 
insulin resistance observed in South Asians, such that reduced mitochondrial function 
does not seem to be the mechanism underlying increased insulin resistance in this 
population.  This finding is consistent with the study by Nair and colleagues (Nair et 
al. 2008), which reported increased skeletal muscle capacity for oxidative 
phosphorylation and a higher mitochondrial DNA copy number in South Asians.  
 
An alternative hypothesis is that the reduced capacity of South Asians to oxidise fat 
during exercise represents a defect in substrate delivery rather than impaired 
mitochondrial function.  Conceivably, the observed increase in oxidative and lipid 
metabolism gene expression within South Asians‟ skeletal muscle may represent  a 
compensatory “up-regulation” to attempt to attenuate the effect of, for example, 
reduced fuel delivery to skeletal muscle or to the mitochondria itself.   
 
It is not possible to quantify skeletal muscle oxidative capacity, capacity for fat 
utilisation and insulin sensitivity by examining only expression of these oxidative and 
lipid metabolism genes, without investigating enzyme activity, or indeed by 
examining mitochondrial function alone, as mitochondrial size, density and 
distribution may also be important.  Indeed a recent study investigating mitochondrial 
location found that intermyofibrillar mitochondrial content was lower in insulin 
resistant and diabetic subjects than in lean, insulin-sensitive subjects, and that 
intermyofibrillar mitochondrial content was correlated significantly with clamp-  141 
derived measures of insulin sensitivity and indices of fat oxidation (Chomentowski et 
al 2011). 
 
In addition, macrovascular and microvascular circulation (i.e. capillary density and 
recruitment) will also have an effect on oxidative capacity.  As mentioned in Chapter 
1, South Asian men are known to have impaired endothelial function in forearm 
resistance vessels (Murpy et al. 2007)and reduced nitric oxide bioavailability both at 
rest and during exercise (Cubbon et al. 2010), both of which could be important 
factors in determining skeletal muscle oxidative capacity, as both will influence 
substrate delivery to skeletal muscle.  Substrate delivery data is not available from this 
study, nor are there relevant published data in the literature, so clearly further research 
is required to determine whether there are indeed ethnic differences in rates of 
substrate delivery to skeletal muscle, and to confirm the finding of apparently 
increased “mitochondrial efficiency” in South Asians, as both this study and the only 
other study examining ethnic differences in mitochondrial function involved small 
numbers of subjects.   
 
It is also important to recognise that increased fatty acid mobilisation could produce 
the same effect as reduced fat oxidation, as it is the mismatch between mobilisation 
and oxidation of fatty acid, rather than a low ability of muscle to oxidise fat per se, 
which can result in insulin resistance.  Recent studies have demonstrated 
improvements in insulin sensitivity with weight loss which results in a reduction in 
fatty acid mobilisation (Schenk et al. 2009), in the absence of changes in oxidative 
capacity or fatty acid oxidation rates  (Berggren et al. 2008; Schenk et al. 2009; 
Toledo et al. 2008) and have also shown that increasing fatty acid mobilisation by   142 
lipid infusion can abolish improvements in insulin sensitivity elicited by exercise 
training, despite fatty acid oxidation rates remaining elevated (Schenk et al. 2009).  
Thus, capacity for fatty acid oxidation clearly only provides one part of the story, and 
further investigation is also needed to determine whether differences in fatty acid 
mobilisation exist between South Asians and Europeans that may contribute to the 
differences in insulin sensitivity. 
 
5.3 Ethnic differences in insulin signalling  
There have been no previous data comparing insulin signalling molecule expression 
between South Asians and Europeans or indeed data examining insulin signalling 
differences in any ethnic groups.   
 
The principal findings from Chapter 4 were of reduced basal and insulin-stimulated 
protein expression of PI3K p85 subunit and markedly reduced PKB phosphorylation 
at Ser473 in South Asians, but in unadjusted analysis, South Asians also demonstrated 
lower protein expression of IRS-1 and of basal PKB.   
 
IRS-1 is the principal IRS involved in muscle insulin-stimulated glucose transport 
(Sesti et al. 2001), but evidence regarding the role of altered IRS-1 expression in 
insulin resistant states is lacking, due to conflicting results from several studies 
examining this, as detailed in previous chapters.  This suggests that IRS-1 itself may 
not have a major role in insulin resistance, but rather that changes in components of 
the insulin signalling pathway downstream of IRS-1 may play a more important role.   
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The data described in Chapter 4 do imply reduced IRS-1 signalling in South Asians, 
which may manifest as impaired insulin-stimulated glucose transport and a degree of 
skeletal muscle insulin resistance.  IRS-1 expression did not correlate significantly 
with whole-body insulin sensitivity, so it may be that the observed reduction in IRS-1 
expression simply reflects greater adiposity in the South Asian group, rather than a 
fundamental difference in South Asians‟ skeletal muscle function.  The fact that the 
ethnic difference in IRS-1 expression was abolished after adjustment for adiposity 
supports this interpretation. 
The finding of significantly lower basal and insulin stimulated expression of the p85 
subunit of PI3K in South Asians persisted after adjustment for age, BMI and fat mass, 
implying a constitutional difference in this aspect of insulin signalling between South 
Asian and European skeletal muscle.  The implications of altered PI3K p85 subunit 
expression on insulin sensitivity are also unclear in the literature, with the majority of 
published studies reporting increased p85 expression as an association with increased 
insulin resistance in both human and animal skeletal muscle (Bandyopadhyay et al. 
2005; Barbour et al. 2005; Friedman et al. 1999; Hammarstedt et al. 2005).  In 
addition, down-regulation of p85 has been reported to reverse the inhibition of 
insulin-stimulated glucose transport in 3T3-L1 adipocytes caused by constitutively 
active PKB (Adochio et al. 2009).  However, reduced p85 expression has also been 
reported to be associated with obesity in a single study in placenta (Colomiere et al. 
2009).  
 
The reduction observed in South Asians in the current study is, therefore, in 
disagreement with many studies of insulin-resistant cohorts, yet this may indicate that 
there is a requirement for optimal levels of p85 expression, such that increased and   144 
decreased p85 expression both have detrimental consequences in terms of insulin 
sensitivity. 
 
PKB exists as three isoforms, a (Akt1), b (Akt2) and c (Akt3), and, as mentioned in 
Chapter 4, studies in knockout mice have indicated that PKBβ is the principal 
regulator of glucose homeostasis (Cho et al. 2001; Cleasby et al. 2007).  As with the 
other insulin-signalling proteins, studies examining PKB phosphorylation/activity in 
insulin-resistant states have reported differing results. 
 
 In chapter 4, expression and phosphorylation of PKB at Ser473 was assessed using 
antibodies that do not distinguish between the different isoforms.  Interestingly total 
PKB protein expression was 50% lower in South Asians than Europeans, although 
after adjustment for age, BMI and fat mass, this difference was reduced to borderline 
statistical significance (p = 0.054).  In addition, basal Ser473 phosphorylation of PKB 
was over 60% lower in South Asians and differences persisted after adjustment for 
age, BMI and fat mass.  It also correlated significantly with whole body insulin 
sensitivity.  The increased basal Ser473 phosphorylation observed in Europeans is 
unlikely to be a result of effects from endogenous insulin associated with the muscle 
biopsies after washing, as South Asians exhibited higher fasting insulin concentrations 
than Europeans.  In addition, basal PKB Ser473 phosphorylation correlated strongly 
and significantly with whole-body fat oxidation rates during exercise, suggesting that 
differences in capacity for fat oxidation between Europeans and South Asians may 
influence insulin sensitivity via effects at this point in the insulin signaling pathway.   
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There were no differences between South Asian and European muscle in protein 
expression of cytosolic or microsomal PKC β1, which negatively regulates insulin 
signaling (Standaert et al. 1999), suggesting that PKC β1 does not underlie the 
increased skeletal muscle insulin resistance observed in South Asians. 
 
5.4 Interactions between adipose tissue and skeletal muscle  
Results from Chapter 3 and from numerous previous studies demonstrate that adipose 
tissue has a strong association with whole body insulin resistance, and the relationship 
between fat mass and insulin resistance in South Asians suggests increased 
susceptibility to the adverse effects of adiposity. 
 
Because the DEXA imaging technique used in this study was insufficiently detailed to 
distinguish distinct adipose tissue compartments, these were not examined in this 
study, so it is unclear whether the South Asians in the present study had increased 
visceral fat, deep subcutaneous fat or superficial subcutaneous fat, although the issue 
of which of these compartments is most harmful with respect to NEFA mobilisation, 
adipose derived hormones and insulin resistance has yet to to be fully elucidated 
(Banerji et al. 1999; Chandalia et al. 2007; Gautier et al. 1999; Sniderman et al. 2007).  
Computed tomography (CT), magnetic resonance imaging (MRI) and ultrasound (US) 
are able to distinguish visceral and subcutaneous adipose tissue by identification of 
the fascia superficialis, which enables quantification of deep and superficial 
subcutaneous compartments (Smith et al. 2001), and further studies using these 
imaging techniques to compare adipose tissue location in different ethnic groups 
would be useful.   
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As mentioned in Chapter 1, it is likely that adipose tissue function rather than quantity 
or location the more important determinant of insulin sensitivity, supported by the 
finding of reductions in both circulating insulin and leptin concentrations, independent 
of fat mass in response to weight loss (Doucet et al. 2000), along with the intriguing 
discovery of increased adipocyte size in South Asians, associated with insulin 
resistance by Chandalia et al (Chandalia et al. 2007) and Anand et al (Anand et al. 
2011). 
 
The hypothesis of dysfunctional adipose tissue and early ectopic fat deposition in 
South Asians‟ skeletal muscle is broadly in keeping with the study finding of 
differences in insulin signalling between the two ethnic groups described above, as 
ectopic skeletal muscle fat would result in an increased quantity of the harmful lipid 
intermediates which are known to disrupt insulin signalling.  Previously published 
studies, however, have suggested  that this increase in lipid intermediates would be 
likely to manifest itself as an effect on PCK activity, with DAG being a potent 
activator of this enzyme  (Griffin et al. 1999; Laybutt et al. 1999; Wolf 2008).  This 
might imply that increased ectopic fat and lipid intermediates impaired insulin 
signalling in South Asian muscle in a novel way, for example, by reducing PKB 
Ser473 phosphorylation, an effect which is not seen in other insulin resistant groups, 
or it could simply be that DAG has a lesser effect on the 1 isoform of PKC, the 
activity of which was measured in this study, compared its known effect on PKC θ 
(Wolf 2008), which it was unfortunately not possible to measure. 
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Dysfunctional adipose tissue and ectopic skeletal muscle fat accumulation could also 
explain increased expression of the oxidative and lipid metabolism genes.  CPT-1 
activity has been previously repored to be reduced in insulin resistant states) (Kim et 
al. 2000; Simoneau et al.1999) and the unexpected finding of significantly increased 
CPT-1A expression in South Asians, indicating increased delivery of fatty acids to the 
mitochondria for oxidation, probably indicates a problem further upstream.  This 
could implicate increased fatty acid mobilisation from dysfunctional adipose tissue 
depots as a mechanism, and the increased mitochondrial oxidative enzyme gene 
expression might represent an attempt by skeletal muscle to compensate for increased 
fatty acid mobilisation/ delivery.  If this theory is correct, the increase in intracellular 
transport and fat oxidation does not seem to be sufficient to compensate for the 
increase fatty acid mobilisation, resulting in a net gain of fat into the mucle, and 
resultant effects on insulin signalling. 
 
 5.5 Implications for future studies 
Given that findings of the present study and those of Nair et al demonstrate reduced 
whole body fat oxidation in the face of increased oxidative and lipid metabolism 
enzyme activity, the next logical step would be to do a further comparison study to 
attempt to identify some of the missing pieces of the puzzle.  This might involve 
examining indices of endothelial function, fatty acid mobilisation and IMCL 
(including location of lipid within myocyes) together, and confirming the findings of 
reduced oxidative enzyme gene expression and enzyme activity in South Asians.  
More detailed investigation of mitochondrial size and location would also be 
interesting.   148 
A further worthwhile future study would be to examine the effects of an exercise 
intervention on insulin sensitivity and skeletal muscle oxidative function in South 
Asians compared to Europeans, incorporating robust measurement of physical activity 
with accelerometers, both at baseline and during the intervention.   
Conceivably larger numbers of volunteers could be recruited if a non-invasive 
measure of muscle metabolism, such as magnetic resonance spectroscopy was used as 
an alternative to muscle biopsy, and detailed imaging with CT or MRI could help 
further investigate the various hypotheses relating to ethnic differences in adipose 
tissue compartments and adipose tissue function.  Measurement of differential rates of 
adipose tissue mobilisation from the VAT, superficial and deep subcutaneous adipose 
tissue depots in South Asians and Europeans may also provide some insight, and 
genetic studies examining adipose tissue expression of some of the genes implicated 
in insulin resistance could also assist our understanding of the role of adipose tissue 
dysfunction in insulin resstance in South Asians. 
   149 
5.6 Final Conclusions 
In conclusion, this thesis describes studies which have attempted to increase 
understanding of the mechanisms which underlie the characteristic insulin resistant 
phenotype seen in South Asians.  Novel findings from the studies suggest that a key 
feature is reduced whole-body oxidative capacity and capacity for fatty acid 
utilisation, but this does not seem to be a consequence of reduced skeletal muscle 
expression of oxidative and lipid metabolism genes.  These studies provide a small 
part of the picture and further investigation is required to elucidate the mechanism 
underpinning reduced capacity for fat oxidation in South Asians and to explain how 
this relates to their reduced insulin sensitivity.  
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Appendix A1 
 
 
VOLUNTEER INFORMATION SHEET 
 
Insulin resistance in South Asians: role of skeletal muscle and adipose tissue 
function  
 
Does the function of muscle and fat tissue affect risk of diabetes?  
 
 
You are being invited to take part in a research study.  Before you decide 
whether  or  not  to  take  part,  it  is  important  for  you  to  understand  why  the 
research is being done and what it will involve.  Please take time to read the 
following information carefully and discuss it with others if you wish.  Ask us if 
there is anything that is not clear or if you would like more information.  Take 
time to decide whether or not you wish to take part. 
 
 
What is the purpose of the study? 
It is well known that South Asians living in the UK have a much greater risk of 
adult-onset diabetes than their European counterparts.  This is likely to be due 
to differences in their metabolism making insulin less effective at controlling 
their blood sugar levels.  This is known as “insulin resistance” but it is unclear 
what  makes  South  Asians‟  body  tissues  more  resistant  to  the  effects  of 
insulin.  This study will investigate for the first time whether differences in South 
Asians‟ muscles ability to burn fat or differences in the way that fat tissue functions 
can  explain  the  significant  differences  in  their  metabolism,  compared  to 
Europeans  and  provide  new  insights  into  their  increased  risk  for  diabetes.  
This may lead to better therapies to prevent and treat diabetes.   
  
 
Why have I been chosen? 
You have been chosen because you are a healthy adult aged between 18 and 
40, with both parents of either European or South Asian (i.e. Indian, Pakistani, 
Bangladeshi or Sri Lankan) origin.  The study will compare the two different 
groups  to  establish  whether there  are differences  in  insulin  resistance and 
muscles‟ ability to burn fat and the function of fat tissue between Europeans and 
South Asians.   
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Do I have to take part? 
It is up to you to decide whether or not to take part.  If you do decide to take 
part you will be given this information sheet to keep and be asked to sign a 
consent form. If you decide to take part you are still free to withdraw at any 
time and without giving a reason. 
 
 
Who is organising and funding the research? 
 
  Diabetes UK, the largest UK organisation working for people with 
diabetes.  It aims to help people live with diabetes through campaigning 
and funding research. 
 
  Wyeth pharmaceuticals are a major drug company in the United  
States with a UK base in Surrey, England. 
 
 
What is my part in the study? 
If you agree to take part in the study and meet entry requirements then your 
participation will consist of 4 or 5 visits over a period of two to four weeks.  
Most visits will last around two hours. 
 
 
What do I have to do? 
Firstly you will be asked to attend for a screening visit where we will discuss 
with  you  and  complete  confidential  questionnaires  regarding  your  health, 
family history, physical activity and diet.  We will also measure your blood 
pressure and take a small blood sample (20 ml or 4 teaspoons) to check the 
fat and sugar levels in your blood.  We will also check for any abnormalities in 
the  function  of  your  liver,  kidneys  and  thyroid  gland  to  ensure  that  it  is 
perfectly safe for you to participate in this study.  There will be an opportunity 
for you to ask questions. 
 
During the remaining visits we will ask you to undertake a number of tests to 
determine your level of health and fitness. 
 
  On  the  second  visit  a  screening  exercise  (walking)  test  will  be 
performed.    This  test  will  involve  walking  on  a  treadmill  with  self-
adhesive electrodes attached to your chest to monitor how hard your 
heart is working.  This test will last for a maximum of 12 minutes and 
will confirm whether it is safe for you to take part in this study. This visit 
can be combined with the initial screening visit. 
 
  The third and fourth visits we will perform tests to look at the amount of 
oxygen you are breathing in and the amount of carbon dioxide your 
body is producing at rest.  This is a way of measuring your body‟s 
resting metabolism.  There will then be two additional tests where you 
will walk on a treadmill at different speeds and gradients and we will 
monitor your heart rate and collect the air you breathe out to determine   179 
your fitness level.  We will also take tiny „finger prick‟ blood samples 
during one of the tests.   One test will involve a maximal effort and will 
last for about 10 to 20 minutes.  The other test will not involve a 
maximal effort and will last for about 40 minutes.    
 
  On the final visit we will repeat the resting metabolic rate test.  Then we 
will perform muscle and fat tissue biopsies.  The muscle biopsy 
involves taking a very small sample of muscle (less than half a gram) 
from the side of your thigh.  We will numb the area with anaesthetic 
beforehand and take the sample using a special device designed to 
take very small pieces of muscle through a small (3 to 5 mm) cut in the 
skin.  The biopsy site will then be closed with sterile strips which stick 
to the skin and covered with a dressing.  No aftercare is needed and 
you can the remove the strips and dressing yourself after 2 or 3 days. 
You may feel slight discomfort during the biopsy and experience some 
bruising at the site afterwards but this should subside within 2-3 days.  
For the fat tissue biopsy we will take a small fat sample from your 
tummy by „liposuction‟.  This involves numbing the skin with a local 
anaesthetic then sucking up 1 to 2 grams of fat (about the size of a pen 
top) with a needle and syringe. This is no more painful than having a 
blood sample taken. 
 
  In addition, during the final visit you will have a glucose tolerance test.  
We will ask you to drink a sugary drink and take blood samples before 
the drink and for two hours after the drink to assess how your body 
deals will this sugar.  This will help us to determine how well the insulin 
in your body is working. This will be no more painful than a simple 
blood test as samples will be obtained from a tiny plastic tube called a 
„cannula‟ placed in a forearm vein.  We will take approximately 120 ml 
(about an eggcup full) of blood over the course of this test. 
 
  We will also measure your weight and height and measure around your 
waist and hips.  We will perform a scan of your body to calculate how 
much fat you are carrying.  These tests will take about 15 minutes in 
total and can be carried out on the same day as other tests.  You will 
also be asked to complete questionnaires about your diet and levels of 
physical activity. 
 
 
For all of the visits to the University, you will need to be fasted (i.e. not 
having had anything to eat or drink, except water, for at least 12 hours).  It 
may, therefore be more convenient for you arrange visits in the morning.  
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What are the possible disadvantages and risks of taking part? 
  One  of  the  exercise  tests  will  be  at  a  maximal  level  and  the  possibility 
exists that, very occasionally, certain changes may occur during or shortly 
after the test. They include abnormal blood pressure, fainting or a change 
in the normal rhythm of the heartbeat.   
  Blood sampling via the cannula may cause minor bruising, an inflammation 
of the vein or haematoma (a small accumulation of blood under the skin). 
Good practice, however, minimises this risk.  Some people may feel faint 
when they give blood. 
  Taking the muscle and fat biopsies carries a small risk of minor bruising or 
an infection. Good sterile practice reduces this risk. 
  The scan to determine your level of body fat uses a very small dose of 
radiation.  Each scan is equivalent to about on twentieth of a chest X-ray or 
the amount of natural background radiation that we are exposed to in 4 
hours.   
  There is a small possibility that taking part in this study will reveal a health 
problem  that  you  already  have  such  as  high  cholesterol  or  high  blood 
pressure.  If such a problem is revealed, we will inform your GP to ensure 
that you receive appropriate treatment.  If necessary, a clinical consultant 
physician (Professor Naveed Sattar) will supervise any follow-up care.  
 
 
What are the possible benefits of taking part? 
The  information  gained  during  the  study  will  allow  us  to  give  you  detailed 
feedback about  your fitness  level,  body  fat,  dietary  intake,  blood  pressure, 
cholesterol,  blood  sugar  and  level  of  “insulin  resistance”.    In  addition,  the 
knowledge  gained  from  your  participation  may  benefit  people  who  have 
diabetes in the future by increasing our understanding of why South Asians 
are at increased risk of developing diabetes.  It will also help guide future 
research  investigating  how  to  reduce  this  increased  risk  through  lifestyle 
changes and may also help direct the development of drugs to prevent and 
treat diabetes in groups at increased risk of the disease.  
 
 
What if something goes wrong? 
The  chance  of  something  going  wrong  is  extremely  small.    All  of  the 
procedures  involved  in  this study  are  low  risk  and our screening  tests are 
designed to ensure that you will only participate if it is safe for you to do so. In 
the unlikely event that you are harmed due to someone's negligence, then you 
may  have  grounds  for  a  legal  action  but  you  may  have  to  pay  for  it.  
Regardless of this, if you wish to complain, or have any concerns about any 
aspect of the way you have been approached or treated during the course of 
this study, the normal National Health Service complaints mechanisms may 
be available to you. 
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Will my taking part in this study be kept confidential and who will have 
access to my personal information? 
All information which is collected about you during the course of the research 
will be kept strictly confidential.  Any information about you which leaves the 
University will be anonymised (i.e. will have your name and address removed 
so that you cannot be recognised from it and you will only be identified by a 
code number).  Anonymised information collected about you may be shared in 
future  with  other parties  including  researchers  working  on  behalf  of Wyeth 
Pharmaceuticals in the United States, the UK and in other countries.  None of 
your personal information  will be  shared  with  anybody  or any  organisation 
outside the University of Glasgow without your specific consent. 
   
What will happen to my samples after the study has finished? 
The blood and fat tissue samples that you provide for this study may be useful  
for future research into the prevention and treatment of diabetes and heart 
disease;  this  may  involve  analysis  of  certain  genes  associated  with  these 
diseases.  These samples may be shared in future with other parties including 
researchers working on behalf of Wyeth Pharmaceuticals in the United States, 
UK and in other countries.  Any use of your samples for future research will 
require further approval from a Research Ethics Committee and samples will 
be analysed in such a way that the results will not be directly traceable to you.  
If you do not wish your samples to be used for future research, please indicate 
this on the consent form. 
 
Who has reviewed the study? 
This study has been reviewed and approved by the North Glasgow NHS Trust 
Research Ethics Committee. 
 
 
Contact for Further Information 
You may ask any questions you like now or at any time about your rights as a 
participant in a research study or about the research study itself.  Dr Lesley 
Hall will be available to discuss these issues with you if you phone her on 
0141 330 6588 or or e-mail l.hall@bio.gla.ac.uk 
 
 
 
You will be given a copy of this information sheet and a signed consent 
form to keep for your records. 
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Appendix A2 
 
 
Volunteer Identification Number for this trial: 
 
CONSENT FORM 
 
Title of Project: Insulin resistance in South Asians: role of skeletal muscle and adipose 
tissue function.  
 
 
 Name of Researcher:_______________________________ 
Please initial box 
 
1.  I confirm that I have read and understand the 
information sheet dated 14
th June 2007 (version 3) 
for the above study and  
  have had the opportunity to ask questions. 
 
2.  I understand that my participation is voluntary and that I am free to      
  withdraw at any time, without giving any reason, without my medical  
  care or legal rights being affected. 
 
3.  I agree to take part in the above study.   
 
 
 
4.  I agree for my samples to be used for future research 
into the prevention and treatment of diabetes and heart 
disease.  This may involve analysis of genes associated 
with these diseases. 
 
 
 
 
           
                     
Name of Volunteer  Date  Signature 
 
       
Name of Person taking consent  Date  Signature 
(if different from researcher) 
 
Yes  
No   183 
     
Researcher  Date  Signature 
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Appendix A3 
 
HEALTH SCREEN FOR STUDY VOLUNTEERS 
 
 
Name: ………………………………………………………. 
 
It is important that volunteers participating in research studies are currently in good health and 
have  had  no  significant  medical  problems  in  the  past.    This  is  to  ensure  (i)  their  own 
continuing well-being and (ii) to avoid the possibility of individual health issues confounding 
study outcomes. 
 
Please complete this brief questionnaire to confirm fitness to participate: 
 
At present, do you have any health problem for which you are: 
(a)  on medication, prescribed or otherwise      yes [  ]  no [  ] 
(b) attending your general practitioner       yes [  ]  no [  ] 
(c)  on a hospital waiting list        yes [  ]  no [  ] 
In the past two years, have you had any illness which required you to: 
(a)  consult your GP            yes [  ]  no [  ] 
(b) attend a hospital outpatient department      yes [  ]  no [  ] 
(c)  be admitted to hospital          yes [  ]  no [  ] 
 
Have you ever had any of the following: 
(a)  Convulsions/epilepsy          yes [  ]  no [  ] 
(b)  Asthma             yes [  ]  no [  ] 
(c)  Eczema             yes [  ]  no [  ] 
(d)  Diabetes            yes [  ]  no [  ] 
(e)  A blood disorder          yes [  ]  no [  ] 
(f)  Head injury            yes [  ]  no [  ] 
(g)  Digestive problems          yes [  ]  no [  ] 
(h)  Hearing problems          yes [  ]  no [  ] 
(i)  Problems with bones or joints        yes [  ]  no [  ] 
(j)  Disturbance of balance/co-ordination      yes [  ]  no [  ] 
(k)  Numbness in hands or feet        yes [  ]  no [  ] 
(l)  Disturbance of vision          yes [  ]  no [  ] 
(m) Thyroid problems          yes [  ]  no [  ] 
(n)  Kidney or liver problems        yes [  ]  no [  ] 
(o)  Chest pain or heart problems        yes [  ]  no [  ] 
(p)  Any other health problems        yes [  ]  no [  ] 
 
4.   Have any of your family (parents, grandparents, brothers, sisters, children, aunts, uncles, 
cousins) ever had any of the following: (if yes please give details including age of first 
diagnosis) 
(a)  Any heart problems          yes [  ]  no [  ] 
(b)  Diabetes            yes [  ]  no [  ] 
(c)  Stroke              yes [  ]  no [  ] 
(d)  Any other family illnesses        yes [  ]  no [  ] 
7.     Do you currently smoke          yes [  ]  no [  ] 
  Have you ever smoked          yes [  ]  no [  ]   185 
   
  If so, for how long did you smoke and when did you stop? …………………… 
 
8.  How many units of alcohol do you typically drink in a week? …………………. 
 
9.  What is your mother‟s country of origin?............................................................... 
 
10.  What is your father‟s country of origin?................................................................. 
 
If YES to any question, please describe briefly if you wish (e.g. to confirm whether 
problem  was  short-lived,  insignificant  or  well  controlled.)  (Use  a  separate  sheet  if 
necessary) 
…………………………………………………………………………………………………
……………… 
…………………………………………………………………………………………………
………………….….……………………………………………………………………………
…………………………………………………………………………………………………
……………………………………………………..……………………………………………
……………… 
 
Name and address of GP 
………………………………………………………………………………… 
         
………………………………………………………………………………… 
         
…………………………………………………………………………………   
 
Blood pressure measured at screening…………………..mm Hg  
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Appendix A4 
 
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
(October 2002) 
 
LONG LAST 7 DAYS SELF-ADMINISTERED FORMAT 
 
 
FOR USE WITH YOUNG AND MIDDLE-AGED ADULTS (15-69 years) 
 
The International Physical Activity Questionnaires (IPAQ) comprises a set of 4 
questionnaires. Long (5 activity domains asked independently) and short (4 generic items) 
versions for use by either telephone or self-administered methods are available. The 
purpose of the questionnaires is to provide common instruments that can be used to obtain 
internationally comparable data on health–related physical activity. 
 
Background on IPAQ 
The development of an international measure for physical activity commenced in Geneva in 
1998 and was followed by extensive reliability and validity testing undertaken across 12 
countries (14 sites) during 2000. The final results suggest that these measures have 
acceptable measurement properties for use in many settings and in different languages, and 
are suitable for national population-based prevalence studies of participation in physical 
activity. 
 
Using IPAQ  
Use of the IPAQ instruments for monitoring and research purposes is encouraged. It is 
recommended that no changes be made to the order or wording of the questions as this will 
affect the psychometric properties of the instruments.  
 
Translation from English and Cultural Adaptation 
Translation from English is encouraged to facilitate worldwide use of IPAQ. Information on 
the availability of IPAQ in different languages can be obtained at www.ipaq.ki.se. If a new 
translation is undertaken we highly recommend using the prescribed back translation 
methods available on the IPAQ website. If possible please consider making your translated 
version of IPAQ available to others by contributing it to the IPAQ website. Further details on 
translation and cultural adaptation can be downloaded from the website. 
 
Further Developments of IPAQ  
International collaboration on IPAQ is on-going and an International Physical Activity 
Prevalence Study is in progress. For further information see the IPAQ website.  
 
More Information 
More detailed information on the IPAQ process and the research methods used in the 
development of IPAQ instruments is available at www.ipaq.ki.se and Booth, M.L. (2000). 
Assessment of Physical Activity: An International Perspective. Research Quarterly for 
Exercise and Sport, 71 (2): s114-20. Other scientific publications and presentations on the 
use of IPAQ are summarized on the website.   187 
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
 
We are interested in finding out about the kinds of physical activities that people do as part 
of their everyday lives. The questions will ask you about the time you spent being physically 
active in the last 7 days. Please answer each question even if you do not consider yourself 
to be an active person. Please think about the activities you do at work, as part of your 
house and yard work, to get from place to place, and in your spare time for recreation, 
exercise or sport. 
 
Think about all the vigorous and moderate activities that you did in the last 7 days. 
Vigorous physical activities refer to activities that take hard physical effort and make you 
breathe much harder than normal. Moderate activities refer to activities that take moderate 
physical effort and make you breathe somewhat harder than normal. 
 
PART 1: JOB-RELATED PHYSICAL ACTIVITY 
 
The first section is about your work. This includes paid jobs, farming, volunteer work, course 
work, and any other unpaid work that you did outside your home. Do not include unpaid work 
you might do around your home, like housework, yard work, general maintenance, and 
caring for your family. These are asked in Part 3. 
 
1.  Do you currently have a job or do any unpaid work outside your home? 
 
    Yes 
 
  No  Skip to PART 2: TRANSPORTATION 
 
The next questions are about all the physical activity you did in the last 7 days as part of 
your paid or unpaid work. This does not include traveling to and from work. 
 
2.  During the last 7 days, on how many days did you do vigorous physical activities 
like heavy lifting, digging, heavy construction, or climbing up stairs as part of your 
work? Think about only those physical activities that you did for at least 10 minutes 
at a time. 
 
_____  days per week 
 
  No vigorous job-related physical activity  Skip to question 4 
 
3.  How much time did you usually spend on one of those days doing vigorous physical 
activities as part of your work? 
 
  _____  hours per day 
  _____  minutes per day 
 
4.  Again, think about only those physical activities that you did for at least 10 minutes at 
a time. During the last 7 days, on how many days did you do moderate physical 
activities like carrying light loads as part of your work? Please do not include 
walking. 
 
_____  days per week 
 
  No moderate job-related physical activity  Skip to question 6   188 
5.  How much time did you usually spend on one of those days doing moderate physical 
activities as part of your work? 
 
  _____  hours per day 
  _____  minutes per day 
 
6.  During the last 7 days, on how many days did you walk for at least 10 minutes at a 
time as part of your work? Please do not count any walking you did to travel to or 
from work. 
 
  _____  days per week 
 
    No job-related walking  Skip to PART 2: TRANSPORTATION 
 
7.  How much time did you usually spend on one of those days walking as part of your 
work? 
 
  _____  hours per day 
  _____  minutes per day 
 
 
PART 2: TRANSPORTATION PHYSICAL ACTIVITY 
 
These questions are about how you traveled from place to place, including to places like 
work, stores, movies, and so on. 
 
8.  During the last 7 days, on how many days did you travel in a motor vehicle like a 
train, bus, car, or tram? 
 
  _____  days per week 
 
    No traveling in a motor vehicle  Skip to question 10 
 
9.  How much time did you usually spend on one of those days traveling in a train, bus, 
car, tram, or other kind of motor vehicle? 
 
  _____  hours per day 
  _____  minutes per day 
 
Now think only about the bicycling and walking you might have done to travel to and from 
work, to do errands, or to go from place to place. 
 
10.  During the last 7 days, on how many days did you bicycle for at least 10 minutes at 
a time to go from place to place? 
 
  _____  days per week 
 
    No bicycling from place to place  Skip to question 12   189 
11.  How much time did you usually spend on one of those days to bicycle from place to 
place? 
 
  _____  hours per day 
  _____  minutes per day 
 
12.  During the last 7 days, on how many days did you walk for at least 10 minutes at a 
time to go from place to place? 
 
  _____  days per week 
 
    No walking from place to place  Skip to PART 3: HOUSEWORK, 
    HOUSE MAINTENANCE, AND 
    CARING FOR FAMILY 
 
13.  How much time did you usually spend on one of those days walking from place to 
place? 
 
  _____  hours per day 
  _____  minutes per day 
 
 
PART 3: HOUSEWORK, HOUSE MAINTENANCE, AND CARING FOR FAMILY 
 
This section is about some of the physical activities you might have done in the last 7 days 
in and around your home, like housework, gardening, yard work, general maintenance work, 
and caring for your family. 
 
14.  Think about only those physical activities that you did for at least 10 minutes at a 
time. During the last 7 days, on how many days did you do vigorous physical 
activities like heavy lifting, chopping wood, shoveling snow, or digging in the garden 
or yard? 
 
  _____  days per week 
 
  No vigorous activity in garden or yard  Skip to question 16 
 
 
15.  How much time did you usually spend on one of those days doing vigorous physical 
activities in the garden or yard? 
 
  _____  hours per day 
  _____  minutes per day 
 
16.  Again, think about only those physical activities that you did for at least 10 minutes at 
a time. During the last 7 days, on how many days did you do moderate activities like 
carrying light loads, sweeping, washing windows, and raking in the garden or yard? 
 
  _____  days per week 
 
  No moderate activity in garden or yard  Skip to question 18   190 
17.  How much time did you usually spend on one of those days doing moderate physical 
activities in the garden or yard? 
 
  _____  hours per day 
  _____  minutes per day 
 
18.  Once again, think about only those physical activities that you did for at least 10 
minutes at a time. During the last 7 days, on how many days did you do moderate 
activities like carrying light loads, washing windows, scrubbing floors and sweeping 
inside your home? 
 
  _____  days per week 
 
    No moderate activity inside home  Skip to PART 4: RECREATION, 
      SPORT AND LEISURE-TIME 
      PHYSICAL ACTIVITY 
 
19.  How much time did you usually spend on one of those days doing moderate physical 
activities inside your home? 
 
  _____  hours per day 
  _____  minutes per day 
 
 
PART 4: RECREATION, SPORT, AND LEISURE-TIME PHYSICAL ACTIVITY 
 
This section is about all the physical activities that you did in the last 7 days solely for 
recreation, sport, exercise or leisure. Please do not include any activities you have already 
mentioned. 
 
20.  Not counting any walking you have already mentioned, during the last 7 days, on 
how many days did you walk for at least 10 minutes at a time in your leisure time? 
 
  _____  days per week 
 
  No walking in leisure time  Skip to question 22 
 
21.  How much time did you usually spend on one of those days walking in your leisure 
time? 
 
  _____  hours per day 
  _____  minutes per day 
 
22.  Think about only those physical activities that you did for at least 10 minutes at a 
time. During the last 7 days, on how many days did you do vigorous physical 
activities like aerobics, running, fast bicycling, or fast swimming in your leisure 
time? 
 
  _____  days per week 
 
  No vigorous activity in leisure time  Skip to question 24 
   191 
23.  How much time did you usually spend on one of those days doing vigorous physical 
activities in your leisure time? 
 
  _____  hours per day 
  _____  minutes per day 
 
24.  Again, think about only those physical activities that you did for at least 10 minutes at 
a time. During the last 7 days, on how many days did you do moderate physical 
activities like bicycling at a regular pace, swimming at a regular pace, and doubles 
tennis in your leisure time? 
 
  _____  days per week 
 
    No moderate activity in leisure time  Skip to PART 5: TIME SPENT 
      SITTING 
 
25.  How much time did you usually spend on one of those days doing moderate physical 
activities in your leisure time? 
  _____  hours per day 
  _____  minutes per day 
 
 
PART 5: TIME SPENT SITTING 
 
The last questions are about the time you spend sitting while at work, at home, while doing 
course work and during leisure time. This may include time spent sitting at a desk, visiting 
friends, reading or sitting or lying down to watch television. Do not include any time spent 
sitting in a motor vehicle that you have already told me about. 
 
26.  During the last 7 days, how much time did you usually spend sitting on a weekday? 
 
  _____  hours per day 
  _____  minutes per day 
 
27.  During the last 7 days, how much time did you usually spend sitting on a weekend 
day? 
 
  _____  hours per day 
  _____  minutes per day 
 
 
This is the end of the questionnaire, thank you for participating.   192 
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Appendix B1 – Method of analysis for insulin   
 
 
Reagents 
1 x 96 well coated plate 
Calibrators: 3, 10, 30, 100 and 200mU.l
-1 
Calibrator 0 
Enzyme conjugate 
Enzyme conjugate buffer 
Wash buffer 
Substrate TMB 
Stop solution 
 
Reagent preparation 
Wash buffer: the concentrated wash buffer was diluted with distilled water by the 
addition of 35 ml of buffer to 700 ml of distilled water. 
Enzyme conjugate: the enzyme conjugate was diluted with enzyme conjugate buffer 
by the addition of 1.0 ml of the enzyme conjugate to 10 ml of buffer. 
 
Procedure 
1.  25 µl aliquots of calibrators and plasma samples were added to the appropriate 
wells. 
2.  100 µl of enzyme conjugate was added to each well. 
3.  The plate was incubated for 1 hour at room temperature on a plate shaker. 
4.  The plate was washed using an automated plate washer, with 350 µl of wash 
buffer added to and then aspirated from each well a total of six times. 
5.  200 µl TMB was added to each well before being incunated in the dark at 
room temperature for 15 minutes 
6.  50 µl stop solution was added to each well and the plate lightly shaken for 5 
seconds 
7.  The plate was read at an optical density of 450 nm. 
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Appendix B2 - Method of analysis for glucose 
 
 
Principle of method 
 
HK 
Glucose + ATP                 glucose-6-phosphate + ADP 
 
      G-6-PDH 
Glucose-6-phosphatase + NADP
+   gluconate-6-phosphatase 
+ NADPH + H
+ 
 
 
Reagents 
R1: Buffer / coenzymes 
R2: Dilutent 
2. Reagent 
 
Reagent preparation 
Reagent was added to R2  
 
Procedure 
Plasma glucose concentrations were determined by the author and colleagues at the 
faculty of biomedical and life sciences at University of Glasgow.  The procedure for 
this analysis is property of the faculty. 
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Appendix B3 - Method of analysis for NEFA 
 
 
Principle of method 
 
     ACS 
RCOOH (NEFA) + ATP + CoA-SH      Acyl-Co-A + AMP + PPi  
 
 
ACOD 
Acyl-CoA + O2      2,3-trans-Enoyl-CoA + H2O2 
 
 
        POD 
2 H2O2  + 4-Aminophenazone + MEHA     Quinonelmine-colour + 4 H2O 
 
 
Reagents 
R1: Solvent A 
R1a: Colour reagent A 
R2: Solvent B 
R2a: Colour reagent B 
CAL: NEFA C standard 
 
Reagent preparation 
Colour reagent solution A: The contents of R1a were dissolved with 10 ml of R1 and 
mixed well 
Colour reagent solution B: The contents of R2a were dissolved with 20 ml of R2 and 
mixed well 
 
Procedure 
Plasma NEFA concentrations were determined by the author and colleagues at the 
faculty of biomedical and life sciences at University of Glasgow.  The procedure for 
this analysis is property of the faculty. 
 
 
 
 
 
 
   202 
Appendix B4 - Method of analysis for triglyceride 
 
 
Principle of method 
A lipoprotein lipase derived from micro-organism is used to rapidly and completely 
hydrolyse TG to glycerol.  Glycerol is then oxidised to dihydroxyacetone phosphate 
(DHAP) and hydrogen peroxide.  Subsequently, hydrogen peroxide reacts with 4-
aminophenazone and 4-chlorophenal under the catalytic action of peroxidise to form a 
red dyestuff. 
 
        LPL 
TG + 3 H2O      glycerol + 3 RCOOH 
 
GK 
Glycerol + ATP      glycerol-3-phosphate + ADP 
Mg
2+ 
 
      GPO 
Glycerol-3-phosphate + O2      DHAP + H2O2 
 
   Peroxidase 
H2O2 + 4-aminophenazone + 4-cholrophenol  4-(p-benzoquinone-
monoimino)-phenazone + 
2 H2O + HCl 
 
 
Reagents 
R1 Buffer / 4-chlorophenol / enzymes 
Calibrator S1: 0.9% NaCl 
Calibrator S2 
Quality control sera 
 
Procedure  
Plasma TG concentrations were determined by the author and colleagues at the 
faculty of biomedical and life sciences at University of Glasgow.  The procedure for 
this analysis is property of the faculty. 
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Appendix B5 - Method of analysis for lactic acid 
 
 
Principle of method 
Lactic acid concentration was measured according to the method of Maughan[306], 
which depends on the use of fluorimetry to determine the concentration of the reduced 
co-enzyme NADH.  The analysis depends on the interconversion of lactate linked to a 
change in the oxidation state of NAD
+ , as demonstrated by the reactions: 
 
LDH     
L-lactate + NAD
+           pyruvate + NADH + H
+   
 
 
   HBDH 
D-3-OH butyrate + NAD
+                         acetoacetate + NADH + H
+ 
 
ADH 
L-alanine + NAD
+ + H
2O        
    pyruvate + NADH + NH4
+ 
 
 
Reagents 
1 x 96 well coated plate 
Hydrazine (1.1 moll
-1, pH 9.0)  
NAD (5 mmoll
-1)  
LDH (2.75 Units/ ml) 
 
Procedure 
1.  Capillary blood was collected, dispensed into perchloric acid, centrifuged, 
separated and stored as described in chapter 2.   
2.  All samples were defrosted at room temperature. 
3.  20 µl of calibrators with know lactate concentrations (1,2,3 and 5 mmoll
-1) and 
a quality control sample (8 mmoll
-1) were each added to 200 μl of 0.4 moll
-1 
perchloric acid. 
4.  20 µl aliquots of calibrators and samples were added to the appropriate wells. 
5.  200 µl of reagent was added to each well 
6.  The plate was read at an optical density of 325 nm, λex 420 by a microplate 
fluorometer (Fluoroskan Ascent, Thermo Fisher scientific, Waltham, 
Massachussets, USA).     204 
Appendix B6 - Method of analysis for leptin 
 
 
Principle of method 
A fixed concentration of a labelled tracer is incubated with a constant dilution of 
antiserum.  In this situation, the concentration of antigen binding sites is limited.  The 
addition of unlabelled antigen introduces competition between the labelled tracer and 
unlabelled antigen for the limited number of abntibody binding sites.  Therefore, as 
the concentration of unlabelled antigen increases, the amount of tracer attached to the 
antibody will decrease.  This process is measured by separating the bound antibody 
from the free tracer and counting either if both of the fractions.  
 
Reagents and procedure 
1.  Radioiodinated leptin was prepared using a solid phase lactoperoxidase 
procedure 
2.  Leptin was purified by Sephadex G-25 gel filtration followed by G-50 using 
0.1 mol.l
-1 phosphate, 7.7 mmol sodium azide.l
-1, BSA and 0.5 ml.l
-1 Triton X-
100 elution buffer 
3.  0.1 ml of test plasma was incubated with the leptin standard, 0.1ml donkey 
serum, 0.1 ml assay buffer, sheep antileptin antiserum and 125I-labelled leptin 
at 4
oC for 16 hours. 
4.   Sepharose-donkey antisheep globulin was added after incubation and the 
samples were then re-incubated for one hour at room temperature. 
5.  The free and bound fractions were separated by centrifugation using 3 ml 
washes with 0.15 mmol.l
-1 sodium chloride containing Tween 20.  
6.  The bound fraction was counted for 60 seconds on a multichannel counter. 
 
 
 
 
 
 
 
 
 
 
 